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- J. R. R. Tolkien 1955 
 
 
“I’ve seen things you people wouldn’t believe. 
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All those moments will be lost in time, like tears in rain. 
Time to die” 
- Roy Batty 1982 
 
 
“Honesty is my only excuse.” 
- James Hetfield 1986 
 
 
 “I’m digging my way to something better.” 
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Three simple protocols for the determination of the enantiomeric excess of chiral 
amines, hydroxylamines and diols have been developed utilising boronic acid 
templates. In Chapter 1 some of the existing methods for determining the 
enantiomeric excess of chiral substrates have been reviewed including the use of 
chiral solvating agents, chiral derivatization agents, chiral gas chromatography, 
chiral HPLC, circular dichroism, UV-visible spectroscopy and fluorescence 
spectroscopy. 
In Chapter 2 the previous work by the Bull-James group is discussed along with the 
cited uses of our three-component derivatization protocols for determining the 
enantiomeric excess of chiral amines and diols. The syntheses of a range of α-




In Chapter 3 the first reported chiral derivatization protocol for determining the 





developed by formation of nitrono-boronate ester complexes whose structures have 
been confirmed by X-ray crystallography. A range of chiral hydroxylamines have 
been prepared and the mechanism for the conversion of a chiral amine to its 
corresponding hydroxylamine has been proposed by analysis of the side product 
formed during the final reaction step converting an oxaziridine to the desired 
hydroxylamine. 
In Chapter 4 the Horeau Principle is discussed and its applications in the literature 
reviewed. A new derivatization protocol based on this principle has been developed 
employing an achiral boronic acid template to form diastereomeric dimeric boronate 
complexes by its reaction with two equivalents of a chiral diol. The scope and 
limitations of this protocol have been determined and molecular modelling has been 
used to explain the differences in diastereomeric resonances observed for the 
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1 Methods for the Determination of Enantiomeric Excess: A 
Review of the Literature 
1.1 Introduction 
Chirality is prevalent throughout chemistry and biology and compounds can be 
synthesised in an enantiomerically enhanced or pure form by a range of methods 









 and chiral pool synthesis.
10
 Nature itself makes and 
employs chiral compounds, for example for the biosynthesis of proteins using chiral 
amino acids. 
A chiral molecule is one which is non-superimposable upon its mirror image. Each 
of the enantiomers of a chiral compound has identical physical, chemical and 
spectroscopic properties when in an achiral environment, but often behave 
differently when in a chiral environment. Biologically active molecules such as 
proteins and sugars are chiral polymers built from a series of chiral building blocks. 
As a result, enantiomers of chiral compounds can have drastically differing 
biological activity, with the case of thalidomide perhaps being the most famous of 
examples.
11
 As a result of this, chiral drugs are now required to ideally be 
administered in an enantiomerically pure form and there is therefore a high demand 
for asymmetric methodologies and for techniques of rapidly determining the 
enantiopurity and absolute configuration of chiral compounds.
12
 
There are a number of different types of chirality with point chirality being the most 
common. Molecules with point chirality normally have one or more stereogenic 
carbon centres which are attached to four different substituents. The absolute 
configuration of a point chiral centre is determined by using the Cahn-Ingold-Prelog 
rules and given a stereodescriptor based on the priorities of atoms about the centre 
assigned according to atomic number.
13
 When a viewpoint is taken where the lowest 
priority group is directed away from the viewer then, a priority which rotates to the 
right is denoted as rectus (R), with its opposite enantiomer denoted as sinister (S) 
(Figure 1). 






Figure 1 - Assignment of absolute configuration according to the Cahn-Ingold-Prelog rules 
 
Molecules without stereogenic centres can also be chiral in special cases due to axial 
chirality. Axial chirality is commonly observed in allenes and biaryl systems such as 
BINOL. Due to the orbital alignment of their π-bonds, the terminal substituents of 
allenes containing even numbers of connected double bonds are held at 90° to each 
other and can be viewed down its axis as a pseudo tetrahedron (Figure 2). Since 
these compounds can be viewed as pseudo tetrahedral structures their 
stereochemistry can also be assigned by application of the Cahn-Ingold-Prelog rules. 
 
 
Figure 2 - Chiral allene viewed as a pseudo tetrahedron 
 
Biaryl structures such as BINOL also possess axial chirality which arises from 
hindered rotation about the bond connecting the two ring systems. Due to the locked 
geometry about this axis, the two mirror images of the molecule are not 
superimposable and the molecule is therefore chiral. Its stereochemistry can be 
assigned by viewing the molecule along this chiral axis and assigning priority to the 




substituents connected to either end of the axis. In this case, the priority of the 
nearest groups are assigned first, with its absolute configuration once again assigned 
based on the direction in which the priories rotate (Figure 3). 
 
 
Figure 3 - Assignment of the chirality of (S)-BINOL 
 
Amines and phosphines with three different substituents become chiral due to their 
lone pair acting as a fourth substituent. However, amines exhibit no optical activity 
as the lone pair of amines invert too rapidly to make either enantiomer isolable 
unless the nitrogen atom is part of a rigid cyclic molecule. The energy of inversion 
of phosphines and their oxides is very high, making their enantiomers isolable. 




Figure 4 - Chirality at nitrogen, phosphorus and sulphur 
 
The ability to discern the chirality and enantiopurity of a compound is important to 
the modern synthetic chemist. Chemists have a constant need to measure 
enantiopurity for such purposes as determining the effectiveness of a chiral 






 or when screening large numbers of asymmetric catalysts.
15
 Techniques 





 and spectroscopic analysis
15,19
 and NMR 
spectroscopy
20,21
 are therefore highly desired. This thesis deals with the 
development of new NMR spectroscopic methods to determine the enantiomeric 
excess of chiral amines, hydroxylamines and diols. Consequently, the remainder of 
this chapter will highlight some of the major methods employed for determining the 
enantiomeric excess of chiral compounds. 
 
1.2 Methods for the Determination of Enantiomeric Excess 
1.2.1 Chiral Solvating Agents 
Chiral solvating agents form in situ, diastereomeric complexes with chiral 
substrates. These complexes are transient in nature unlike the long-lived covalent 
complexes formed with Chiral Derivatization Agents (CDAs). 
In 1966, Pirkle reported the first use of a chiral solvating agent to determine the 
enantiomeric excess of a chiral alcohol.
22
 It was discovered that enantiomerically 
pure α-methylbenzylamine 1 formed reversible diastereomeric complexes 3a and 3b 
with (rac)-2,2,2-trifluoro-1-phenylethanol 2 through hydrogen bonding interactions 
between the amine group of the α-methylbenzylamine and the hydroxyl proton of 
the alcohol (Scheme 1). Inspection of the 
19
F NMR spectrum of a mixture of α-
methylbenzylamine 1 and (rac)-2,2,2-trifluoro-1-phenylethanol 2 also showed 
distinct diastereomeric resonances for the fluorine atoms of the CF3 group. 
 





Scheme 1 – The first reported chiral solvating agent for alcohols reported by Pirkle 
 
A further publication by Pirkle et al. demonstrated how enantiodiscrimination could 
also be performed using 
1
H NMR spectroscopy by using 1-(1-naphthyl)-ethylamine 
4 as a chiral solvating agent (Scheme 2). In this case, baseline separated methyl 
resonances for the diastereomeric iso-propyl groups were observed in the 
1
H NMR 
spectrum of the resultant mixture of diastereomeric complexes 5a and 5b. 
 
 
Scheme 2 - 1-(1-Naphthyl)-ethylamine 4 used as a 
1
H NMR chiral solvating agent 
 
For the enantiomeric discrimination of chiral amines, crown ethers are often used as 
chiral solvating agents. In particular, 18-crown-6 type ethers have the correct 
geometry to associate with protonated primary amines as the oxygen atoms in the 
crown ether can form hydrogen bonds with the ammonium protons. Wenzel et al. 




have reported how (18-crown-6)-2,3,11,12-tetracarboxylic acid is a useful agent for 
the discrimination of secondary chiral amines.
23
 Wenzel proposed that secondary 
amines protonated by one of the carboxylic acid groups on crown ether 6 would 
hydrogen bond with two of the ether oxygens in the ring structure, thus forming an 
ionic interaction between the ammonium nitrogen and the deprotonated carboxylic 
acid (Figure 5). 
 
 
Figure 5 – Complexation between (18-crown-6)-2,3,11,12-tetracarboxylic acid and a chiral 
secondary amine 
 
For the case of the addition of the crown ether to (rac)-N-methyl-α-
methylbenzylamine, the 
1
H NMR spectrum of the resultant mixture of 
diastereomeric complexes showed pairs of resonances for the diastereomeric N-
methyl and C-methyl moieties of N-methyl-α-methylbenzylamine. Scalemic 
sampling (enrichment of one enantiomer over the other) proved that these pairs of 
resonances were due to enantiodiscrimination rather than solvent effects. Wenzel 
also noted that it was possible to increase baseline separation of these signals by 
addition of further amounts of crown ether up to a 2:1 ratio of crown 
ether:secondary amine. This method was shown to be effective for the 
enantiodiscrimination of a range of chiral secondary amines, with further 






Pérez-Trujillo et al. have reported the use of chiral solvating agents to determine the 
enantiomeric excess of a number of pharmaceutical compounds.
26
 Two anthracene 




based compounds 7 and 8 were shown to form diastereomeric complexes with the 
pharmaceuticals carvedilol 9, fluoxetine 10, and N-methyl-3-phenyl-3-(4-
(trifluoromethyl)phenoxy)propan-1-amine 11 which were readily distinguishable by 
1
H NMR spectroscopy (Figure 6). 
 
 
Figure 6 – Chiral anthracene solvating agents 7 and 8 used to determine the enantiopurity of 
the pharmaceuticals carvedilol 9, fluoxetine 10 and N-methyl-3-phenyl-3-(4-
(trifluoromethyl)phenoxy)propan-1-amine 11 
 
Upon mixing of CSA 7 with carvedilol 9, the resultant 
1
H NMR spectrum showed 
very good degrees of signal splitting for the methoxy protons of the carvedilol, with 
accurate integrations of diastereomeric protons easily obtainable. Similar results 
were obtained for the mixture of CSA 8 with 11 and it was noted that baseline 
separation of the C-methyl resonance was further improved by addition of up to 2.5 
equivalents of 8. Finally, the (S,S)-analogue of CSA 7 was shown to be effective for 
determining the enantiomeric excess of fluoxetine 10. 
Kawęcki et al. have reported the use of BINOL as a chiral solvating agent for 
sulfinimines.
27
 Substituted t-butyl and p-tolylsulfinyl derivatives of sulfinimines 
were mixed with varying amounts of (S)-BINOL 12 in CDCl3 (Scheme 3) and a pair 




of baseline resolved signals for the imine proton were seen when racemic 
sulfinimine was employed. 
  
 
Scheme 3 - Use of BINOL 12 as a chiral solvating agent for sulfinimines 
 
In all cases, it was reported that an increase in the amount of (S)-BINOL added 
above a 1:1 molar ratio increased the separation between the pair of diastereomeric 
imine resonances, with up to 10.5 equivalents of (S)-BINOL being needed to 
achieve maximum separation. However, additions of large amounts of chiral 
solvating agent were shown to, on occasion, cause line broadening in the 
1
H NMR 
spectra. This problem could be resolved by using C6D6 as solvent, which in some 
cases, produced Δδ (the difference in ppm between the shifts of two diastereomeric 
protons in the 
1
H NMR spectrum) values twice those observed in CDCl3. In all 
cases, the diastereomeric imine protons were sufficiently well resolved to provide 
integration accurate enough to determine enantiomeric excess to within 1% of true 
values. It was noted that the sulfinimine resonance was an excellent diagnostic tool 
since it was always a singlet, and so baseline separation could be achieved at smaller 
Δδ values than for broader multiplet resonances which can potentially overlap. 
Jolly et al. have published an extensive study into the use of mandelic acid 13 as a 
chiral solvating agent for the determination of the enantiomeric excess and absolute 
configuration of chiral cyanohydrins 14.
28
 It was reported that it was possible to 
determine the enantiomeric excess for both aldocyanohydrins and ketocyanohydrins 










Scheme 4 - Formation of diastereomeric complexes for determining the enantiomeric excess of 
cyanohydrins 
 
For aldocyanohydrins the α-proton was found to be diagnostic since, in all cases, a 
pair of baseline resolved resonances were seen for each diastereomer in the 
1
H NMR 
spectra of the resultant mixtures. These resonances were sufficiently separated so 
that no problems were encountered when the resonance for the α-proton was a 
multiplet rather than a simple singlet, and thus accurate integration was possible to 
determine the enantiomeric excess for all aldocyanohydrins. For the case of 
ketocyanohydrins, where no α-proton is present, other protons in the complexes 
were used to determine enantiomeric excess, with the presence of α-methyl protons 
in the chiral analyte being particularly diagnostic. Conversely, it was later 
discovered by Jolly et al. that a chiral cyanohydrin, such as 4-




In 2011, Sirit et al. reported four phthalimide based chiral solvating agents 15-18 for 
determining the enantiomeric excess of chiral carboxylic acids (Figure 7).
30
 





Figure 7 – Phthalimide based chiral solvating agents for determining the enantiomeric excess of 
carboxylic acids 
 
The four chiral solvating agents 15-18 were prepared from (R)-N-(2,3-
epoxypropyl)phthalimide and the appropriate chiral amine or amino alcohol. They 
were then mixed with a number of chiral carboxylic acids in CDCl3 and the 
1
H 
NMR spectra obtained. These spectra showed that, for all solvating agents, splitting 
was seen for a number of resonances of the carboxylic acid. In particular, a pair of 
diastereomeric resonances were observed for the methine proton of mandelic acid, 
which were baseline separated enough that they could be accurately integrated in 
order to determine enantiomeric excess. However, this approach only resulted in 
small separations for the resonances of diastereomeric protons of certain types of 
carboxylic acid. Solvating agents 15 and 17 showed the largest chemical shift 
differences between diastereomeric protons for 2-chloromandelic acid of varying 
enantiomeric excess. Integration of the diastereomeric methine resonances in the 
1
H 
NMR spectra showed that enantiomeric excess could be determined to within 1% of 
the true value. However, this required that diastereomeric proton resonances were 
sufficiently baseline separated, which was not the case for all carboxylic acids 
investigated. 
 





Figure 8 – The range of chiral carboxylic acids resolved by macrocycles 15 and 17 
 
Two further chiral solvating agents for the enantiopurity determination of carboxylic 




H NMR spectra of a range of 
carboxylic acids and N-protected amino acids were obtained after mixing them with 
one equivalent of macrocycle 19 or 20 (Figure 9), with pairs of baseline resolved 
peaks corresponding to each of the diastereomeric complexes being observed in the 
1
H NMR spectrum. 
 
 
Figure 9 – Macrocycles 19 and 20 employed by Ai to determine the enantiomeric excess of 
chiral carboxylic acids and amino acids 
 
In the majority of cases the α-proton was the most useful diagnostic resonance in the 
1
H NMR spectra with macrocycle 19 proving to be the most effect chiral solvating 
agent, affording resolved resonances for almost every chiral compound investigated. 
Scalemic sampling demonstrated that the use of both these macrocycles for 




determining the enantiopurity of chiral carboxylic acids and N-protected amino 
acids produced accurate results within 2% of known e.e. values. 
Recently, Suryaprakash et al. have demonstrated a method for determining the 
enantiomeric excess of chiral amines and amino alcohols by formation of a complex 
between a boronic ester and a chiral substrate.
32
 It was reported that mixing 
triphenylborate 21 and a chiral amine for 45 seconds followed by addition of (R)-
BINOL 12 led to formation of an N-B complex between a boronate ester and the 
chiral amine (Scheme 5). 
 
 
Scheme 5 – The use of a BINOL based chiral solvating agent for determining the enantiomeric 
excess of chiral amines 
 
A range of chiral primary, secondary, tertiary amines and amino alcohols could be 
discriminated upon complexation by 
1
H NMR spectroscopy. At least two 
diastereomeric pairs of proton resonances could be used to determine enantiomeric 
excess for each chiral substrate with enantiomeric excess calculated to within 2% of 
the known values of starting substrate. 
Suryaprakash et al. then turned their attention to determining the true structure of 
the complexes formed in this method.
33
 DFT calculations and analysis of the 
11
B 
NMR spectrum for the complex formed between triphenylborate 21, (R)-BINOL 12 
and α-methylbenzylamine 1 led to the suggestion that the structure was not in fact 




the N-B complex suggested previously (Scheme 5), but an ion pair complex formed 
between a boronate anion and an ammonium cation (Scheme 6). 
 
 
Scheme 6 – Chiral salt formation that enables the enantiomeric excess of chiral amines to be 
determined 
 
BINOL has also been recently reported to be a useful chiral solvating agent for 
determining the enantiomeric excess of crispine A 22 (Figure 10) and related amines 





Figure 10 – Structure of (rac)-crispine A 22 
 
It was found that a mixture of five equivalents of (R)- or (S)-BINOL with racemic 
crispine A 22 in CDCl3 led to differing signals in the 
1
H NMR spectrum for each of 
the transient diastereomeric complexes formed in the mixture. The aryl and methoxy 
protons of crispine proved particularly useful for enantiopurity determination as 
their resonances were completely baseline resolved. It was also discovered that 




using C6D6 as solvent provided a larger chemical shift difference between the pairs 
of methoxy proton resonances than when CDCl3 was employed. 
Chiral solvating agents are a convenient tool with which to determine the 
enantiomeric excess of chiral substrates. They are experimentally simple to use, 
reactions can be performed in an NMR tube and no problems arising from kinetic 
resolution and racemisation occur. However, the chemical shift differences seen in 
the NMR spectra obtained from these experiments can often be very small, making 
accurate integration problematic at times. It has been shown that chemical shift 
differences can be improved by addition of excess amounts of chiral solvating 
agents; however, this can be a disadvantage if the chiral solvating agent is 
expensive, or has limited solubility. 
1.2.2 Chiral Derivatization Agents 
Chiral derivatization agents are chiral auxiliaries that form long-lived diastereomeric 
covalent complexes after reaction with a chiral substrate. This method of 
stereodiscrimination exploits the fact that, whereas the chemical shifts of 
enantiomeric protons in NMR spectra are the same, the chemical shifts of 
diastereomeric protons are often different. A significant advantage of chiral 
derivatization agents is that generally, the chemical shift differences observed are 
far greater than those observed using chiral solvating agents.  
However, it is necessary to use an enantiomerically pure derivatizing agent, or 
inaccurate enantiomeric excesses may be calculated. Kinetic resolution can also 
cause problems as the process relies on statistical formation of diastereomeric 
complexes based on the enantiomeric excess of the chiral substrate. If kinetic 
resolution occurs and one diastereomer is formed preferentially over another then an 
inaccurate value for enantiomeric excess will be calculated. 
The first chiral derivatization agent for NMR spectroscopic analysis was published 
by Raban in 1965 through reaction of 1-(o-fluorophenyl)-ethanol 23 and 2-
phenylpropanoyl chloride 24 (Scheme 7).
35
 





Scheme 7 – Raban’s chiral derivatization agent for alcohols, first published in 1965 
 
Upon inspection of the 
1
H NMR spectrum of the diastereomeric mixture formed in 
the reaction, Raban noted that the methyl resonances for each diastereomer were 
resolved and accurate integration was able to determine the diastereomeric ratio 
(d.r.) of compound 25 as 68:32. This was confirmed to be in excellent agreement 
with the value of 67:33 obtained from analysis via gas chromatography. Raban also 
postulated that the use of 
19
F NMR spectroscopy would be effective for determining 
the enantiomeric excess of amino acids by derivatization with chiral N-trifluoroacyl 
transfer reagents. 
Some of the most commonly employed chiral derivatization agents are those 
reported by Mosher and Trost. In 1969, Mosher first reported the use of α-methoxy-
α-trifluoromethylphenylacetic acid (Mosher’s acid) chloride 26 as a chiral 
derivatization agent for determining the enantiomeric excess of alcohols and amines 
using 
1









Scheme 8 – Mosher’s acid 26 as a chiral derivatization agent for alcohols and amines 
 
During initial studies, Mosher’s method was shown to determine enantiomeric 
excess within 1% of known values for a range of secondary alcohols and amines. 
Mosher’s acid proved to be a more successful chiral derivatization agent than the 
previously reported α-methoxyphenylacetic acid 27, which was found to undergo 
racemisation by exchange of its relatively acidic α-proton during derivatization of 
sterically hindered alcohols.
36
 Mosher’s acid contains no such α-proton and is 
therefore unable to undergo racemisation via this enolisation mechanism. The work 
of Riguera would then show conformational analysis of the ester and amide 
derivatives formed and rationalise the diastereomeric resonances seen in the 
1
H 
NMR spectra of derivatized substrates. 
Since its initial publication this approach has proven to be particularly popular for 
determining enantiomeric excess and a number of groups have used molecular 
modelling and NMR studies to show that both α-methoxyphenylacetic acid and 
Mosher’s acid ester and amide derivatives exist in solution as an interconverting 
mixture of syn-periplanar and anti-periplanar conformers in equilibrium, with each 
conformer exhibiting its own anisotropic shielding effects.
37
 Riguera reported that 
the phenyl groups of the lowest energy syn-periplanar conformers of α-
methoxyphenylacetic acid ester derivatives are orientated to maximise shielding 
effects, but that the anti-periplanar conformers are less populated and exhibit 
weaker shielding effects. As a result, Riguera suggested a simple empirical model to 
rationalise the chemical shift differences of diastereomeric α-methoxyphenylacetic 
acid ester derivatives that considers the shielding effects of the lowest energy syn-




periplanar conformer, and ignores contributions from the minor anti-periplanar 
conformers (Scheme 9). 
 
 
Scheme 9 - Newman projections of the syn- and anti-periplanar conformers of α-
methoxyphenylacetic acid 27 diastereomeric esters, red arrows denote shielding effects 
 
In this model, the R-substituent of the syn-periplanar diastereomeric ester conformer 
formed between (S)-α-methoxyphenylacetic acid 27a and a chiral alcohol is 
anisotropically shielded by the aromatic ring of the acid fragment. However, in the 
diastereomer incorporating (R)-α-methoxyphenylacetic acid 27b the phenyl group 
shields the R
1
-substituent and causes a relative shift of its resonance in the 
1
H NMR 
spectrum to a higher δ value. It was determined that decreasing the temperature of 
the NMR probe resulted in a shifting of the bias of equilibrium towards the more 
stable syn-periplanar conformer, thus increasing the diastereomeric shift difference 
in the 
1
H NMR spectrum. 
For the case of amide derivatives of α-methoxyphenylacetic acid 27, Riguera 
reported that the most stable conformer adopted an anti-periplanar configuration, 
resulting in a predictive model that is the reverse of that reported for chiral 
alcohols.
38
 The difference in conformation between amide and ester derivatives was 
proposed by Trost to be due to an intramolecular hydrogen bond between the amide 
proton and the methoxy group (Figure 11).
17
 





Figure 11 - Anti-periplanar conformers for amides of α-methoxyphenylacetic acid 27 formed 
due to intramolecular hydrogen bonding between the amide proton and methoxy group 
 
Similar conformational investigations have also been reported for Mosher’s acid to 
determine the enantiomeric excess of chiral amines by formation of amide 
derivatives.
36
 Mosher’s amide derivatives have been shown to exist as a mixture of 
three different conformers in solution. As has been reported for the derivatives of α-
methoxyphenylacetic acid and chiral alcohols, the phenyl groups of the lowest 
energy syn-periplanar conformers are in an orientation which maximises shielding 
effects, whilst the two less populated anti-periplanar conformers are in orientations 
with weaker shielding effects. For the lowest energy conformer, the R-substituent of 
the amide product is in a syn-periplanar conformation to the anisotropically 
shielding phenyl ring (Scheme 10). For the derivative employing the opposing 
enantiomer of the amine it is the R
1
-substituent that is anisotropically shielded by 












Scheme 10 - Conformational analysis of diastereomeric amide derivatives formed between 
Mosher's acid and a chiral amine 
 
The difference in these anisotropic effects and the resultant difference in chemical 
shifts of the two diastereomers formed make both α-methoxyphenylacetic acid and 
Mosher’s acid very useful reagents for determining the enantiomeric excess of chiral 
amines. It has also been reported that consideration of the sign of the Δδ values 
obtained can be used to predict the absolute configuration of a chiral amine by 
consideration of the conformational model described above.
40
 Derivatization of an 
enantiopure chiral amine of unknown configuration with both enantiomers of 
Mosher’s acid will result in a pair of diastereomers with differing anisotropic effects 
and therefore different chemical shifts for their R and R
1
 substituents. Derivatization 
of the amine with the (S)-enantiomer of Mosher’s acid will result in an upfield shift 
in the resonance for the R-substituent in the 
1
H NMR spectrum since it will be 
anisotropically shielded by the phenyl ring of the acid fragment. Conversely, 
derivatization of the amine with the (R)-enantiomer of Mosher’s acid will result in 
the resonance for the R
1
 substituent being shifted upfield due to anisotropic 
shielding by the aromatic ring. With this model in mind the sign of the Δδ value can 
then be used to predict the absolute configuration of the chiral amine. Models have 




Similar conformational models have also been developed by Riguera for the 
application of α-methoxyphenylacetic acid as a chiral derivatization agent for amino 






 Here, two equivalents of either the (R)- or (S)- enantiomer of the 
derivatization agent react with the amino alcohol; one with the amine moiety and 
one with the alcohol functionality (Scheme 11). 
 
 
Scheme 11 - Derivatization of (R)-2-amino-1-(p-tolyl)ethan-1-ol 28 with two equivalents of (R)-
α-methoxyphenylacetic acid 27b 
 
The absolute configuration of the amino alcohol can then be determined by 
1
H NMR 
spectroscopic analysis of the resultant derivatization product and consideration of 
the conformational model.
45
 Once again, Riguera noted that for the amide unit of the 
derivatized amino alcohol the major conformer is anti-periplanar, whilst for the 
ester unit the syn-periplanar conformer dominates. 
 





Scheme 12 - Conformational equilibrium for bis-(R)-α-methoxyphenylacetic acid derivatives of 





Riguera reported that the absolute configuration of the chiral amino alcohol could be 
determined by comparing the Δδ values obtained from two 1H NMR spectra, one at 
room temperature and the second spectrum at -60 °C. At room temperature, the α-
proton of the major conformer of the ester of bis-(R)-α-methoxyphenylacetic acid 
with (S)-1-aminopropan-2-ol was shielded, whilst the α-proton of the amide was 
deshielded. At lower temperature, this effect is enhanced causing predictable 
changes to the Δδ between these two resonances. The same effect is seen for the bis-
(R)-α-methoxyphenylacetic acid derivative formed from (R)-1-aminopropan-2-ol. A 
close up of the CαH and methoxy regions of the 1H NMR spectrum of a derivatized 
amino alcohol are shown in Figure 12 which show the typical Δδ seen when α-
methoxyphenylacetic acid is employed as a derivatization agent. 
 










N-Boc Protected phenylglycine acid chloride 29 has been reported to be an excellent 
chiral derivatization agent for a range of chiral amines.
46
 This derivatization agent is 
an improvement upon α-methoxyphenylacetic acid and Mosher’s acid because the 
Δδ values in the 1H NMR spectra for the diastereomeric amide derivatives are up to 
three times greater in comparison to the equivalent derivatives using α-
methoxyphenylacetic acid and Mosher’s acid. The increase in Δδ is due to the 
increased anisotropic shielding effects of the aromatic ring in the major anti-
periplanar conformer (Scheme 13). 
 
 
Scheme 13 - The use of N-Boc protected phenylglycine acid chloride 29 as a chiral 
derivatization agent for a wide range of primary amines 




Riguera also noted that the sign of the Δδ values obtained is always the opposite of 
those seen for amides derived from α-methoxyphenylacetic acid and Mosher’s acid. 
For the case of (R)-α-methoxyphenylacetic acid and Mosher’s acid amides the R1 
substituent is anisotropically shielded by the phenyl ring in the major conformer and 
for (S)-α-methoxyphenylacetic acid and Mosher’s acid amides the aromatic ring 
anisotropically shields the R group in the major conformer. However, when a 
phenyl glycine based chiral derivatization agent is employed the opposite is true, 
with (R)-phenylglycine derived amides having their R substituents anisotropically 
shielded by the aromatic ring, whilst for (S)-phenylglycine derived amides their R
1
-
substituents are anisotropically shielded by the phenyl ring. This results in a switch 
in sign of the Δδ values observed in their 1H NMR spectra. The differing models for 
the amide derivatives formed using all three of these derivatization agents are 
summarised in Scheme 14.  
 
 
Scheme 14 – A summary of the differences in anisotropic shielding effects of the R and R1 
substituents of amide derivatives of i) Mosher's acid chloride 26, ii) α-methoxyphenylacetic acid 
chloride 27 and iii) N-Boc protected phenyl glycine acid chloride 29. Red arrows denote 
anisotropic shielding effects 




Takeuchi et al. have proposed an alternative derivatization to Mosher’s acid for the 
determination of the enantiomeric excess of chiral secondary alcohols which boasts 
improved reactivity compared to α-methoxy-α-trifluoromethylphenylacetic acid. α-
cyano-α-fluoro-p-tolylacetic acid 31 was shown to be an effective derivatization 
agent for determining the enantiomeric excess of chiral benzhydrols 30 and it was 
demonstrated that the absolute configuration of the benzhydrol could be determined 
from the sign of the Δδ values for the aromatic protons (Scheme 15). 
 
 
Scheme 15 - Conformational model showing shielding effects upon derivatization of (S)-
benzhydrols with α-cyano-α-fluoro-p-tolylacetic acid chloride 31 
 
The above conformational model was developed by Takeuchi for all (S)-
benzhydrols investigated where upon derivatization with (R)-α-cyano-α-fluoro-p-
tolylacetic acid 31 the substituted aromatic group of the alcohol fragment is 
anisotropically shielded by the p-tolyl group and thus appears upfield of the 
equivalent resonance for the underivatized alcohol. Conversely, when the (S)-
diastereomer is formed it is the phenyl group of the alcohol fragment which is 
anisotropically shielded by the p-tolyl group and its corresponding proton 
resonances are shifted upfield. The CN group induces the opposite anisotropic 
deshielding effect and causes a downfield shift in the phenyl and substituted 
aromatic resonances in the (R)- and (S)-diastereomers respectively. Using these 




observations it was therefore possible to determine the configuration of unknown 
benzhydrols by examination of the shift in the proton resonances of their aromatic 
groups upon derivatization with α-cyano-α-fluoro-p-tolylacetic acid 31 of known 
configuration. 
Dufrasne et al. have reported the use of 1R-myrtenal 32 as a reagent for determining 
the enantiomeric excess for a range of α- and β-aryl amines.47 This simple approach 
exploits the fact that these amine containing compounds can readily form imines 
with the aldehyde moiety of myrtenal (Scheme 16). 
 
 
Scheme 16 - The formation of diastereomeric imines between 1R-myrtenal 32 and α- or β-aryl 
amines 
 
It was shown that integration of the imine protons in the 
1
H NMR spectrum of the 
derivatization product was particularly useful for determining the diastereomeric 
ratio (and thus the enantiomeric ratio of the starting amine) as their resonances were 
unhindered by other resonances. The determination of the enantiomeric excess of 
amino alcohols which do not contain aryl groups proved difficult using this method 





 This updated method found that resonances for 
both of the carbon atoms attached to the imine nitrogen could be accurately 
integrated to determine enantiomeric excess. 
The formation of imine diastereomers was also reported by Gellman et al. for 
determination of the enantiopurity of α-substituted aldehydes synthesised in chiral 
pyrrolidine-catalysed Michael addition reactions.
49
 By derivatization of the Michael 




addition products with either amine 33 or 34 (Scheme 17), it was reported that the 
1
H NMR spectrum of the resultant diastereomeric imines could be used to determine 
the enantiomeric excess of the δ-keto-aldehyde products. 
 
 
Scheme 17 - Derivatization of Michael addition products with amines 33 and 34 to determine 
their enantiomeric excess 
 
Gellman reported that in all cases the imine doublet resonances were able to be used 
to determine the enantiomeric excess of the δ-keto-aldehyde products with 
enantiomeric excess values obtained from both amine derivatization agents in good 
agreement with each other, and with values obtained from GC or HPLC analysis. 
In 2006, Alexakis et al. reported a number of derivatization agents 35-37 (Figure 









Figure 13 – Diamino-phosphorus chiral derivatization agents developed by Alexakis 
 
Alexakis demonstrated how 
31
P NMR spectroscopy was a useful tool to determine 
enantiomeric excess using diamino-phosphorus (III) compounds to form 
diastereomers from their reaction with cyclic secondary alcohols (Scheme 18). 
 
 
Scheme 18 – A chiral diamino-phosphorus auxiliary 35 developed for determining the 
enantiopurity of chiral alcohols 
 
It was reported that reaction of a chiral cyclic secondary alcohol with derivatization 
agent 35 led to a pair of diastereomeric P(III) complexes via formation of a 
phosphorus oxygen bond. The 
31
P NMR spectrum of this mixture of complexes 
showed distinct baseline separated resonances for the phosphorus atom in each 
diastereomer. These signals could be integrated, the ratio of which correlated to the 
enantiomeric excess of the starting alcohol. The chiral derivatization agents derived 
from cyclohexane-diamine were deemed the best since the rigidity of the 




cyclohexane ring of their adducts produced greater chemical shift differences and 
their synthesis was less expensive than the diphenyl derivative. Alexakis noted that 
reaction of the complexes with sulphur resulted in stable P(V)=S complexes that 
could be purified by chromatography. In some cases, this further reaction with 
sulphur produced greater baseline separation in the 
31
P NMR spectra. It was also 
noted that this protocol could be used to determine the absolute configuration of a 
chiral cyclic secondary alcohol of unknown stereochemistry. This was because 
alcohols with an (S)-configuration shifted the phosphorus resonance upfield in the 
31
P NMR spectrum of the derivatized complex relative to the corresponding 
complex of its (R)-enantiomer. 
A similar study by De Parrodi et al. reported how this class of chiral derivatization 
agent was also applicable to determining the enantiomeric excess of chiral 
carboxylic acids.
51
 De Parrodi used a similar chiral phosphorus derivatization agent 
(38) which was reacted with chiral carboxylic acids to demonstrate that baseline 
separated resonances for the resultant diastereomeric mixture in the 
31
P NMR 
spectrum could be accurately integrated to determine the enantiomeric excess of the 
parent carboxylic acid (Scheme 19). 
 
 
Scheme 19 – Diamino-phosphorus derivatization agent 38 for chiral carboxylic acids reported 
by De Parrodi 
 
The report showed that for the case of carboxylic acids, the 4-cyclohexene-1,2-
diamine derived phosphorus compound 38 provided the largest separation of 




phosphorus resonances compared to similarly derived cyclohexane compounds and 
the derivatization agent 35 reported by Alexakis
50
 for chiral cyclic secondary 
alcohols. 
In recent years, Garner et al. reported the use of menthyl chloroformate 39 as a 
chiral derivatization agent for determining the enantiopurity of chiral tertiary 
phosphines.
52
 The reaction of racemic menthyl chloroformate with chiral 
phospholane 40 produced a mixture of diastereomeric salts which were found to be 
distinguishable by 
31
P NMR spectroscopy (Scheme 20). 
 
 
Scheme 20 – Diastereomeric salts formed from the use of menthyl chloroformate 39 as a chiral 
derivatization agent for chiral phosphines 
 
Garner demonstrated that this technique led to clean formation of the diastereomeric 
salts and baseline separation of a pair of phosphorous resonances associated with 
these diastereomers. Scalemic sampling proved that enantiomeric excesses of up to 
98% could accurately be determined and that no kinetic resolution occurred upon 
derivatization. 
A chiral shift reagent for amino acids based on resonance-assisted hydrogen 
bonding was reported by Chin et al. in 2004.
53
 BINOL based aldehyde 41 was found 
to form stable imines with the amine moiety of amino acids (Scheme 21) whose 










Scheme 21 - The use of BINOL based aldehyde 41 for determining the enantiomeric excess of 
chiral amino acids by formation of hydrogen bonded imines 
 
It was reported that the 
1
H NMR signal for the imines formed were very strongly 
shifted downfield to an area of the spectrum devoid of other resonances due to the 
resonance-assisted hydrogen bonding. This results in the integration of the 
diastereomeric resonances being more accurate. Computational analysis determined 
that the minimum structures for the diastereomeric imines had their carboxylate 
groups in van der Waals contact with the nitro groups. Chin demonstrated how these 
computational studies could be used to determine the absolute configuration of an 
amino acid since, for L-alanine, the imine hydrogen bond is shorter than for D-
alanine and therefore stronger. This results in the imine proton resonance being 
shifted further downfield for the L-alanine diastereomer than the D-alanine 
diastereomer. This relationship was found to be consistent for other chiral amines 
with protons at their α-position. 
Wagner et al. presented the first known trifluoromethanesulfonamide-containing 
derivatizing agent for determining the enantiomeric excess of chiral amines and 
amino alcohols.
54
 Derivatization agent 42 was synthesised from (1S,2S)-
cyclohexane diamine and its isothiocyanate fragment reacted with a range of chiral 
primary and secondary amines to afford thiourea derivatives (Scheme 22). 
 





Scheme 22 – The first chiral derivatization agent (42) to utilise a diagnostic CF3 group 
 
Upon derivatization with a racemic amine, two resonances were seen in the 
19
F 
NMR spectrum for the diastereomeric trifluoromethyl groups of the resultant 
mixture of complexes. These resonances were sufficiently resolved to allow for 
accurate integration and further investigation with scalemic samples of chiral amine 
proved the technique’s viability for determining the enantiomeric excess of chiral 
amines. It is notable that Δδ values were large enough to provide accurate 
integration, which is remarkable given the large distance (up to 8 atoms) between 
the diagnostic trifluoromethyl group and the chiral centre of the amine in the 
derivatization complex. 
A few years ago, Ananikov reported a selenium-based NMR protocol which was 




Se NMR spectroscopy was identified as an excellent tool for determining 
enantiomeric excess through modelling studies. (R)-2-phenylselenopropanoic acid 
43 was prepared and reacted with a number of chiral amines and alcohols to yield 
well resolved diastereomeric amide and ester complexes respectively (Scheme 23). 
 





Scheme 23 - Selenium-based NMR protocol for determining the enantiomeric excess of chiral 
alcohols and amines 
 
The advantage of this approach is that the only resonances seen in the 
77
Se NMR 
spectrum after derivatization are well resolved for each of the two diastereomeric 
complexes formed. This avoids the problems sometimes associated with using 
1
H 
NMR spectroscopy whereby diagnostic resonances can overlap with other signals in 




C NMR spectroscopy 
could be used to determine enantiomeric excess, however, 
77
Se NMR spectroscopy 




C NMR spectroscopy. 
1.2.3 Chiral Gas Chromatography 
Chiral chromatographic methods are frequently used for the separation of 
enantiomeric compounds and for determining their enantiomeric excess. One of the 
most common chromatographic methods employed is chiral gas chromatography. 
The technique typically exploits hydrogen bonding and coordination interactions
56,57
 
between a chiral stationary phase and the chiral analyte to separate enantiomers, 
with modified cyclodextrins
58
 often used as chiral stationary phases. The chiral 
stationary phase is formed by attachment of a chiral compound, such as a 
cyclodextrin (Figure 14) to the surface of an achiral stationary phase such as silica. 
The two enantiomers of the chiral substrate to be separated are vaporised and passed 
through the column as the mobile phase and will interact differently with the chiral 
stationary phase based on their affinity towards it. The two enantiomers will thus be 




retained on the column for different amounts of time and become separated from the 
mixture. This method can be advantageous over other chromatographic methods 
such as HPLC because it is very fast, efficient and highly sensitive. However, the 
principle disadvantage of this technique is that it can only be used to analyse 
compounds that are volatile and thermally stable. The high temperatures at which 
the separations are carried out can also reduce the lifetime of the chiral stationary 





Figure 14 - Structures of typical chiral gas chromatography stationary phases, α-cyclodextrin 
44, β-cyclodextrin 45 and γ-cyclodextrin 46 
 




In 1977, Frank et al. published the separation of amino acid enantiomers using a 
chiral polysiloxane stationary phase which was found to be thermally stable at the 
separation temperature of 175 °C.
60
 
In 1999, Jacobsen et al. reported the determination of the enantiomeric excess of a 
range of hetero-Diels-Alder products using chiral gas chromatography.
61
 Jacobsen 
reported the use of chiral tridentate chromium(III) catalysts to catalyse the reaction 
between O-silyl-protected hexadienes 47a-d and a range of aldehydes 48a-h to 
afford substituted tetrahydropyranones 50a-h after silyl deprotection (Scheme 24). 
 
 
Scheme 24 - Chromium(III) catalysed enantioselective hetero-Diels-Alder reactions between 
hexadienes 47a-d and aldehydes 48a-h to afford chiral substituted tetrahydropyranones 50a-h 
 
Jacobsen reported excellent diastereoselectivity and enantioselectivity for these 
chromium(III) catalysed hetero-Diels-Alder reactions, particularly those catalysed 
by 49f, and was able to determine the enantiomeric excesses of the 
tetrahydropyranone products using chiral gas chromatography. Jacobsen employed a 




β-cyclodextrin 45 chiral stationary phase operating between 110 °C and 165 °C to 
provide good separation for the tetrahydropyranone enantiomers. 
Reetz et al. have reported a method for high throughput screening of chiral catalysts 
for optimising acylation based kinetic resolution reactions of racemic 2-phenyl-1-
propanol catalysed by mutant lipases.
62
 This method uses a configuration of two 
columns and injectors in one oven so that two samples can be analysed in tandem. 
However, for this method to be truly effective multiple columns and detectors would 
be required to be coupled together, so that large numbers of samples could be run 
continuously, which would obviously incur large costs. 
1.2.4 Chiral HPLC 
High performance liquid chromatography is a technique used to separate 
compounds in a mixture by pumping them in a mobile phase at high pressure over a 
stationary phase. The components are separated due to their differing interactions 
with the stationary phase; these interactions can be based on molecular size and 
ionic or polar interactions. In order to be applied to the separation of chiral 
components a chiral stationary phase must be used. Typically, a chiral molecule is 
coated onto a stationary phase such as silica and it is the differing diastereomeric 
interactions between the chiral components and the chiral stationary phase that 
determines the retention time of each of the chiral components.  
The advantage of this technique is that it can be automated once an appropriate 
chiral stationary phase and solvent system have been identified. However, the pre-
packed columns required for the technique are very costly, cannot handle crude 
reaction mixtures as they are often irreversibly modified by reaction impurities, and 
their separation power deteriorates over time. There is also no universal chiral 
stationary phase to separate all chiral compounds, which leads to significant 
development costs associated with determining the appropriate column/conditions 
required to separate the enantiomers of a target chiral compound. There are also 
sustainability issues arising due to the relatively large amount of solvents used by 
this chromatographic technique. In order to use this technique for the quick or 
constant analysis of a large number of samples, arising from a catalyst screening, it 




is often necessary to screen a number of columns and detectors before a suitable 
system is determined. This screening process can therefore have significant cost 
implications which need to be evaluated to determine whether chiral HPLC is an 
appropriate technique to determine enantiomeric excess.
63
 
Nevertheless, this approach has proven to be very popular, primarily due to its 
ability to be automated. For example, in 1998 Olsen et al. reported a chiral HPLC 
method for determining the enantiomeric excess of the selective serotonin reuptake 
inhibitor, fluoxetine hydrochloride 51,
64
 using a chiral stationary phase comprised of 
cellulose tris-(3,5-dimethylphenyl carbamate) coated silica (Figure 15). 
 
 
Figure 15 – Cellulose based chiral stationary phase - Chiralcel OD-H and the structure of (rac)-
fluoxetine hydrochloride 51 below 
 
Olsen reported that, separation of the enantiomers of fluoxetine on the chiral 
stationary phase was highly sensitive towards the presence of isopropyl alcohol used 
in the mobile phase at room temperature, and determined that peak separation could 
be improved greatly by cooling the column down to 1 °C. 
Meldal et al. have reported methodology for the preparation of a number of racemic 









Scheme 25 – Meldal’s synthesis of α-azido acid amides 52 
 
By using the antibiotic teicoplanin A2 immobilised onto silica gel, it was shown that 
these racemic α-azido acid amides could be separated cleanly since the immobilised 
teicoplanin fragments bind to the D- enantiomers more strongly than their L-
counterparts. Teicoplanin A2 is a mixture of components, each of which contains a 
different side amide chain R. The five major components of teicoplanin A2 are 
shown in Figure 16. This resulted in the L-form being eluted more quickly than the 
D-form. Clean separation was reported for amides 52b-d, however, the α-methyl 
amide 52a could not be separated by the teicoplanin column, due to the relative 
similarity in size of its methyl and ethyl R groups. 
 
 
Figure 16 - Structure of the five major components of teicoplanin 
 




In a typical screening approach, Welch et al. demonstrated high-throughput HPLC 
analysis for determining the enantiopurity and concentration of (R,S)-hydrobenzoin 






Figure 17 - Structures of (R,S)-dihydrobenzoin 53, (S)-benzoin 54a and (R)-benzoin 54b 
 
This chiral HPLC protocol was used to screen a range of chiral catalysts for the 
stereoselective reduction of benzoin 54 to (R,S)-hydrobenzoin 53. It’s use enabled 
the enantiomeric excess of mixtures of varying amounts of (R,S)-dihydrobenzoin, 
(R)-benzoin and (S)-benzoin present in a 96-well plate format to be determined by 
HPLC analysis using an amylose tris-(3,5-dimethylphenyl carbamate) coated silica 
chiral stationary phase (Figure 18). 
 
 
Figure 18 – Amylose based chiral stationary phase - Chiralpak AD-H 
 
This chiral stationary phase was able to cleanly separate the three components of the 
mixture in under six minutes per sample with the enantiomeric excess of the benzoin 
determined to within 2% of known enantiomeric excess values. This work 




demonstrates how chiral HPLC analysis can be used as an accurate and quick 
procedure for catalyst screening for the asymmetric reduction of benzoin to (R,S)-
dihydrobenzoin. It was noted that using multi-parallel HPLC analysis enabled 96-
well plate analysis of chiral samples in as little as 1.5 hours. 
1.2.5 Polarimetry and Circular Dichroism 
An important property of enantiomers is that they rotate plane polarised light to an 
equal degree in opposite directions. Polarimetry uses a polarimeter to measure the 
optical rotation of a solution of chiral material in a specific solvent at a known 
temperature and concentration. To measure the optical rotation the polarimeter 
shines monochromatic light of a given wavelength through a plane-polarizing filter 
and through the chiral solution onto a detector which measures the rotation of the 
plane polarized light due to its interaction with the chiral solution. A chiral solution 
will rotate the light to a degree related to the enantiomeric excess of the solution 
with the absolute configuration determined by the sign of the rotation. A racemic 
solution will produce a net rotation of zero, since equal amounts of each enantiomer 
will rotate the plane polarized light equally, but in opposite directions. The specific 
rotation value obtained can be compared with a known value for an 
enantiomerically pure sample of a chiral compound, as long as it is measured at the 
same concentration, solvent and temperature. Furthermore, the sign of rotation can 
also be used to assign the configuration of the chiral compound. 
However, polarimetry is now less well used to determine enantiomeric excess since 
more accurate methods have been developed, and it is primarily used to just 
determine absolute configuration from the sign of the rotation of the plane polarized 
light. The method does still have the advantage that it requires no chemical reactions 
or derivatization before taking the measurement. However, it has the disadvantage 
that contamination from chiral impurities can severely affect the specific rotation 
obtained, with the relationship between the value of the optical rotation and 
enantiomeric excess not always linear. 
Although polarimetry is now disfavoured as a method of determining enantiomeric 
excess, another optical method, circular dichroism is becoming increasingly 




popular. Circular dichroism measures the differential absorption of left and right 
polarized light by a chiral medium. Equal amounts of left and right circularly 
polarized light are alternately radiated into the sample, a chiral sample absorbs the 
two polarizations by differing amounts and the measurement of this difference 
across a range of wavelengths is used to produce the CD spectrum. The 
characteristic change in the CD curve in the region of the absorption band of a chiral 
compound is known as a Cotton effect and the absorbance maximum of this effect is 
used to determine the enantiomeric excess by comparison with a sample that is 
known to be enantiomerically pure. Enantiomers have identically opposite CD 
spectra as they interact in equally opposite amounts with the left and right circularly 
polarized light that the sample is irradiated with. Whilst circular dichroism is an 
accurate technique that doesn’t require any chiral derivatization before analysis, it 
often requires complexation of the chiral compound to a chromophore when the 
chiral molecule being analysed does not contain one within its structure. 
In 2001, Hattori et al. developed the method of using a racemic derivatization agent 
for measuring enantiomeric excess by circular dichroism spectroscopy.
67
 Chiral 




Scheme 26 – Hattori’s derivatization approach for determining enantiomeric excess by CD 
spectroscopy 
 




The binaphthyl derivatization agent chosen by Hattori has a strong CD signal and it 
was shown that the CD spectrum of the diastereomeric ester or amide products 
formed was influenced by the enantiopurity of the respective alcohol or amine 
component. Thus, a discernible difference between the CD spectra of the 
diastereomers formed between reaction of racemic 55 and an alcohol was observed. 
Scalemic sampling showed that the value of Δε at 234 nm changed linearly with 
respect to the enantiomeric excess of the alcohol. After prior calibration with a 
sample of known 100% enantiomeric excess it was reported that enantiomeric 
excess could be determined with an accuracy of ±5%. 
Anslyn et al. have published a method for determining the enantiomeric excess of 
chiral carboxylic acids using circular dichroism.
68
 The reported method involves 
formation of a copper (II) complex 56 with a chiral carboxylic acid (Figure 19). 
 
 
Figure 19 - Copper complex 56 of carboxylic acids whose enantiomeric excess are determined 
by CD spectroscopy 
 
Anslyn reported that addition of a chiral carboxylic acid to copper complex 56 
resulted in strong signals being observed in the resultant CD spectrum. The 
absorption of the first Cotton effect in the CD spectra was positive when the (S)-
carboxylic acid was used and negative when the (R)-enantiomer was employed, with 
a λmax observed at 238 nm. This is due to formation of chiral copper propeller 




compounds. For the case of (S)-2-phenylbutyric acid an M propeller complex was 
formed, whilst for (R)-2-phenylbutyric acid, a P propeller was produced. Since the 
(S)- and (R)-complex spectra are equal and opposite to each other, a calibration 
curve was produced from which it was determined that enantiomeric excess changed 
linearly at an absorption value at 238 nm, with a maximum positive absorption 
observed for the enantiopure (S)-enantiomer, and a maximum negative absorption 
observed for the enantiopure (R)-enantiomer. The method reported was able to 
determine enantiomeric excess to within 4% of the true value, with lower errors 
seen for carboxylic acids that produced the largest amplitudes in the CD spectra. 
In 2012 Anslyn et al. produced another circular dichroism method for determining 
the enantiomeric excess of chiral secondary alcohols.
69
 Diastereomeric zinc 
complexes were formed from pyridine-2-carboxaldehyde 57, bis-(2-
pyridylmethyl)amine 58, zinc triflate and a chiral secondary alcohol, using 4-(2-
chloroethyl)morpholine hydrochloride 59 as a catalyst (Scheme 27). 
 
 
Scheme 27 - Synthesis of propeller-like zinc complexes by Anslyn 
 
It was reported that the CD spectra for the zinc complexes formed correlated to the 
chirality of the alcohol used, with all (S)-alcohols investigated producing a positive 




Cotton effect, with their corresponding (R)-enantiomers giving mirrored negative 
Cotton effects. Scalemic sampling using three chiral alcohols (Figure 20) was used 
to produce calibration curves which showed a linear relationship between ellipticity 
(measured at the λmax of the first Cotton effect) and enantiomeric excess. Samples of 
unknown enantiomeric excess were employed to determine the validity of Anslyn’s 
method, and it was noted that enantiomeric excess could be determined to within 
3% of their true value. 
 
 
Figure 20 – Chiral alcohols investigated using Anslyn’s propeller system 
 
More recently, Wolf et al. published a versatile protocol for determining the 
enantiomeric excess of chiral amines, diamines, amino acids, amino alcohols and α-
hydroxy acids.
70
 These substrates were reacted with binaphthol 60 and diethylzinc 




Scheme 28 – The formation of zinc dimers for determining the enantiomeric excess of chiral 
amines, diamines and amino alcohols by CD spectroscopy 
 




Upon inspection of the CD spectra of these zinc complexes, Wolf noted that the sign 
of the maximum CD amplitude related to the absolute configuration of the substrate. 
Amino alcohols with a single (R) stereocentre gave a positive CD response at 350 
nm, whilst (S) enantiomers gave a negative signal. Conversely, amines with an (R) 
configuration gave a negative CD response and for (S) configured amines a positive 
CD maximum was observed. It was observed that enantiomeric excess related to the 
chiroptical response in a non-linear manner, however, calibration enabled 
enantiomeric excess to be determined for samples of diamines and amino alcohols 
of unknown e.e. to within 3% of their true values. For the cases of α-hydroxy acids 
and amino acids, Wolf employed a boron based approach, substituting 




Scheme 29 – A boron based CD sensor for use with α–hydroxy acids and amino acids 
 
As with the zinc based complexes Wolf reported that it was possible to discern the 
configuration of amino acid and α-hydroxy acid substrates, however, he did not 
report the use of this method to determine enantiomeric excess. In both of Wolf’s 
reported systems the configuration of the binaphthol 60 is induced by its 
complexation to the zinc or boron atom, since the starting binaphthol 60 has no 
inherent stereochemistry due to free rotation about the bond connecting the two ring 
systems. Derivatization with a chiral substrate then creates diastereomeric 
complexes that are sufficiently different in energy to enable their ratio to be 
analysed by circular dichroism. 









 Anslyn et al. have developed a method for determining the enantiomeric 
excess of α-chiral aldehydes 61a-c using circular dichroism spectroscopy.74 The 
aldehydes were converted to hydrazones 63a-c by condensation with 2-(1-
methylhydrazine)pyridine 62 in acetonitrile and then mixed with iron triflate to form 
six-coordinate metal complexes 64a-c which were CD active (Scheme 30). 
 
 
Scheme 30 – Anslyn’s reported protocol for determining the enantiopurity of chiral aldehydes 
61a-c 
 
These hydrazones were formed exclusively as their E-isomers due to disfavoured 
interactions between the R groups and the N-methyl moiety. A large CD response 
was seen for the octahedral iron complexes formed from chiral aldehydes 61a-c 
between 334 and 345 nm. Calibration curves were generated for the individual 
complexes using three control samples of known enantiomeric excess, confirming a 
linear relationship between enantiomeric excess and the measured molar ellipticity. 




Anslyn noted that this method could be used to determine the enantiomeric excess 
of α-chiral aldehydes to within 5% for all the aldehydes analysed, and that this 
protocol was an excellent method for high throughput analysis, since the 
derivatization process from initial imine formation, through complexation, to CD 
analysis of 96 samples could be achieved in around one hour. 
1.2.6 Ultraviolet-visible and Fluorescence Spectroscopy 
Other spectroscopic techniques have also been employed to determine enantiomeric 
excess with Wolf et al. demonstrating that UV-vis spectroscopy could be used to 
determine the enantiopurity of amino acids, amines, amino alcohols and carboxylic 
acids in aqueous solution.
75
 Wolf reported how chiral substrates could competitively 
bind to Sc[N,N’-dioxide 65]2 (Figure 21) displacing the N,N’-dioxide 65 ligand and 




Figure 21 - The structures of N,N'-dioxide 65 ligand and Sc[N,N'-dioxide 65]2 complex 




Since the Sc(III) complexes of amino acids, amines, amino alcohols and carboxylic 
acids exhibit no UV absorption above 350 nm then any absorption measured relates 
to the Sc[N,N’-dioxide 65]2 complex. The competitive binding was found to be 
stereoselective since (S)-valine was more effective in replacing the N,N’-dioxide 65 
from the metal centre of the Sc[(+)-65]2 complex. Thus, a calibration curve for 
enantiomeric excess vs absorption could be fitted by titration of enantiopure 
Sc[N,N’-dioxide 65]2 complexes with each chiral substrate. Scalemic sampling 
showed good agreement between the values obtained using the calibration curves 
and the known enantiomeric excess for valine, camphanic acid, α-
cyclohexylethylamine and threoninol. Wolf noted that this method may be 
preferable to other protocols for enantiopurity determination due to it avoiding 
substrate derivatization, and its dependence on highly sensitive changes in UV-vis 
absorptions. 
In 2008, Bailey et al. reported a fluorescence dye displacement based protocol for 
determining the enantiomeric excess of D-amino acids.
76
 Bailey observed that the 
decarboxylation of L-lysine 66 to cadaverine 67 by lysine decarboxylase led to a 
measurable decrease in fluorescence. Dapoxyl 68 was used as a fluorescent dye 
which displays 200 times more fluorescence when complexed to the macrocycle 
cucurbituril, than when uncomplexed. Cadaverine is able to compete with Dapoxyl 
for complexation with the cucurbituril and therefore the presence of cadaverine 




Scheme 31 - Conversion of L-lysine 66 to cadaverine 67 by lysine decarboxylase causes 
displacement of Dapoxyl 68 from its cucurbituril complex 




Since lysine decarboxylase is enantiospecific for the L-form of lysine it is possible 
to relate the amount of reduction in fluorescence to the amount of L-lysine present in 
a scalemic sample of lysine. This relationship can be seen in Figure 22 which 
reveals that the rate of fluorescence decrease is linearly dependent on concentration 
of L-lysine in the sample. Scalemic sampling was able to show how this method was 
applicable to determining a broad range of enantiopurities, enabling enantiomeric 
excess of D-lysine to be measured as high as 99.98%, by detecting the small 




Figure 22 - Linear relationship between the e.e. of D-lysine and the reaction rate, shown for 
three ranges of enantiomeric excess 
 




Pu et al. have also reported a fluorescent sensor which is able to determine the 
enantiomeric excess of chiral diamines.
77
 Pu found that whilst (S)-trifluoromethyl 
ketone based BINOL 69 exhibits no fluorescence emission, upon addition of 
enantiopure (R,R)-1,2-diaminocyclohexane 70 two emissions were seen, the first 
emission at 370 nm and a second emission at 438 nm. Upon treatment of 69 with the 
(S,S)-enantiomer of the amine the same emission was seen at 370 nm, however, the 
emission at 438 nm was much smaller showing that the sensor displayed high 
enantioselectivity towards the chiral diamine. The measured fluorescence emissions 
were attributed to the formation of stable carbinolamine products 71 and 72 which 
are subsequently converted to bis-imine 73 over time (Scheme 32). 
 
 
Scheme 32 - Reaction of trifluoromethyl ketone BINOL derivative 69 with diamine 70 to yield 
fluorescent hemiaminal products 71 and 72 
 




The accuracy of this fluorescent sensor method was evaluated by analysis of 
scalemic samples of known enantiomeric excess of chiral diamine 70. This method 
was shown to be very accurate for high values of enantiomeric excess (1-4% 
accuracy), however, it was found that as enantiomeric excess decreased then the 
accuracy of this method diminished. 
In summary, the ability to discern the chirality of a compound or determine its 
enantiomeric excess is of great importance to modern science. This requirement is 
exemplified by the number of different protocols that have been developed to date, 
with new, more efficient methods still being developed for determining the 
enantiomeric excess of different types of chiral compound. In this respect it is 
important for chemists to determine which technique is most efficient for their 
particular need. For example, it is not uncommon to have to screen a number of 
different chiral HPLC columns before satisfactory conditions are identified to 
resolve the enantiomers of a target chiral analyte. Furthermore, it is often necessary 
to investigate a number of different solvent systems before a clean separation of 
enantiomers is achieved to enable the enantiomeric excess of a chiral product to be 
determined. A chiral HPLC system taking 20 minutes to achieve separation and 
running at 1 mL/min of solvent uses 20 mL of solvent per enantiomeric excess 
determination. By comparison, a chiral derivatization NMR spectroscopic protocol 
needs only 0.3 mL of deuterated solvent per experiment. Thus for a small scale 
laboratory, interested in optimising the sustainability of their research program, a 
chiral derivatization protocol may be a more desirable method of enantiomeric 
excess determination than the use of chiral HPLC. 
   




2 A Simple Protocol for NMR Analysis of the Enantiomeric Purity 
of α-Arylglycines 
Most of the joint research published by the Bull-James group involves the 
development of new synthetic protocols and analytical methods constructed around 
the chemistry of boron. Simple protocols for determining enantiomeric excess by 
NMR spectroscopy are of great interest to the group and previous publications have 
demonstrated how boronic acids can be used as templates for determining the 
enantiomeric excess of chiral molecules. 
2.1 Introduction 
The work described in the subsequent chapters of this thesis is based on the use of 
boronic acids as templates to develop new chiral derivatization methods. The 







 the three valence electrons have little shielding from the 
nucleus and therefore have high ionization energies. The bonding of boron is 
chemically similar to carbon and can form covalently bonded networks, its 
electronegativity is also similar to carbon but slightly more electropositive and thus 
when forming covalent bonds the boron centre is left electron deficient. This 
bonding character means the boron atom is sp
2
 hybridised in simple organoboron 
compounds and therefore trigonal planar, with an R-B-R bonding angle of 120° 
(Figure 23). Boron also has an empty 2p orbital which sits perpendicular to the 
plane of the B-R bonds that is not involved in bonding. 
 
 
Figure 23 - The bonding in simple organoboron compounds 
 




Boron’s vacant 2p orbital readily interacts with electron rich species and results in 
boron compounds often acting as Lewis acids. These compounds can react with 
Lewis bases to form neutral donor-acceptor complexes that change the hybridisation 
of the boron to an sp
3
 tetrahedron. This donation into the empty 2p orbital and the 
resultant change in shape is crucial to a lot of the chemistry and mechanisms 
involving the boron centre. 
Organoboron reagents have long been noted for their effectiveness in synthetic 
reaction routes with research by Brown and Krishnamurthy earning them a Nobel 
Prize in 1979.
78
 Donor-acceptor complexes containing N-B interactions are also 
well known
79,80
 with the first example being reported in 1862 by Frankland, where 
evidence for a H3N-BMe3 donor-acceptor complex was reported.
81
 
Yamamoto et al. demonstrated the usefulness of this type of interaction for the 
stereoselective formation of β-amino esters from the stereoselective condensation of 





Scheme 33 - Diastereoselective synthesis of β-amino ester 75 
 
It was reported that use of the chiral boronate ester 74 resulted in diastereoselective 
formation of β-amino ester product 75 in 92% diastereomeric excess (d.e). This can 
be rationalised as nucleophilic attack occurring preferentially at the Re face of the 




imine due to prior formation of an N-B complex with the imine substrate which 
blocks approach of the nucleophilic enolate species at the Si face (Figure 24). 
 
 
Figure 24 - Stereoselective nucleophilic attack at the Re face of an imine 
 
Boronate ester 74 was also shown to be an effective catalyst for asymmetric aza-
Diels-Alder reactions.
83,84
 Having developed this methodology Yamamoto et al. 
went on to investigate the design of various iminoboronate complexes, reporting 
their ability to direct good diastereofacial control for both aza-Diels-Alder and 
Mannich reactions.
85
 It was found that certain boronic acid complexes had the 
ability to sterically hinder one face from nucleophilic attack at an N-B 
iminoboronate complex, resulting in the generation of a new chiral centre with high 
enantiocontrol (Table 1). A significant advantage of such complexes reported by 
Yamamoto is their ability to form crystalline substrates and this property resulted in 
air stable compounds that improved their ease of handling during synthesis. 
 




Table 1 - Effect of boronic ester on diastereomeric excess of β-amino ester formation 
 
 
The formation of iminoboronate complexes has also attracted the interest of 
macrocyclic chemists.
86
 In 2005, Barba et al. reported their route to a number of 
substituted iminoboronate compounds.
87
 This approach utilised imine based diol 77 
and phenylboronic acid template 78 to afford stable cyclised iminoboronate 
structures 79a-h (Scheme 34). 
 
 
Scheme 34 - Formation of monomeric iminoboronate complexes 79a-h 
 




Reactions for the formation of iminoboronate complexes 79a-h returned relatively 
high yields with the N-B interaction confirmed from their x-ray crystal structures. 
These monomeric iminoboronates were then utilised in a new stereoselective route 
to 3,4-dihydroquinolines.
88
 This success prompted the synthesis of the dimeric 
iminoboronate analogue where benzene-1,4-diboronic acid was used instead of the 
phenyl boronic acid derivatives, which reacts with two molecules of the imine.
87
 
Once again, this reaction afforded high yields for the synthesis of a small range of 




Scheme 35 - Synthesis of dimeric iminoboronate complexes 81a-c 
 
Barba et al. reported that variation of the length of the aliphatic chain in imine diol 
80 to a two-carbon chain (82) resulted in an alternative dimeric iminoboronate 









Scheme 36 - Alternative dimeric iminoboronates from aliphatic imine diol 82 
 
A variety of imine analogues were synthesised using all variations of the R and R1 
groups with their structures confirmed by NMR, mass spectroscopy and X-ray 
crystallography. The variation of the R and R1 groups was seen to have no effect on 
the reaction pathway for product formation. These compounds were found to be 
more stable than those previously synthesised which contained no R substituents 
and an oxygen bridge between the two boron centres.
90
 
In 2001, Anslyn et al. published a study into the effect of pH on N-B coordinate 
bonds by studying the structures observed for these complexes, which contained 













B NMR spectroscopy to detect the N-B interaction. 
11
B NMR 
spectroscopy is a useful technique for determining the structure of boron compounds 
since the shift of the boron resonance is greatly affected by the hybridisation of the 
boron centre. A purely tetrahedral sp
3
 boron centre will have a resonance around 0 
ppm whilst a purely trigonal planar sp
2
 boron centre has a chemical shift of around 
30 ppm. It was reported that the shift of the boron resonance changed from around 
28 ppm at low pH to 8 ppm at a pH of 5.5. This demonstrates that boron changes 
hybridisation once the pH rises above 5.5 to a tetrahedral structure. At low pH the 
amine will be protonated and as the pH rises to 5.5 (pKa1) and up to neutral the 
boron becomes tetrahedral and this can be assumed to be due to formation of the N-
B interaction. In a rise to more basic pH (pKa2) however, this tetrahedral structure 
can be accounted for by the two structures 84 and 85, one of which incorporates an 
N-B interaction and the second of which incorporates an extra hydroxide. Further 
evidence for the N-B interaction at neutral pH was observed in the X-ray crystal 
structure of compound 86 which showed the presence of a tetrahedral boron centre, 
confirmed by 
11
B NMR spectroscopy at 9.4 ppm, and a tetrahedral nitrogen centre 
(Figure 25). 
 





Figure 25 - Polyaza compound 86 as evidence for N-B interactions at neutral pH 
 
Exploitation of these types of N-B interactions has been used to promote formation 
of boronate esters with 1,2- and 1,3- diols to develop fluorescent sensors for 
saccharides,
92
 as well as in our groups research into NMR protocols for determining 
enantiomeric excess which will be discussed in the following sections. 
 
2.2 Previous Work by the Group 
The Bull and James groups have developed a number of simple NMR protocols for 
the determination of enantiomeric excess of chiral molecules. In 2006, their groups 
published a simple three component protocol for determination of the enantiomeric 
excess of chiral primary amines.
93,94
 This protocol involves derivatization of a chiral 
amine 87 with 2-formylphenylboronic acid 88 and enantiopure (R)-BINOL in 
CDCl3 to quantitatively afford a mixture of diastereomeric iminoboronate esters 89 
and 90 (Scheme 38). 
 









H NMR spectrum of the mixture of resultant iminoboronate complexes it 
is possible to accurately measure the integration of each peak of two diastereomeric 
protons, with the ratio of these integrations enabling the diastereomeric excess to be 
measured. As an enantiomerically pure diol is used, the enantiomeric excess of the 
amine determines the diastereomeric excess of the iminoboronate. Therefore, the 
enantiomeric excess of the amine can be inferred from the diastereomeric excess of 
the resulting complexes. Splitting of the diastereomeric imine proton was observed 
for almost all amines investigated. This is a useful feature of this protocol as this 
region of the 
1
H NMR spectrum is free from any other resonances which could 
potentially overlap and hinder accurate integration. The imine signals are also 
removed from all other resonances associated with the diol fragment of the 
iminoboronate complex 89/90, therefore acting as diagnostic signals for integration, 
independent of the amine being derivatized (Table 2).  




Table 2 - Chemical Shift Differences (Δδ) in the 300 MHz 1H NMR Spectra of 50:50 Mixtures 
of (R,R)-89a-m and (R,S)-90a-m Derived from Racemic Primary Amines 87a-m 
 
a A negative value indicated that the resonance corresponding to the (R,R)-diastereomer is more deshielded than the (R,S)-
diastereomer. b The quartet corresponding to the methine proton of the (R,R)-89a diastereomer partially overlaps with the 
resonance of phenolic protons of residual (R)-BINOL; these signals no longer overlap on addition of 5 mol % of d6-acetone to 
the NMR tube. c The quartet corresponding to the methine proton of (R,S)-90e partially overlaps with the resonance of penolic 
protons of residual (R)-BINOL. d 1H NMR spectra recorded in d6-acetone. 
e Unable to assign a sign to the Δδ values of these 
resonances because enantiopure samples of amines 87l and 87m were not available.  




From Table 2 it can be seen that in all cases at least one pair of diastereomeric 
resonances were seen in the 
1
H NMR spectra which could be used to determine the 
enantiomeric excess of the chiral amine, and in the majority of cases three or more 
pairs of diastereomeric resonances were potentially available for comparison. The 
derivatization protocol was able to determine the enantiomeric excess of a wide 
range of amines including those with remote stereocentres at carbons up to five 
bonds removed from the amine. Inspection of the 
1
H NMR spectra of iminoboronate 
esters 89/90d, 89/90g and 89/90i revealed that the tert-butoxy and methoxy 
resonances of the (R,R)-diastereomers were more deshielded than those of the 
corresponding (R,S)-diastereomers, indicating that the sign of the Δδ value could be 
used to determine the absolute configuration of α-amino esters. Similarly for 
diastereomeric iminoboronate esters 89/90a, 89/90c and 89/90e comparison of the 
Δδ values for the imine, α-methyl and α-proton resonances revealed the same sign 
and magnitude of chemical shift difference, thus demonstrating that this 
derivatization protocol can be used to predict the absolute configuration of α-
arylethylamines. 
This same method could also be applied to determine the enantiomeric excess of 
chiral diols.
95,96
 In this case, mixtures of iminoboronate complexes are formed from 
a chiral diol, 2-formylphenylboronic acid and enantiopure α-methylbenzylamine in 
CDCl3 (Table 3). The enantiomeric excess of the chiral diol could then be measured 
by integration of a pair of diastereomeric protons in the 
1
H NMR spectrum of the 
resultant mixture. 
 




Table 3 - Chemical Shift Differences (Δδ) in the 400 MHz 1H NMR Spectra of 50:50 Mixtures 
of (S,R)-92a-i and (S,S)-93a-i Derived from Racemic Diols 91a-i 
 
a A negative value indicates that the resonance corresponding to diastereomer 92 was more shielded than that of diastereomer 
93. b 1H NMR spectra recorded in d6-acetone. 
c Unable to assign a sign to the Δδ values of these resonances because 
enantiopure samples of diols 91b and 91e were not available. 
 
  




Scalemic sampling studies revealed that both protocols were highly accurate, 
enabling the enantiomeric excess of chiral amines or diols to be determined within 
2% of their known values. 
The use of this method has advantages over previously reported chiral derivatization 





. However, the Mosher method often requires the use of both 
1
H NMR and 
19
F NMR spectroscopy in order to accurately determine the enantiomeric excess of 
amines, whilst the Trost method requires the use of moisture sensitive acid chlorides 
to determine enantiomeric excess. Problems associated with kinetic resolution have 
also been found when using the Mosher method which could lead to the 
measurement of an inaccurate enantiomeric excess for a chiral substrate. The three 
component derivatization protocols reported by our group are experimentally simple 
to perform, as they involve the use of commonly available reagents, occur under 
ambient conditions and do not require rigorously anhydrous conditions. The 
diastereomeric iminoboronate complexes are formed in five minutes and 
enantiomeric excess can be determined quickly by 
1
H NMR spectroscopy alone. 
These two protocols have since been used by a number of groups for determination 
of the chirality and enantiopurity of chiral amines and diols produced as part of their 
syntheses. In 2008, Chopard et al. reported the formation of iminoboronate 
complexes to determine the enantiomeric excess of cis-dihydrodiols formed by 





Scheme 39 - Enantioselective dihydroxylation of N-methyl-2-pyridone 94 to dihydrodiol 95 
 






H NMR of the reaction between 2-formylphenylboronic acid 88, (R)-
phenylglycine tert-butyl ester 96 and dihydrodiol 95 (Scheme 40) confirmed 
formation of their product with an enantiomeric excess of >98% e.e.. 
 
 
Scheme 40 - Use of the Bull-James protocol to determine the enantiopurity of dihydrodiol 95 
 
Anslyn et al. have reported the use of the Bull-James protocol a number of times to 
verify the enantiopurities of Sharpless dihydroxylation products (Scheme 41) that 
were synthesised as part of their studies into high throughput screening methods 
using indicator-displacement assays
99





Scheme 41 – Representative Sharpless dihydroxylation reaction to form a diol 
 
Anslyn synthesised a number of chiral diols in order to determine a high throughput 
screening method for evaluating the effectiveness of a number of chiral 
dihydroxylation catalysts. As part of this study, the enantiomeric excesses of all the 
diols employed in the study were determined by application of the Bull-James 
protocol. 




In 2012, Inoue et al. published the total synthesis of four possible stereoisomers of 





Figure 26 – Synthesis of the syn-98a and anti-98b diastereomers of resolvin E3 via diol 
intermediate 97 
 
Inoue used the three component protocol to determine the enantiomeric excess of 
four chiral diol intermediates 97 formed in the synthesis of each diastereomer of 
resolvin E3, thus confirming the high stereoselectivity of their reported 
methodology (Scheme 42). 
 





Scheme 42 - Enantiomeric excess of syn- and anti- diol intermediates 97 determined using the 
Bull-James protocol 
 
Kressler et al. similarly used our reported diol protocol to determine the chirality of 





Scheme 43 - Determination of the chirality of poly(glycerol methacrylate)s 99 using the Bull-
James protocol 
 
(R), (S) and (rac) samples of polymer 99 were shown to have identical 
1
H NMR 
spectra. However, upon derivatization with 2-formylphenyl boronic acid 88 and (S)-
α-methylbenzylamine the protons on the diastereomeric polymeric diol fragment 




were shown to appear at different chemical shifts for the (R) and (S) polymer thus 
enabling the chirality of the polymer to be determined. 
In 2013, Bull and Fordred reported the asymmetric synthesis of a range of chiral 
1,3-diols 101 from the tandem asymmetric hydroboration/reduction reaction of 
trisubstituted β,γ-unsaturated esters 100 (Scheme 44) and determined the 
enantiomeric excess of the resultant 1,3-diols 101 using the three component 









Scheme 45 - Determination of the enantiomeric excess of chiral 1,3-diols 101 
 
In 2011, Aldrich et al. employed the group’s published method for determining the 
enantiomeric excess of chiral amines to evaluate the enantiopurity of amine 103 that 




was formed from cobalt catalysed stereoselective [3,3]-rearrangement of allyl-





Scheme 46 - Aldrich's synthesis of amine 84, e.e. determined by Bull-James protocol 
 
In 2008, the Bull-James groups reported a protocol for determining the enantiomeric 










H NMR spectrum of the reaction between 1,2-diphenylethane-1,2-diamine, 2-
formylphenylboronic acid and BINOL in CDCl3 revealed the presence of 
diastereomeric imidazolidine complexes. Scalemic studies, using diamine 104 of 
known enantiomeric excess, validated this method as a protocol for determining the 




enantiomeric excess of these types of diamines. Enantiomeric excesses calculated 
from the 
1
H NMR spectrum were within 4% of the known values, with baseline 
resolved resonances observed for a number of pairs of diastereomeric protons, 
making accurate integration easy. 
A protocol for determining the enantiomeric excess of chiral β-amino alcohols was 
reported by the group in 2009.
106
 It was first hypothesised that the same approach 





However, it was found that addition of (S)-BINOL and 2-formylphenylboronic acid 




Scheme 48 – Formation of dimeric side products when the Bull-James protocol was initially 
applied to chiral unprotected 1,2-amino alcohols 
 
1
H NMR spectroscopy showed the expected iminoboronate ester 106, boracycle 
species 107 and unreacted (S)-BINOL. Consequently, a modified protocol was 
devised in which the hydroxyl moiety of the amino alcohol was O-silyl protected 
using a tert-butyldimethylsilyl group and (syn)-methyl-2,3-dihydroxy-3-
phenylpropionate 108 used as a chiral diol in place of BINOL (Scheme 49). 
 





Scheme 49 – Bull-James protocol for determining the enantiomeric excess of chiral O-silyl-
amino alcohols 
 
This led to quantitative formation of the desired iminoboronate esters 109 and 110 
which enabled the enantiopurity of a range of scalemic samples of chiral amino 
alcohols, indicating that no dynamic kinetic resolution occurs, with baseline 
splitting of up to four distinct proton resonances observed. 
The derivatization procedures discussed to this point have focussed on the use of 
1
H 
NMR spectroscopy as the analytical tool with which to determine enantiomeric 
excess. However, in 2008, the group reported how 
19
F NMR spectroscopy could 
also be used for determining the enantiomeric excess of chiral diols using this three 
component derivatization approach. The previously reported protocol for chiral 
diols
95,96
 was adapted by using an enantiopure diol and (rac)-α-methyl-4-
fluorobenzylamine 111 in place of α-methylbenzylamine (Scheme 50).107 
 
 
Scheme 50 - Determining the enantiomeric excess of chiral diols by 
19
F NMR spectroscopy 
 




Although the fluorine atom is in a relatively remote position, diastereomeric 
resonances were still seen in the 
19
F NMR spectrum. However, the protocol using α-
methyl-4-fluorobenzylamine 111 is clearly only able to be used to determine the 
enantiomeric excess of chiral diols and not chiral amines as the fluorine 
functionality is attached to the amine chiral auxiliary. In order to broaden the 
suitability of this protocol to be able to determine the enantiopurity of chiral amines, 
the fluorine functionality was incorporated into the boronic acid template by 
synthesis of 4-fluoro-2-formylphenylboronic acid 113 (Scheme 51). 
 
 
Scheme 51 - Synthesis of fluorous 2-formylphenylboronic acid 113 
 
The three-step synthetic route was designed to be simple, using commercially 
available 2-bromo-5-fluorobenzaldehyde 112 as a starting material which was also 
demonstrated to be amenable to large scale preparation. Fluorous boronic acid 113 
was then treated with (rac)-α-methylbenzylamine and a range of chiral diols 




F NMR spectra of the resultant 50:50 
mixture of diastereomeric iminoboronate ester complexes showed baseline 
resolution for at least two pairs of diastereomeric resonances in the 
1
H NMR spectra 
and a pairs of baseline resolved signals for the aryl-fluorine resonances of each 
diastereomer in the proton decoupled 
19
F NMR spectra. 
 





Scheme 52 – Determination of the enantiomeric excess of chiral amines and diols using fluorous 
2-formylphenylboronic acid 113 
 
The detection limits for this protocol were investigated through complexation of 
scalemic samples of methyl-(2S,3R)-dihydroxy-3-phenylpropionate of 80%, 90% 
and 98% with α-methylbenzylamine and 4-fluoro-2-formylphenylboronic acid. The 
values calculated from integration of the relevant diastereomeric resonances in the 
1
H NMR spectra showed full agreement with the known enantiopurities of the 
starting diol of 80%, 90% and 98% respectively. Values calculated from the 
19
F 
NMR spectrum also showed excellent accuracy with values of 80%, 90% and 96% 
obtained respectively. 
 





Figure 27 - Expansion of the 
1
H NMR and 
19
F NMR spectra of mixtures of the diastereomeric 
complexes prepared from derivatization of methyl-(2S,3R)-dihydroxy-3-phenylpropionate of 






H NMR spectroscopy is still extremely useful for determining the 
enantiomeric excess of chiral amines and diols, this protocol demonstrates that 
19
F 
NMR spectroscopy can also be used either to validate the results obtained from 
1
H 
NMR spectroscopy, or as a complimentary analytical tool due to its comparable 
accuracy. 
In 2010, in collaboration with Tucker et al., the group developed an electrochemical 
method for determining enantiomeric excess using a variation of the three 









Scheme 53 - Enantiomeric excess determination by electrochemical analysis of iminoboronate 
ester complexes derived from ferrocene 
 
An electrochemically active coupling protocol was devised using chiral ferrocenyl 
amine 114 as a redox active amine to react with 2-formylphenylboronic acid 88 and 
BINOL to form the three component complex 116. It was reported that the 
configuration of the benzylic position adjacent of the chiral ferrocene auxiliary 
controlled the strength of the binding of BINOL enantiomers to the boronic acid. 
When the benzylic position had an (R) geometry, (R)-BINOL was more strongly 
bound to the complex than the (S) enantiomer. The opposite case was also found to 
be true, an (S) benzylic geometry resulted in (S)-BINOL binding more strongly than 
(R)-BINOL. Square wave voltammetry revealed electrochemical discrimination 
between the (R) and (S)-BINOL enantiomers since the (R,R)-complex showed a 
larger positive shift in electrode potential when compared to the (R,S)-complex 
(Figure 28). 
 





Figure 28 - Square wave voltammograms of (R)-115 in the presence of a 10-fold excess of 




Scalemic sampling showed a gradual positive shift in electrode potential as the 
enantiomeric excess of (R)-BINOL increased and a linear relationship between 
enantiomeric excess and observed electrode potential between 60% and 98% e.e., 
indicating that these redox active complexes could be used to determine 
enantiomeric excess (Figure 29). 
 





Figure 29 - Calibration curve showing linear dependence of Eobs against % e.e. of (S)-BINOL 




Subsequently, collaboration with the Anslyn group led to publication of a circular 
dichroism method for determining the enantiomeric excess of α-chiral amines using 





Scheme 54 - Three component coupling reaction between (R)-BINOL, 2-formylphenylboronic 
acid 88 and α-methylbenzylamine 
 
It was reported that the CD spectrum of the reaction between 2-
formylphenylboronic acid 88, (S)-BINOL and α-methylbenzylamine showed a 
difference in response to the presence of the (R) and (S) enantiomers of the amine. 
Generation of a calibration curve using samples of known enantiomeric excess of 




chiral amine showed a linear relationship between CD response and enantiomeric 
excess (Figure 30). 
 
 





Using a linear equation for the line of best fit it proved possible to determine the 
enantiomeric excess of an unknown sample of chiral amine based on the measured 
CD response at 240 nm after three component derivatization. It was noted that the 
method was most accurate when determining higher levels of enantiomeric excess 
(to within 1.8%). Although accuracy decreased at lower levels of enantiomeric 
excess, these values are normally less important when attempting to optimize an 
asymmetric protocol. This CD procedure was also shown to be valid for a range of 
α-chiral primary amines as well as α-methylbenzylamine. 
Recently, Suryaprakash and co-workers have employed our three-component 
protocol for the determination of the enantiomeric excess of α-hydroxy acids.110 By 
formation of an iminoboronate ester complex from 2-formylphenylboronic acid 88, 
enantiopure α-methylbenzylamine and a chiral α-hydroxy acid 117 it was 
demonstrated that the enantiopurity of the α-hydroxy acid could be determined from 
the 
1
H NMR spectrum of the resultant iminoboronate ester complexes 118 and 119 
(Scheme 55). 





Scheme 55 – 1H NMR protocol for determination of enantiomeric excess of chiral α-
hydroxyacids 
 
Suryaprakash showed that the shifts for a number of protons in the 
1
H NMR spectra 
for each of the pair of diastereomeric complexes 118 and 119 formed in the three-
component coupling reactions differed sufficiently such that accurate integration of 
these resonances could be used to calculate the enantiomeric excess of the α-
hydroxy acid employed. 
 
2.3 Results and Discussion 
This chapter has discussed the various methods for determining the enantiomeric 
excess of chiral substrates using the three-component methods developed by the 
Bull-James group that employed NMR spectroscopic analysis of diastereomeric 
complexes to determine the enantiomeric excess of chiral molecules. The discussion 
will now focus on the development of a simple synthetic protocol for the synthesis 
of α-arylglycines and the determination of their enantiomeric excess using this 
simple boronic acid based derivatization methodology. 
2.3.1 Auxiliary Controlled Strecker Syntheses of α-Arylglycines 
The Strecker reaction is often the chosen route for the synthesis of α-amino nitriles 
which can be hydrolysed to amino acids.
111,112
 This is due to the relative 
experimental simplicity and wide substrate scope of the reaction. There has been 
much research into stereoselective catalytic variants of the reaction, with both metal 








 being employed. As an alternative to 
chiral catalysts, we decided to investigate the use of chiral auxiliaries in the Strecker 
reaction. The use of α-methylbenzylamine as a chiral auxiliary for the Strecker 
reaction was first proposed by Harada.
116
 We decided to investigate the use of (S)-1-
(4-methoxyphenyl)ethanamine hydrochloride 121 as a chiral auxiliary since, this 
auxiliary can be cleaved simply with acid hydrolysis and could provide steric bulk 
to direct the incoming cyanide anion to preferentially attack the Si face of the 
intermediate iminium ion formed from reaction of (S)-1-(4-
methoxyphenyl)ethanamine hydrochloride 121 and an aryl aldehyde. The selectivity 
of the chiral auxiliary can be explained by consultation of the conformational model 
shown in Scheme 56. 
 
 
Scheme 56 - Conformational model for the auxiliary controlled addition of cyanide to an 
intermediate iminium ion 
 
In this model the lowest energy conformer would be that involving the proton and 
aryl substituents of the iminium bond being straddled by the methyl and proton of 
the (S)-1-(4-methoxyphenyl)ethanamine fragment. As the cyanide anion approaches 
along the Bürgi-Dunitz angle of 107° the Re face of the iminium bond is partially 
blocked by the positioning of the methyl group, thus there will be some directing of 
the cyanide ion towards the Si face generating (S,S)-α-amino nitrile. 




In a variant of the reported literature procedure
117,118
 benzaldehyde 120a was treated 
with (S)-1-(4-methoxyphenyl)ethanamine hydrochloride 121 and sodium cyanide in 
H2O:MeOH (1:1) and the resultant solution stirred for 16 hours at room temperature 
(Scheme 57). The hydrochloride salt of the chiral auxiliary was used since initial 
attempts using the free auxiliary resulted in relatively low yields. 
 
 
Scheme 57 – Chiral auxiliary controlled Strecker synthesis to form α-amino nitrile 122a 
 
1
H NMR spectroscopic analysis of the crude reaction mixture showed that the α-
amino nitrile product was formed in a 3:1 diastereomeric ratio in favour of the (S,S)-
122a diastereomer by integration of the α-proton resonance. Purification of the 
major diastereomer, (S,S)-122a was achieved by recrystallization of the crude 
reaction mixture from saturated methanolic HCl and diethyl ether, giving (S,S)-122a 
in a >99:1% diastereomeric ratio and 62% yield. 
This Strecker procedure was then successfully applied to a range of aryl-substituted 
benzaldehydes 120b-h which resulted in the formation of their respective α-amino 
nitriles 122b-h in diastereomeric ratios of >95:5 (Table 4). 
 




Table 4 – Chiral auxiliary controlled asymmetric Strecker reactions for the synthesis of α-
amino nitriles 122a-h 
 
a Determined by 1H NMR spectroscopic analysis. b Obtained after recrystallization of the crude product from saturated 
methanolic HCl and diethyl ether. 




It was found that for the Strecker reactions of substituted benzaldehydes 120b-f, the 
resultant α-amino nitriles were formed as 3:1 mixtures of diastereomers from which 
the major (S,S)-α-amino nitrile diastereomer precipitated out of the reaction mixture 
and was able to be collected by filtration in a >99:1 diastereomeric ratio without 
need for further purification. However, for benzaldehydes 120g,h this was not the 
case and crystalline precipitates were not afforded. However, the major (S,S)-α-
amino nitrile diastereomers 122g,h were purified via fractional crystallization of 
their crude reaction mixtures (77:23 and 80:20 d.r. respectively) from saturated 
methanolic HCl and diethyl ether in a >99:1 diastereomeric ratio. 
In this process an iminium species is formed between the aldehyde and amine 
auxiliary which subsequently undergoes stereoselective nucleophilic attack by a 
cyanide nucleophile (Scheme 58). 
 
 
Scheme 58 - Mechanism for the three-component formation of an α-amino nitrile119 
 




The relative configuration of p-tolyl substituted α-amino nitrile 122b in relation to 
the (S)-1-(4-methoxyphenyl)ethanamine hydrochloride 121 of known absolute 
configuration was assigned by X-ray crystallographic analysis (Figure 31). 
 
 
Figure 31 - X-ray crystal structure of (S,S)-p-tolyl-α-amino nitrile 122b 
  
X-ray crystallographic analysis revealed the presence of intermolecular hydrogen 
bonding within the crystal lattice between the amine proton and the lone-pair of the 
nitrile moiety (Figure 32). 
 
  
Figure 32 - Hydrogen bonding between amine and nitrile groups in the crystal structure of 
(S,S)-p-tolyl-α-amino nitrile 122b 
 




For the removal of the chiral auxiliary fragment, it had previously been reported that 
trifluoroacetic acid
120
 or formic acid/triethylsilane
121,122
 could be used to cleave the 
N-1-(4-methoxyphenyl)ethyl fragment. Thus, it was theorized that aqueous acidic 
conditions would be sufficient for removal of the auxiliary fragment from α-amino 
nitriles 122a-h whilst concomitantly hydrolysing their nitrile groups to afford the 
corresponding α-arylglycines in one-pot. Thus, (S,S)-α-amino nitrile 122a was 
heated at reflux in 6M hydrochloric acid for 4 hours which resulted in both 
hydrolysis of the nitrile moiety, and cleavage of the N-1-(4-methoxyphenyl)ethyl 




Scheme 59 - Concomitant hydrolysis and deprotection of α-amino nitrile 124a 
 
The crude product was purified by suspending the reaction mixture in chloroform 
and filtering the resultant suspension to yield (S)-α-phenylglycine hydrochloride 
124a as a white solid in a 60% yield. The absolute configuration of (S)-α-
phenylglycine 124a was confirmed by comparison of the negative sign of its 
specific rotation with that of commercially available (S)-α-phenylglycine. This 
hydrolysis and deprotection protocol was then applied to α-amino nitriles 122b-h to 
afford their corresponding α-arylglycines 124b-h in moderate yields (52-81%) and 
high enantiomeric excess (88-96%) (Table 5). 
 




Table 5 - Hydrolysis and deprotection of α-amino nitriles 122a-h to α-arylglycines 124a-h 
 
a e.e. determined by 1H NMR spectroscopic analysis of the iminoboronate complexes formed from derivatization of the 
corresponding methyl esters using 2-formylphenylboronic acid and (S)-BINOL. 




In this process the hydrolysis and deprotection steps are likely to occur in tandem 
due to the excess of aqueous acid present, however, for simplicity the relevant 
mechanisms are shown separately in Scheme 60 and Scheme 61. 
 
 
Scheme 60 - Hydrolysis of a nitrile group to a carboxylic acid 
 





Scheme 61 - Hydrolysis of the N-1-(4-methoxyphenyl)ethyl auxiliary fragment by acid 
hydrolysis 
 
It has been previously reported that acid hydrolysis of an α-amino nitrile can lead to 
some racemisation of the α-centre of the α-arylglycine product.123 As a result of this, 
it was decided to determine the enantiomeric excess of α-arylglycines 124a-h using 
our published chiral derivatization protocol.
93,94
 In order to determine the 
enantiomeric excess of these α-arylglycines they were first converted to their 
corresponding methyl esters in a quantitative yield by refluxing in hydrochloric acid 
and methanol (Scheme 62), a process known to proceed without racemisation. 
 
 
Scheme 62 - Synthesis of methyl esters 125a-h from their parent α-arylglycines 124a-h 
 





Scheme 63 – Mechanism of conversion of an α-arylglycine to its corresponding methyl ester 
 
Amino esters 125a-h were then treated with 2-formylphenylboronic acid 88, (S)-
BINOL and caesium carbonate in deuterated chloroform using our previously 
reported optimum conditions (Scheme 64). 
 
 
Scheme 64 - Derivatization of α-arylglycine methyl esters 125a-h using the Bull-James protocol 
 
This resulted in formation of mixtures of diastereomeric iminoboronate complexes 
126 and 127 whose ratio was determined by integration of the appropriate baseline 
separated diastereomeric resonances in their 
1
H NMR spectrum. The 
1
H NMR 
spectra obtained from the mixtures of diastereomeric complexes from derivatization 
of amino ester 125a with 2-formylphenylboronic acid 88, caesium carbonate and 
rac-BINOL and (S)-BINOL respectively can be seen in Figure 33. 





Figure 33 – 1H NMR spectra obtained from derivatization of amino ester 125a a) with 2-
formylphenylboronic acid 88, rac-BINOL and Cs2CO3 and b) with 2-formylphenylboronic acid 
88, (S)-BINOL and Cs2CO3. Proton resonances of the methyl ester resonances used for e.e. 
determination 
 
Analysis of the resultant 
1
H NMR spectrum for the derivatization of amino ester 
125a with rac-BINOL (Figure 33) revealed that unlike with our previously reported 
diol derivatization protocol where the imine proton resonance was a useful 
diagnostic resonance for determining enantiomeric excess, here, the imine resonance 
was not resolved and the α-proton resonance at 5.5ppm was only partially resolved. 
However, a large Δδ of around 0.5ppm was revealed for the well resolved methoxy 
resonance which was used for enantiomeric excess determination. This enabled us 
to determine that all of the α-arylglycine methyl esters produced using our 











Although the Bull-James protocol has been employed by a number of groups to 
determine the enantiomeric excess of a wide range of chiral amines (as discussed 
above) in 2009 Urriolabeitia et al. reported that racemization occurred when this 
protocol was applied to commercially available (R)-phenylglycine methyl ester.
124
 
In order to reinvestigate their report, we derivatized commercially available (S)-α-
phenylglycine methyl ester hydrochloride of known 98% enantiomeric excess with 
2-formylphenylboronic acid and (S)-BINOL. It was decided to investigate the role 
of the base and time in the derivatization protocol, since it was postulated that if the 
caesium carbonate is left in the reaction mixture for prolonged periods then 
epimerisation of the α-centre of the (S)-α-phenylglycine methyl ester might occur. 
Potassium carbonate was employed as an alternative to caesium carbonate since it is 
less soluble in chloroform, and less likely to result in unwanted epimerisation (Table 
6). 
 
Table 6 - Investigating the effect of base and reaction time on epimerisation of iminoboronate 
complexes 126a and 127a 
 
a Reaction time until filtering excess base. b d.r. determined by 1H NMR spectroscopic analysis 
 
The results in Table 6 show that when the ten minute reaction time suggested in the 
original publication of our protocol is followed that there is no evidence of any 




epimerisation at the α-centre of the (S)-α-phenylglycine methyl ester since the 
measured d.r. from the 
1
H NMR spectroscopic analysis directly correlates with the 
expected 98% e.e. of the commercial (S)-α-phenylglycine methyl ester. However, 
when the reaction was left to run for prolonged periods of time, such as for entries 2 
(5 hrs) and 3 (24 hrs) in Table 6, partial racemisation of the α-centre occurred. In 
fact, after a 24 hour period, the measured diastereomeric ratio shows that the methyl 
ester has been epimerised to such a degree that it has become essentially a 50:50 
mixture. When potassium carbonate was employed as base in the derivatization 
protocol, clean formation of the expected diastereomeric iminoboronate complexes 
is seen after ten minutes and once the excess base is filtered from the reaction 
mixture, these complexes are configurationally stable. For example, a 
1
H NMR 
spectrum acquired after 24 hours revealed that no epimerisation has occurred (entry 
5, Table 6). This confirms that potassium carbonate is an improved alternative to 




In summary, a three-component Strecker reaction for the asymmetric synthesis of α-
arylglycines has been developed employing (S)-1-(4-methoxyphenyl)ethanamine as 
a chiral auxiliary. This three-component protocol involves the addition of 
arylaldehydes to a solution of (S)-1-(4-methoxyphenyl)ethanamine and sodium 
cyanide, with the resultant crystalline diastereomerically pure α-amino nitriles 
treated with 6M aqueous hydrochloric acid to yield the corresponding α-
arylglycines. The enantiomeric excess of these α-arylglycines was determined by 
derivatization with 2-formylphenylboronic acid and (S)-BINOL followed by 
1
H 
NMR spectroscopic analysis of the resultant mixtures of diastereomeric 
iminoboronate esters. Potential problems arising from epimerisation of the α-centre 
of the α-arylglycines has been addressed by employing the less soluble base 
potassium carbonate in place of caesium carbonate in the derivatization protocol. 
Results showed that simple filtration of the base after a reaction time of 10 minutes 
completely eliminates any epimerisation from occurring.
14
  





3 A Simple Protocol for NMR Analysis of the Enantiomeric Purity 
of Chiral Hydroxylamines 
The Bull-James group has so far published chiral derivatization protocols for 









 and α-arylglycines.14 Hydroxylamines are important chiral 
molecules particularly in biochemistry, this chapter will discuss the development of 
simple methodology for their synthesis from their parent chiral amines and the 
development of the first derivatization protocol for determining their enantiopurity. 
3.1 Introduction 
Chiral hydroxylamines and their derivatives exhibit a wide range of biological 
properties,
125-128
 and have been used as substrates for a wide range of synthetic 
methodologies. This includes reaction with α-keto-acids to afford amide bonds, with 
Bode recently reporting that chemoselective amide ligations were possible by 
simply warming the two reagents in dimethylformamide, without the need for 




Scheme 65 – α-Ketoacid-hydroxylamine amide ligation 
 
In 2012, Bode reported the mechanism for these types of ketoacid-hydroxylamine 
amide forming ligation reactions involving the formation of an intermediate nitrone 
and α-lactone (Scheme 66).130 
 






Scheme 66 - Proposed mechanism for α-ketoacid-hydroxylamine amide ligation 
 
Their use as reagents for the asymmetric α-oxyacylation of cyclic ketones,131 as 
substrates for the preparation of chiral Weinreb amide derivatives
132
 and their 
condensation with aldehydes to afford chiral nitrones as substrates for asymmetric 
reactions have also been extensively reported.
133-138
 In 2002, Carreira et al. 
published the first synthesis of optically pure propargylic N-hydroxylamines from 










Scheme 67 - Asymmetric synthesis of propargylic N-hydroxylamines from nitrones 
 
Hydroxylamines have also been employed as versatile chiral building blocks for the 
preparation of chiral hydroxamic acids,
139,140
 β-amino acids,141,142 peptides143 and a 
number of natural products.
144-147
 In 1999, Holmes et al. published the synthesis of 
Histrionicotoxin 129 which employed a chiral hydroxylamine intermediate 128 as a 










Scheme 68 - Synthesis of Histrionicotoxin 129 starting from hydroxylamine 128 
 
Hydroxylamines are normally prepared via oxidation of a parent chiral amine,
148-152
 
stereoselective reduction of the corresponding oxime,
153
 or via amination of chiral 
enolates.
154
 Therefore, the development of a simple, rapid and inexpensive chiral 
derivatization protocol to enable the enantiomeric excess of chiral hydroxylamines 
to be determined by NMR spectroscopic analysis would be of great interest to the 
wider synthetic community. 
 
3.2 Results and Discussion 
3.2.1 Synthesis of Chiral Hydroxylamines 
As discussed above chiral hydroxylamines can be prepared in a number of different 
ways. 
148-154
 For our purposes, chiral hydroxylamines were synthesised from their 
parent chiral amines by adaptation of the literature procedure of Wovkulich and 










Scheme 69 - General synthesis of chiral hydroxylamines 
 
Initially, it was decided to optimise this methodology using (R)-α-
methylbenzylamine as a model substrate. Therefore, (R)-α-methylbenzylamine 130a 
was converted to its corresponding imine 132a in quantitative yield by addition of p-
anisaldehyde 131. The optimum conditions, to give the highest conversions for 
imine formation were found to be using methanol (MeOH) as solvent and 
magnesium sulphate (MgSO4) as a drying agent to drive the reaction towards 
complete imine formation after 24 hours (Scheme 70). The well-established 





Scheme 70 – The reaction between (R)-α-methylbenzylamine 130a and p-anisaldehyde 131 to 
form imine 132a 
 






Scheme 71 - Mechanism of imine formation from (R)-α-methylbenzylamine 130a and p-
anisaldehyde 131 
 
The resultant imine 132a was then oxidised with meta-chloroperoxybenzoic acid 
133 (mCPBA) in dichloromethane (CH2Cl2) at 0 °C to give oxaziridine 134a in 69% 
yield (Scheme 72). It was found that the yield of the oxidation reaction could be 
improved by first drying a solution of mCPBA in CH2Cl2 with MgSO4 and using 
anhydrous CH2Cl2 as solvent.
153,154
 Presumably, the presence of MgSO4 removes 
water from the reaction mixture, thus preventing unwanted hydrolysis of the imine 
substrate back to its parent aldehyde. A reasonable mechanism for the formation of 
oxaziridine 134a is shown in Scheme 73. 
 






Scheme 72 - Oxidation of imine 132a to oxaziridine 134a using mCPBA 133 
 
 
Scheme 73 – Mechanism of the oxidation of an imine to an oxaziridine 
 
The crude oxaziridine 134a was then transformed into its corresponding 
hydroxylamine via treatment with hydroxylamine hydrochloride in methanol to 
afford (R)-N-(1-phenylethyl) hydroxylamine 135a in 54% yield (Scheme 74). 
 






Scheme 74 – Conversion of oxaziridine 134a into hydroxylamine 135a 
 
This final step produces the hydroxylamine as its hydrochloride salt, with the free 
hydroxylamine then being precipitated in its pure form from the aqueous layer using 
a basic workup (sodium bicarbonate). 
The mechanism for the conversion of the oxaziridine 134a to its corresponding 
hydroxylamine 135a had not, to date, been discussed in the literature. In order to 
propose a mechanism for this step in the synthesis route, the composition of the 
aqueous washings after the basic workup was inspected using 
1
H NMR 
spectroscopy to determine what by-product had been formed from cleavage of the 
para-methoxybenzyl fragment. We postulated that the hydroxylamine hydrochloride 
was likely to attack the oxaziridine ring at its benzylic position to afford a bis-
hydroxylamine intermediate 136 that then fragments to afford desired 
hydroxylamine 135a and the oxime of p-anisaldehyde 131 (Scheme 75). 
 






Scheme 75 - Proposed mechanism for the conversion of an oxaziridine into a hydroxylamine 
 
In order to confirm this hypothesis, the appropriate oxime 137 was prepared 
independently by addition of hydroxylamine hydrochloride to p-anisaldehyde 131 in 
a 5:1 ethanol:water mixture (Scheme 76). 
 
 
Scheme 76 – Synthesis of oxime 137 
 
The presence of this oxime 137 as a by-product of the hydroxylamine reaction was 
confirmed in the residue obtained from the aqueous washings by comparison of its 
mass spectroscopic and 
1
H NMR spectroscopic data with that of the independently 
synthesised oxime. The confirmation of the formation of an oxime species as a by-
product of hydroxylamine formation gives credence to our proposed mechanism for 
the conversion of oxaziridine 134a to hydroxylamine 135a. 





This method was then repeated using a number of commercially available primary 
amines in order to synthesise the range of chiral hydroxylamines 135a-h shown in 
Table 7. 
 
Table 7 – Synthesis of a range of chiral hydroxylamines from their parent amines 
 





Hydroxylamines 135a-h were synthesised in moderate to good yields from their 
parent amines with their structures confirmed by the presence of a broad OH stretch 




C spectroscopic analysis. The 






 agreed with previously reported data, 
however, characterisation data was not available in the literature for hydroxylamines 
135b, 135c, 135d, 135g and 135h and is reported herein. Substitution of the aryl 
ring in analogues 135a-e was generally well tolerated with a small effect on the 
yield for the tolyl and naphthyl hydroxylamines 135d and 135e, whilst the 
conversion of amino 135f was also shown to proceed in good yield. 
3.2.2 Development of a Protocol to Determine the Enantiomeric Excess 
of Chiral Hydroxylamines 
As described, our group have previously reported the development of chiral 









 Consequently, we decided to develop a 
three component coupling protocol to accurately determine the enantiomeric 
excesses of our chiral hydroxylamines. Initially, 1.0 equivalent of (R)-N-(1-
phenylethyl) hydroxylamine 135a was treated with 1.0 equivalent of 2-
formylphenylboronic acid 88, 1.1 equivalents of (rac)-BINOL and 1.1 equivalents 
of caesium carbonate (Cs2CO3) in CDCl3 in the presence of MgSO4 and the resultant 
reaction mixture stirred for 15 minutes. 
 
 
Scheme 77 – Three component NMR protocol for determining the enantiomeric excess of chiral 
hydroxylamines 
 





The reaction mixture was then filtered and a 
1
H NMR spectrum acquired, which 
revealed the clean formation of a 50:50 mixture of diastereomeric nitrono-boronate 
ester complexes (R,R)-138a and (R,S)-139a in a quantitative yield, with baseline 
resolution observed for the benzylic and methyl protons of each diastereomer 
respectively. This meant that the relative intensities of the two different sets of 
diastereomeric integrals could potentially be compared to accurately determine the 
enantiopurity of a scalemic sample of the parent hydroxylamine by 
1
H NMR 
spectroscopy (Figure 34). 
 
 
Figure 34 - 
1
H NMR spectrum of nitrono-boronate diastereomers 138a and 139a 
 
11
B NMR spectroscopic analysis of the resultant mixture of diastereomeric 
complexes formed by derivatization of hydroxylamine 135a showed a single 
resonance at 11.8 ppm for the boronate environment and 
1
H NMR spectroscopic 
analysis revealed the diastereomeric imine resonances to be at 7.93 ppm and 8.23 
ppm. The comparable resonances for the diastereomeric iminoboronate complexes 









hydroxylamine 135a) are at 14.0 ppm in the 
11
B NMR spectrum for the boronate 
environment and 8.16 ppm and 8.33 ppm for the imine resonances in the 
1
H NMR 




H NMR spectra indicated to us 
that nitrono-boronate structures were formed in the derivatization reactions with 
coordination of the hydroxylamine oxygen to the boron atom. 
The structure of these nitrono-boronate complexes was then confirmed by X-ray 
crystallographic analysis (vide infra). This class of compound has not been 
extensively reported in the literature,
158,159





 in the 1960’s via the reaction of 2-formylphenylboronic acid 88 and 
hydroxylamine (Scheme 78). 
 
 




To investigate the scope and limitations of this chiral derivatization protocol further, 
the remaining hydroxylamines 135b-h were then derivatized under the same 
conditions. Analysis of the 500 MHz 
1
H NMR spectra of the resultant nitrono-
boronate esters 138b-h/139b-h revealed baseline resolution of at least two sets of 
resonances had occurred in all cases. For example, analysis of the 500 MHz 
1
H 
NMR spectrum of a 50:50 mixture of nitrono-boronate esters 138e and 139e 
revealed that baseline resolution had occurred for three distinct sets of resonances 
with the largest Δδ value of 0.193 ppm being observed for their imine protons. In all 
cases splitting of the α-protons and methyl protons of the hydroxylamine fragments 
of 138a-h/139a-h were observed. Contrary to the previously reported protocols by 
the Bull-James group using iminoboronate complexes,
93,95
 baseline resolution of the 
imine protons of complexes 138a-h/139a-hwas not achieved in all cases. This was 





because they were obscured by aromatic resonances, although baseline resolution of 
the imine protons of the complexes 138a-h/139a-h was observed. 
The individual resonances of each pair of diastereomers were assigned by 
comparison with the 
1
H NMR spectra of authentic samples of diastereomerically 
pure 138a-h and 139a-h that were prepared independently via separate reaction of 
enantiopure hydroxylamines 135a-h with (R)-BINOL and (S)-BINOL respectively. 
The Δδ differences in the chemical shifts observed for each pair of diastereomeric 
nitrono-boronate esters are reported in Table 8. Independent preparation of 138a-h 
and 139a-h from reaction of hydroxylamines 135a-h with (R)-BINOL and (S)-
BINOL respectively also demonstrated to us that the synthetic protocol for 
converting an enantiopure amine into a hydroxylamine via an oxaziridine proceeded 
with full retention of stereochemistry and thus yielded enantiopure hydroxylamines 
in all cases since, using the example of the preparation of 138a, only a single quartet 
at 5.15 ppm and single doublet at 1.75 ppm were seen in the resultant 500 MHz 
1
H 
NMR spectrum after derivatization. Had loss of stereochemistry occurred during 
this synthetic protocol to yield hydroxylamine 135a then the 
1
H NMR spectrum of 
138a would have contained diastereomeric resonances, such as those seen in Figure 
34, whose integrals would have corresponded to the enantiopurity of the 
hydroxylamine. 
 





Table 8 - Chemical Shift Differences in the 500 MHz 
1
H NMR Spectra of 50:50 Mixtures of 
Diasteromers 138a-h and 139a-h Derived from Hydroxylamines 135a-h 
 
a Diastereomer 138 corresponds to homochiral (R,R) or (S,S)-complex, and diastereomer 139corresponds to heterochiral (R,S) 
or (S,R) complex. b A negative value for Δδ indicates that the resonance corresponding to the heterochiral diastereomer 139 is 
more deshielded than that of the homochiral diastereomer 138. c Δδ calculated for imine carbon resonances of 13C NMR 
spectrum of 138h/139h. 
  





The resonances of the α-protons of the heterochiral diastereomers 139a-h were 
found to be shielded relative to the resonances for their corresponding homochiral 
diastereomers 138a-h. Conversely, the resonances of the α-methyl protons of the 
heterochiral diastereomers 139a-h were deshielded relative to the resonances of 
their corresponding homochiral diastereomers 138a-h. Therefore, consideration of 
the sign of the Δδ value could potentially be used to assign the unknown 
configuration of chiral α-methyl, α-aryl hydroxylamines formed in asymmetric 
protocols. 
The detection limit of this protocol was determined via derivatization of three 
samples of (rac)-BINOL of 98%, 80% and 0% with enantiopure hydroxylamine 
135b and 2-formylphenylboronic acid. Scalemic samples of BINOL and 
enantiopure hydroxylamine were used in this study for experimental convenience. 
However, it follows that use of enantiopure BINOL would enable the enantiopurity 
of a scalemic sample of hydroxylamine 135b to be determined. 
Analysis of the 
1
H NMR spectrum of each sample revealed that the calculated 
diastereomeric ratio of the resultant mixture of (S,S)-138b and (S,R)-139b were in 
good agreement with the known enantiopurity of the starting hydroxylamine 135b 
(Figure 35). 
 






Figure 35 - Expansion of the methoxy region of the 
1
H NMR spectra of mixtures of complexes 
138b and 139b prepared from hydroxylamine (S)-135b, 2-formylphenylboronic acid 88 and 
samples or (R)-BINOL of 0%, 80% and 98% e.e. 
 
For example, the integrals measured from the 
1
H NMR spectra of mixtures for the 
methoxy groups of (S,S)-138b and (S,R)-139b of 98%, 79% and 0% dr were in 
excellent agreement with the known enantiopurity of the starting BINOL of 98%, 
80% and 0% e.e. respectively, indicating that no kinetic resolution had occurred 
during derivatization. These values are well within the 5% error limit normally 
accepted for CDA analysis using NMR spectroscopy,
169,170
 demonstrating that this 
derivatization protocol is a highly effective, cheap and fast method for determining 
the e.e. of hydroxylamines. 
Application of this derivatization protocol to hydroxylamine 135h proved 
problematic, because the α-protons of its diastereomeric nitrono-boronate esters 





138h and 139h were not baseline resolved in its 
1
H NMR spectrum, whilst its α-
methyl protons were obscured by resonances from its alkyl backbone. This meant 
that no pairs of diastereomeric resonances were baseline resolved, thus preventing 
the enantiopurity of the parent hydroxylamine 135h from being determined by 
1
H 
NMR spectroscopy. However, inspection of the 
13
C NMR spectrum of a 50:50 
mixture of nitrono-boronate esters 138h and 139h revealed that baseline splitting 
had occurred for all of the diastereomeric resonances (Figure 36). 
 
 
Figure 36 - Expansion of the 
13
C NMR spectrum of the imine proton of a mixture of 138h and 
139h prepared from (R)-135h, 2-formylphenylboronic acid 88 and (R)-BINOL of 0%, 80% and 
90% e.e. 
 





In order to enable accurate integration of the peak areas of pairs of diastereomeric 
resonances of nitrono-boronates 138h/139h these 
13
C NMR experiments were 
carried out using a d1 delay between pulses of 120 seconds which allows T1 
relaxation to recover fully (the T1 relaxation is the measurement of how quickly the 
net magnetisation vector recovers to its thermodynamic equilibrium in the direction 
of the magnetic field Bo). The experiments were also performed using an inverse-
gated decoupling pulse sequence, this turns off the 
1
H decoupler during the 120 
second recycle delay which stops any NOE build-up (the transfer of nuclear spin 
polarization from one nuclear spin population to another via cross relaxation) which 
can enhance the 
13
C signals in a non-uniform manner. 
As before, samples of BINOL of 90%, 80% and 0% e.e. were derivatized using 
enantiopure (R)-135h and 2-formylphenylboronic acid. Measurement of the 
integrals of the 
13
C NMR spectrum of these mixtures of (R,R)-138h and (R,S)-139h 
revealed d.r.s of 91%, 82% and 0% which were in excellent agreement with the 
known enantiopurity of the starting BINOL. 
X-ray crystallographic analysis of diastereomer (S,R)-139d prepared from (S)-
hydroxylamine 135d and enantiopure (R)-BINOL and recrystallized from deuterated 
chloroform showed that its nitrono-boronate structure was clearly different to the 5-
membered iminoboronate ester reported previously for derivatization of amines 





Figure 37 – X-ray crystal structure of nitrono-boronate ester (S,R)-139d 





Nitrono-boronate ester (S,R)-139d has a tetrahedral sp
3
 boron atom whose presence 
in solution was also confirmed by 
11
B NMR spectroscopic analysis which revealed a 
single resonance visible at δ12.0 ppm. However, in contrast to the iminoboronate 





 arrangement. Further inspection of the crystal structure reveals that its 6-
membered ring is comprised of coplanar carbon, nitrogen and oxygen atoms with its 
spirocyclic boron atom occupying the bow position of a half-chair conformer. 
 
3.3 Conclusions 
In conclusion, a range of chiral hydroxylamines have been synthesised and the first 
known chiral derivatization protocol for determining the enantiopurity of chiral 
hydroxylamines by NMR spectroscopy has been developed.
171
 The range and scope 
of this protocol has been investigated by successfully applying it to a range of chiral 
hydroxylamines, with scalemic sampling proving its accuracy. 
1
H NMR 
spectroscopy has been shown as a quick and effective tool for the determination of 
enantiomeric excess and where this is not possible 
13
C NMR spectroscopy has been 
shown as an accurate alternative. Finally, a mechanism has been proposed for the 
conversion of an oxaziridine intermediate into the product hydroxylamine, which 
was confirmed by isolation of an oxime by-product formed during the synthesis. 
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4 A Simple Protocol for NMR Analysis of the Enantiomeric Purity 
of Chiral Diols Using an Achiral Diboronic Acid Template 
4.1 Introduction 
The following chapter details our investigation into the development of a new 
derivatization protocol for determining the enantiomeric excess of chiral diols. Our 
aim was to employ a bifunctional, achiral template as a derivatization agent to yield 
a series of heterochiral and homochiral diastereomers from which enantiomeric 
excess could be determined by 
1
H NMR spectroscopic analysis. 
4.1.1 The Horeau Principle 
First discovered in the late 1960’s “The Horeau Principle” involves the formation of 
a series of homochiral and heterochiral diastereomers from a bifunctional achiral 
auxiliary and two equivalents of a chiral substrate.
172-174
 The application of this 
principle was first reported by Horeau for the enhancement of optical purity through 
duplication.
173
 Using an example of the reaction between malonyl chloride and two 
equivalents of scalemic 1-phenylethanol to form a series of diastereomeric 
malonates, Horeau demonstrated how material of 90% enantiomeric excess could be 
enhanced to an enantiomeric excess of 99.4% in a single duplication (Scheme 79). 
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Scheme 79 – A single Horeau duplication to enhance (R)-1-phenylethanol from 90% e.e. to 
99.4% e.e. 
 
If no chiral recognition occurs and diastereomer formation is statistical then one 
equivalent of 1-phenylethanol will react with one equivalent of malonyl chloride to 
form the mono-substituted products in the same ratio as the enantiomeric ratio of the 
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1-phenylethanol. For the second addition of 1-phenylethanol to form the 
diastereomeric dimers the statistical addition will form products in the following 
ratios: the mono-substituted (R) enantiomer (95%) will react with the scalemic 1-
phenylethanol to give 90.25% of the (R,R) diastereomer (0.95 x 0.95 = 0.9025) and 
4.75% of the (R,S)-meso-diastereomer (0.95 x 0.05 = 0.0475). Additionally, the 
mono-substituted (S) enantiomer (5%) will react with the scalemic 1-phenylethanol 
to give 0.25% of the (S,S) diastereomer (0.05 x 0.05 = 0.0025) and 4.75% of the 
(S,R)-meso-diastereomer (0.05 x 0.95 = 0.0475). Of these four diastereomers, the 
(R,R) and (S,S) diastereomers make up an enantiomeric pair and the (R,S) 
diastereomer and its apparent (S,R) “enantiomer” are actually identical and are the 
meso compound. Thus, after removal of the meso compound from the mixture of 
diastereomeric products, the enantiomeric pair are present in a 90.25:0.25 ratio 
which when normalised amounts to an enantiomeric ratio of 99.7:0.3 (99.4% 
enantiomeric excess). This process removes the minor (S)-1-phenylethanol 
enantiomer through incorporation into the meso compound which can potentially be 
separated. Therefore if hydrolysis of the homochiral diester product proceeds with 
retention of the 99.7:0.3 stereochemical ratio then the (R)-1-phenylethanol is 
isolated in an enantiomeric excess which has been enhanced from 90% to 99.4%. 
Horeau also proposed that sequential use of this method could enhance chiral 
material of 30% enantiomeric excess to 98.6% over three rounds. However, the 
disadvantage to this procedure is that there is a loss in yield when separating out the 
meso compound, and as the enantiomeric ratio of the chiral substrate tends towards 
racemic, the greater the amount of material will be lost to the meso compound. 
Sequential duplications will compound the effect further, but as rigorously chirally 
purified substrates are highly desirable to asymmetric synthetic protocols a loss in 
yield can become acceptable if it results in isolation of an essentially enantiopure 
chiral substrate. 
Horeau’s method is an example of a positive non-linear effect, a phenomenon which 
has been investigated extensively by Kagan and co-workers as applied to 
asymmetric amplification
175
 and asymmetric catalysis.
176,177
 In asymmetric catalysis, 
it is often accepted that the enantiomeric excess of the product is linearly correlated 
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to the enantiomeric excess of the chiral auxiliary employed, such that it obeys the 
relationship in Equation 1. 
 
 𝑒. 𝑒.𝑚𝑎𝑥 =  𝑒. 𝑒.𝑝𝑟𝑜𝑑𝑢𝑐𝑡 / 𝑒. 𝑒.𝑎𝑢𝑥𝑖𝑙𝑖𝑎𝑟𝑦 (1) 
 
However, as noted by Kagan et al., this does not take into account potential 
interactions between dimeric catalytic species.
178
 It was reported that for a system 
that forms diastereomeric catalytic complexes from two equivalents of chiral ligand 
(an ML2 system), if the chiral ligand is not enantiopure then three different 
diastereomeric catalytic complexes will be formed: MLRLR, MLSLS and MLRLS, 
where MLRLS is the meso catalyst. The amounts of each of the three different 
complexes, if no chiral recognition occurs on formation, will be distributed as 
described above for the formation of diastereomers according to Horeau’s 
duplication method. If the meso complex is less catalytically active than the 
homochiral enantiomeric catalysts then a positive non-linear effect is observed 
(curve B, Figure 38) whereby the enantiomeric excess of the product is higher than 
expected. Conversely, if the meso complex is more catalytically active than the 
homochiral catalyst, a negative non-linear effect is observed (curve C, Figure 38) 
whereby the enantiomeric excess of the product is less than expected as according to 
Equation 1.  
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4.1.2 Enantiomeric Excess Determination by the Horeau Method 
Over a decade after Horeau’s work was published, a number of groups developed 
methodologies using his findings to determine enantiomeric excess of chiral 
molecules with NMR spectroscopy. The first of these published methodologies was 
in 1985 by Marty et al., where the enantiomeric excess of 1-diphenylphosphino-2-










Scheme 80 – Diastereomeric nickel complexes for determining the enantiomeric excess of chiral 
thiols 
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Addition of Ni(NO3)2·6H2O to thiol 140 led to formation of a diastereomeric series 
of trans-nickel complexes of which two were an enantiomeric pair and a meso 
complex. The meso:enantiomer ratio was then determined from integration of P and 




H NMR spectra of the resultant diastereomeric 
mixture and Marty reported that it was possible to determine enantiomeric excess to 
within 0.1% of the known values. 
A large amount of the early research into this area was reported by Feringa et al. 












spectroscopy. Feringa’s initial study showed that addition of PCl3 to racemic alcohol 
produced a series of phosphonate diastereomers, two of which were an enantiomeric 










P NMR spectra of the dimers formed from the addition of PCl3 to a chiral 
alcohol showed that the meso:enantiomer ratio calculated from the corresponding 
resonance integrations gave excellent agreement to within 1% of the 50:50 
enantiomeric ratios of the starting alcohol for a range of structurally diverse 
alcohols. 
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A further report by Feringa et al. attempted to use the same methodology for 
determining the enantiomeric excess of chiral thiols.
181
 However, this was shown 
not to be possible and a new modified reagent was developed, with 
methylphosphonic dichloride 141 shown to be an effective reagent to form 
diastereomeric phosphonates from chiral thiols (Scheme 82). 
 
 
Scheme 82 - Methylphosphonic dichloride as a coupling reagent for chiral thiols 
 
Once again the ratios obtained from 
31
P NMR spectra showed excellent agreement 
with those expected for racemic thiols. This new methodology was also reported to 
be applicable to chiral alcohols, however, reaction times were longer than when 
using PCl3 and chemical shift differences (Δδ) were slightly reduced. 
Methylphosphonic dichloride 141 has a number of advantages over PCl3 as it is a 
solid and thus easier to handle and can also be used with acid sensitive alcohols. 
This type of coupling reagent was further investigated in order to determine the 
optimum structure of the reagent by modifying the heteroatom (between O and S) 
and the length of the alkyl chain.
182
 It was found that methylphosphonic dichloride 
141 was the optimum coupling reagent as it gave the largest chemical shift 
differences between the enantiomeric pair and the corresponding meso diastereomer. 
Feringa’s research extended to developing a method for determining the 
enantiomeric excess of chiral amines and amino esters.
183
 Methylphosphonothioic 
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dichloride 142 was shown to be the reagent of choice since the previously reported 
PCl3 and methylphosphonic dichloride 141 proved not to be effective coupling 
reagents for these types of compound (Scheme 83). 
 
 
Scheme 83 - Methylphosphonothioic dichloride as a coupling reagent for amino esters 
 
This methodology was demonstrated to proceed without racemization or kinetic 
resolution for the formation of the Horeau series of phosphonic diamide 
diastereomers. A number of optically active amines of known enantiomeric excess 
were successfully derivatized and integration of the relevant signals in the 
31
P NMR 
spectra determined the enantiomeric excess of chiral amines to within 3% of true 
values. 
In 1993, Marinetti et al. demonstrated a method for determining the enantiomeric 
excess of optically active phosphiranes as part of their report into the synthesis of 
such compounds.
184
 Marinetti reported that addition of enantiomerically pure (R)-
styrene oxide to molybdenum complex 143 yielded diastereomeric 
(phosphirane)Mo(CO)5 complexes with the phosphirane then liberated by a ligand 
displacement reaction with 1,2-bis(diphenylphosphino)ethane. It was then reported 
that addition of the resultant phosphirane to (COD)2RhPF6 produced a 
diastereomeric series of rhodium compounds of which the meso and chiral 
complexes are easily differentiated by 
1
H NMR spectroscopy (Scheme 84). 
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Scheme 84 - Formation of diastereomeric rhodium complexes to determine the enantiomeric 
excess of phosphiranes by 
1
H NMR spectroscopy 
 
Grotjahn et al. reported a method for measuring the enantiopurity of chiral amines 
which employed non-chiral derivatization agent 144.
185
 By dimerization of (rac)-α-
methylbenzylamine using triphosgene and triethylamine, a Horeau series of 
diastereomeric ureas were synthesised (Scheme 85). 
 
 
Scheme 85 - Formation of diastereomeric urea complexes for determining the enantiopurity of 
chiral amines 
 
Analysis of the 
1
H NMR spectrum of this diastereomeric mixture showed two 
doublets around δ1.30 ppm corresponding to the meso and enantiomeric pair of 
diastereomers in a ratio of 1:1.04 ±0.05, showing good agreement with the expected 
1:1 ratio for a racemic compound. 
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The use of a diol template to form diastereomeric dimers of chiral carboxylic acids 
was reported by Heumann et al. to determine their enantiomeric excess.
186
 After 
investigating a number of diol templates, 2,2-dimethyl-1,3-propanediol 145 was 
found to be the most effective reagent with esterification proceeding with no kinetic 
resolution, or epimerisation of the acid (Scheme 86). 
 
 
Scheme 86 - Esterification with an achiral diol for determining the enantiomeric excess of 
carboxylic acids 
 
Heumann demonstrated that 
1
H NMR spectroscopic analysis of the resultant diesters 
gave clearly defined resonances for the meso and enantiomeric complexes with the 
enantiomeric excess of the carboxylic acids inferred from integration of these 
resonances. This protocol was employed to determine enantiomeric excess up to 
99% with a high degree of accuracy. 
Platzer et al. reported another method for determining the enantiomeric excess of 
carboxylic acids by formation of praseodymium dimers.
187
 By reaction of 
carboxylates with tris(tetraphenylimidodiphosphinato)praseodymium a series of 
diastereomeric praseodymium dimer species were formed. The enantiomeric excess 
of the carboxylic acid was able to be determined from a number of baseline 
separated resonances in the 
1
H NMR spectrum of the diastereomeric mixture. 
More recently, Eames et al. reported another protocol for determining the 
enantiomeric excess of chiral carboxylic acids.
188
 However, unlike the method 
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 Eames’ method removed the need for a coupling template 
and instead, with a direct coupling between two carboxylic acid molecules being 
used to form diastereomeric complexes (Scheme 87). 
 
 
Scheme 87 - Direct homocoupling of α-aryl carboxylic acids in order to determine their 
enantiomeric excess 
 
4.1.3 Enantioenrichment of Intermediates during Synthesis 
There have been a number of reports in the literature where the phenomenon 
discovered by Horeau
173
 has been used to enantioenrich intermediates during 
synthetic protocols. Fleming et al. reported one such exploitation during the 
synthesis of nonactin.
189,190
 Using Horeau’s method Fleming was able to 
demonstrate the enantioenrichment of of (1R)-1-(1’-naphthyl)ethanol 146 from 92% 
to essentially enantiopure levels by dimerization to form an oxalate bis-ester 147 
(Scheme 88). 
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Scheme 88 - Enantioenrichment of naphthalene alcohol 146 during the synthesis of nonactin 
 
After derivatization, removal of the meso compound from the diastereomeric 
mixture was achieved through recrystallization, leading to an enantiomeric mixture 
with an enhanced enantiomeric excess of 99.6%. The oxalates were then hydrolysed 
to return the naphthalene alcohol 146 which has its enantiopurity enhanced from 
92% to 99.6%, albeit with a loss of yield due to removal of the meso diastereomer. 
As part of their reported synthesis of (E)-allylsilanes, Suginome and co-workers 
used the formation of cyclic dimer intermediates from disilanyl ethers of moderate 
enantiomeric excess (79.2% e.e.), in order to synthesise the desired allylsilanes with 
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Scheme 89 - Enantioenriched synthesis of (E)-allylsilanes 
 
In order to achieve the enhancement, Suginome’s synthetic protocol starts with 
disilanyl ether 148 of 79.2% enantiomeric excess which undergoes intramolecular 
bis-silylation, catalysed by palladium(II) acetylacetonate, to give oxasiletane 149. 
This subsequently dimerises to form cyclic species 150. The dimerization step forms 
three diastereomeric species, two of which are an enantiomeric pair and the other of 
which is the meso compound. The chiral material in this mixture was removed by 
recrystallization and although this led to a loss of around 24% of the overall yield, 
this chiral material had an enhanced enantiomeric excess of 99.4%. This 
enhancement occurs as a result of a large portion of the minor enantiomer of the 
disilanyl ether starting material being removed via incorporation into the meso 
compound. 
Farina et al. demonstrated an extension to the Horeau method which utilised the 
formation of trimers to enhance the enantiopurity of triisopropanolamine for the 
synthesis of different stereoisomers of trimethylboratrane 152.
192
 Three equivalents 
of scalemic propylene oxide were added to ammonia solution to form 
triisopropanolamine (Scheme 90) and it was discovered that small amounts of the 
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undesired propylene oxide isomer had no effect on the enantiopurity of the 
symmetrical triisopropanolamine isomer 151. 
 
 
Scheme 90 - Enantioenhancement of triisopropanolamine by trimerisation 
 
Farina concluded that trimerisation could potentially become a more powerful tool 
for enhancement of the enantiopurity of intermediates and that the technique could 
be further extended to the formation of tetramers. However, tetramerisation would 
potentially result in a large number of side products which would need to be 
removed, reducing the overall yield of the target molecule and so in practice is 
likely to be a less useful technique. 
Servi et al. used Horeau’s approach to enantioenrich key intermediate 155 in the 
synthesis of an amino alcohol intermediate 157 used for the industrial synthesis of 
(S)-timolol.
193
 Using terephthaloyl dichloride 153 as a linker to join two molecules 
of isopropylideneglycerol 154, Servi was able to synthesise the resultant diester in 
an enhanced enantiopurity (Scheme 91). 
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Scheme 91 - Enantioenrichment of diester 155 using an achiral bis-acid chloride 153 
 
The meso compound was easily removed in a single recrystallization when seeded 
with the desired enantiomer. The enantiopurified diester was then taken through to 
the tert-butylamino derivative 156 which was then converted to the amino alcohol 
157 by refluxing in methanol (Scheme 92). 
 
 
Scheme 92 - The use of enantioenriched diester 155 for the synthesis of timolol intermediate 
157 
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This enantioenriching synthesis yielded enantiopure (S)-1-(tert-butylamino)propane-
2,3-diol hydrochloride 157, a key intermediate in the industrial synthesis of (S)-
timolol, eliminating the need to use strictly enantiopure isopropylideneglycerol 154 
as a reagent. 
Recently, Khiar et al. have shown how the Horeau method can be used to synthesise 
enantiopure bis-sulfoxide ligands for use in the 1,4-addition of boronic acids to 
electron deficient alkenes.
194
 Diacetone-D-glucose methanesulfinate 158 was treated 
with ferrocenyllithium to form the methylsulfoxide 159 which subsequently 
underwent copper catalysed oxidative dimerization to afford the desired bis-
sulfoxide ligand 160 (Scheme 93). 
 
 
Scheme 93 - Enantiomerically enhanced synthesis of a ferrocenyl bis-sulfoxide ligand 
 
Due to the dimerization step, Khiar was able to synthesise the bis-sulfoxide ligands 
with an enhanced enantiopurity based on the parent methylsulfoxide by removal of 
the (R,S)-meso compound by column chromatography. This synthetic protocol 
produced C2-symmetric ligands in high enantiomeric purity which were then used 
for the enantioselective 1,4-addition of boronic acids to alkenes with enantiomeric 
excesses of the resultant cyclic ketones as high as 97%. 
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In 2002, Hoffmann et al. reported a Horeau amplification for an important 
intermediate as part of their synthetic protocol for the preparation of a 
conformationally flexible β-hairpin mimetic.195 These types of structures are 
designed to be incorporated into peptidic structures in order to create foldamers. 
Alcohol 161 was used to synthesise the two building blocks 162 and 163 which 
were subsequently coupled using a Julia-olefination (acetylation and Na/Hg 
reduction) to yield the (E)-alkenoate 164 (Scheme 94). 
 
 
Scheme 94 - Enantiomerically amplified synthesis of (E)-alkenoate intermediate 164 
 
Although the enantiomeric excesses of the starting alcohol 161 and the two building 
blocks 162 and 163 were 87%, due to a Horeau amplification, the Julia-olefination 
coupling reaction resulted in the desired enantiomer of the alkenoate product being 
produced in an enhanced enantiomeric excess. The undesirable meso-diastereomer 
could be removed by flash column chromatography leaving the desired compound 
in 98% enantiomeric excess. This highly enantiopure material was then converted 
via four further transformations into β-hairpin mimetic 165 (Figure 39). 
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Figure 39 - β-hairpin mimetic 165 
 
4.1.4 Enantioenrichment of Chiral Substrates 
The Horeau principle has also been applied by a number of groups for the 
enantioenrichment of chiral substrates by kinetic resolution, whereby a substrate of 
moderate to high enantiomeric excess can by enhanced to essentially enantiopure 
levels.
196
 BINOL is an important chiral ligand for asymmetric organic synthesis and 
thus a method for obtaining a single enantiomer of BINOL in a quick and simple 
manner is highly desirable. Periasamy et al. demonstrated such a method by forming 
B2L3 complexes from scalemic BINOL and boric acid, where each BINOL unit 
bridges between the two boron atoms (Scheme 95).
197
 NMR data suggested the 





Scheme 95 - Formation of a B2L3 complex to enhance the enantiopurity of BINOL 
 
The optimal conditions for this method were reported to be with a 5:2 ratio of 
BINOL to boric acid, refluxed in acetonitrile. TMEDA was then added to the 
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reaction mixture which caused the symmetrical RRR or SSS complex to be 
precipitated in high enantiomeric excess leaving a soluble mixture of low e.e. 
complexes behind in the filtrate. The enantioenriched BINOL was then liberated 
from the symmetrical complex by addition of dilute HCl. This enrichment protocol 
proved highly successful with scalemic BINOL of 52% e.e. being enriched to 95%. 
In 2008, Paine et al. demonstrated the application of the Horeau principle to enrich 
the enantiomeric excess of commercial samples of scalemic menthol.
199
 As part of 
their research into using para diesters of menthol as resolving agents for chiral 
amines it was shown that commercially available scalemic D-menthol 167 could be 
used to form diesters with pyromellitic dianhydride 166. A series of diastereomers 
168 were formed, with the homochiral para enantiomeric pair being removed from 
the reaction mixture by fractional recrystallization (Scheme 96). 
 
 
Scheme 96 - Chiral purification of D-menthol 167 via formation of diesters 
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The para-diester obtained from the crystallization was of an increased enantiopurity 
compared to the scalemic menthol due to removal of the L-enantiomer through its 
incorporation in the meso compound. The desired D-menthol is then liberated from 
the diester by base hydrolysis with sodium hydroxide to yield the desired 
enantiomer with a chiral enhancement from 96% to 99.95% e.e. (Scheme 97). 
 
 
Scheme 97 - Liberation of essentially enantiopure D-menthol after diester formation 
 
Research into the origins of homochirality in nature
200
 has also led to the discovery 
of systems that are able to enhance the enantiopurity of chiral substrates through 
autocatalysis.
201,202
 In 1995, Soai et al. reported the amplification of the 
enantiomeric excess of a 5-pyrimidyl alkanol 169 from 2% to 88% by reaction with 
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Scheme 98 - Enantioenrichment of 2-methyl-1-(5-pyrimidyl)propan-1-ol 169 by autocatalysis 
 
In this autocatalytic process Soai reported that pyrimidyl alcohol 169 of low 
enantiomeric excess reacts with diisopropylzinc to form alkoxide intermediate 170. 
This compound then acts as an improved catalyst for the addition of diisopropylzinc 
to pyrimidine-5-carboxaldehyde 171 yielding further amounts of alkoxide 170 with 
an increased enantiomeric excess. This alkoxide is then hydrolysed to pyrimidyl 
alcohol 169 of an improved enantiomeric excess which can be cycled back into the 
protocol to sequentially increase the enantiomeric excess up to 88%. 
Soai et al. then published an improved model for autocatalysis in 1999 and reported 
that functionalization of the pyrimidyl ring at the 2-position with an alkynyl group 
increased the enantioselectivity of the autocatalyst, yielding pyrimidyl alkanols with 
>99.5% enantiomeric excess and in a 99% yield. To achieve these high levels of 
conversion and enantioselectivity, 1-(2-tert-butylethynyl-5-pyrimidyl)-2-methyl-1-
propanol 172 was employed as autocatalyst (Figure 40). 
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Figure 40 - The structure of autocatalyst 1-(2-tert-butylethynyl-5-pyrimidyl)-2-methyl-1-
propanol 172 
 
The mechanism of Soai’s autocatalysis reaction has been investigated by 
Blackmond et al. and was reported to involve formation of a series of 
diastereomeric dimers which provide a positive non-linear effect akin to Kagan’s 
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Scheme 99 - Formation of diastereomeric dimer catalysts in Soai's autocatalysis reaction 
 
Blackmond reported that the meso diastereomer 174 is inactive as a catalyst leading 
to an enantioenhancement and positive non-linear effect in the same manner as 
reported by Horeau and Kagan.
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 The homochiral diastereomeric dimers formed 
from two molecules of pyrimidyl alcohol 173 and diisopropylzinc position the Zn 
atoms well for coordination to aldehyde 175, this is then attacked by diisopropylzinc 
yielding the enantioenhanced alkoxide which after hydrolysis gives the desired 
pyrimidyl alcohol 173 in a higher enantiomeric excess. 
More recently, Blackmond et al. have proposed alternative intermediate species, 
dimer 176 and tetramer 177, derived from 
1
H NMR analysis and DFT calculations 
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Figure 41 - The structures of dimer 176 and tetramer 177: autocatalysis intermediates 
proposed from 
1
H NMR analysis and DFT calculations 
 
In 2007, Blackmond reported the formation of hydrogen bonded diastereomeric 
complexes in solution as a method of enantioenrichment of amino acids.
207
 It was 
reported that treatment of scalemic solutions of amino acids with carboxylic acid 
additives such as fumaric acid and oxalic acid led to an increase in the enantiomeric 
excess of the amino acid in solution. This effect is due to the formation of 
diastereomeric hydrogen bonded complexes, with the solubility of the heterochiral 
complex being greatly inhibited (Figure 42), leading to its crystallization out of 
solution, leaving behind a solution of enhanced enantiopurity. 
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Figure 42 – Proposed structure of the heterochiral diastereomeric complex formed between 
phenylalanine and fumaric acid 
 
Enantioenhancement in solution was reported for a range of chiral amino acids, with 
enhancement to essentially enantiopure levels reported for leucine with oxalic acid 
as an additive, and the use of fumaric acid as an additive for both valine and 
phenylalanine. 
The phenomenon of amino acids having a different enantiomeric excess in solution 
compared to the solid state has been reported to occur without carboxylic acid 
additives as well. In 2006, Blackmond reported that scalemic proline exhibits an 
enantiomeric excess of 50% as a solution in DMSO whilst scalemic serine, at its 
eutectic point in water, exhibits an enantiomeric excess of >99% in solution under 
solid-liquid equilibrium conditions.
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 At high catalyst concentrations where solid 
amino acid is in equilibrium with dissolved amino acid, the solid is composed of 
1:1, L:D crystals, with the solution exhibiting a higher enantiomeric excess by 
removal of material of low enantiomeric excess in the crystalline phase. These 
solutions were then shown to cause enantioenhancement in proline catalysed aldol 
reactions, since, despite solid proline of low enantiomeric excess being present, the 
available catalyst in the solution phase is of higher enantiomeric excess (Scheme 
100). 
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Scheme 100 - L-proline catalysed aldol reaction 
 
Blackmond noted that non-linear effects in asymmetric catalysis may not be, in 




In 1991, Carman et al. reported the fractionation of scalemic natural product 179 on 
preparative HPLC silica gel columns.
210
 Cineole 178 is converted to alcohol 179 by 
the female Australian brushtail possum and excreted through urine (Scheme 101). 
 
 
Scheme 101 - The female brushtail possum converts cineole 178 into alcohols 179a and 179b in 
a 40% enantiomeric excess 
 
It was reported that chromatography of a sample of 179 of 40% enantiomeric excess 
caused fractionation on the achiral silica gel column affording initial fractions 
containing 179 in an 80% enantiomeric excess. It was hypothesised that this was 
due to the adhesion of a chiral moving phase onto the silica gel column thereby 
essentially converting it into a chiral HPLC column. The enantiomeric excess of 
fractions obtained from the column was shown to decrease over time thereby 
providing initial fractions in an enhanced enantiomeric excess. 
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This phenomenon was also reported by Kagan et al. in 1994 using preparative flash 
column chromatography.
211
 It was reported that purification of chiral sulfoxides of 
scalemic optical purity with a silica gel flash chromatography column led to 
fractionation of the enantiomers on the column to give the first eluted fractions of 
the chiral sulfoxide in enhanced enantiomeric excess, whilst later eluted fractions 
had a depleted enantiomeric excess. Kagan synthesised a range of chiral sulfoxides 
180a-c
212
 including a number of ferrocenyl derivatives (Scheme 102) and used this 
fractionation method to enhance their enantiomeric excess. 
 
 
Scheme 102 - General synthesis of ferrocenyl chiral sulfoxides 180a-c 
 
Kagan reported that this chromatography method was able to enhance the 
enantiopurity of ferrocenyl methyl sulfoxide 180a from 90.5% to 99.5% in the first 
fractions off the silica gel flash chromatography column. For ferrocenyl phenyl 
sulfoxide 180b the enantioenhancement occurred in the final fractions, with material 
of 65% enantiomeric excess being amplified to 94%. This was proposed to be due to 
the formation of diastereomeric sulfoxide species which have different 
chromatographic mobilities leading to different retention times on the column for 
homochiral and heterochiral diastereomers. 
In summary, the Horeau principle has been employed by a number of groups as a 
tool to determine the enantiomeric excess of chiral substrates by formation of a 
series of diastereomers which are identifiable by NMR spectroscopy. The technique 
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has also been demonstrated for enhancing the enantiomeric excess of chiral 
molecules, either as part of a synthetic protocol, or via kinetic resolution of 
substrates such as BINOL and menthol. Formation of a Horeau series of homochiral 
and heterochiral diastereomers has also been demonstrated to be behind the theory 
for non-linear effects in asymmetric catalysis such as Kagan’s MLn model. 
 
4.2 Results and Discussion 
The Horeau principle enables the use of a non-chiral template to be used to form 
diastereomeric complexes which can then be used to determine the enantiomeric 
excess of a chiral substrate by NMR spectroscopy. Traditional chiral derivatization 
protocols, employ the use of a chiral molecule, as well as, on occasion, other 
building blocks to form chiral recognition complexes. This chiral derivatization 
agent needs to be enantiopure in order to determine the enantiomeric excess of a 
substrate accurately or the diastereomeric excess of the complexes formed will not 
reflect that of the starting enantiomeric material. These enantiopure chiral 
derivatization agents are often very costly and can require a number of reaction 
steps and purifications if they are to be recycled after derivatization. Therefore, it 
was decided to develop a protocol that would employ a cheap, non-chiral 
bifunctional template to determine the enantiopurity of chiral diols. 
Our first attempt to develop a new protocol for determining the enantiomeric excess 
of chiral diols involved reacting dimethyl-DL-tartrate 182a with 1,4-phenyldiboronic 
acid 181, in the presence of 3Å molecular sieves added to remove water from the 
system and drive the equilibrium towards ester formation. It was postulated that the 
two enantiomers of the diol would react in a statistical manner to yield a Horeau 
series of diastereomeric boronate ester complexes, forming an enantiomeric pair and 
a meso compound (containing a plane of symmetry through the central benzene 
ring) which could potentially be distinguished by 
1
H NMR spectroscopy (Scheme 
103). 
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Scheme 103 - Formation of a Horeau series of boronate esters from dimethyl-DL-tartrate 182a 
and 1,4-phenyldiboronic acid 181 
 
Methanol was found to be the best solvent for full conversion of the starting 
materials into the resultant esters, since the parent 1,4-diboronic acid template 181 
was only sparingly soluble in chlorinated solvents, and only partial conversion was 
achieved in solvents such as tetrahydrofuran and acetone. Boronate ester formation 
was confirmed by 
1
H NMR spectroscopy in deuterated chloroform, since the free 
boronic acid is not soluble in CDCl3, whilst 
11
B NMR spectroscopy revealed a 
single boronate ester resonance at 31.7 ppm. Although clean formation of the 
boronate esters was confirmed, there were no diastereomeric protons observed in the 
500MHz 
1
H NMR spectrum of the resultant mixture indicating that 1,4-
phenyldiboronic acid 181 was not a suitable achiral bifunctional template for 
enantiomeric excess determination. 
With this knowledge in hand it was postulated that the distance between the two 
chiral units in the diastereomeric complex formed between 1,4-phenyldiboronic acid 
181 and dimethyl-DL-tartrate 182a was too large to achieve any kind of chiral 
recognition. Thus 1,3-phenyldiboronic 183 was next employed as a template and 
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reacted with dimethyl-DL-tartrate 182a in methanol in the presence of 3Å molecular 
sieves, since this commercially available template would bring the two chiral units 
of its derived bis-boronate ester closer in space (Scheme 104). 
 
 
Scheme 104 - Formation of a Horeau series of boronate esters from dimethyl-DL-tartrate 182a 
and 1,3-phenyldiboronic acid 183 
 
As with the 1,4-boronate complexes, the formation of these 1,3-boronate complexes 
was confirmed by 
1
H NMR spectroscopy in deuterated chloroform, since free 1,3-
phenyldiboronic acid 183 is not soluble in CDCl3. A single boronate resonance was 
also seen at 31.7 ppm in the 
11
B NMR spectrum of the resultant diastereomeric 
mixture and the [M + Na]
+
 seen in the mass spectrum. 
Analysis of the 500 MHz 
1
H NMR spectrum in a number of deuterated solvents 
including deuterated benzene, methanol, tetrahydrofuran and water showed no 
diastereomeric protons present, however, when the 
1
H NMR spectrum was obtained 
in deuterated chloroform a pair of diastereomeric protons were seen for the phenyl 
proton at the 2-position of the central aryl core at 8.48 ppm (Figure 43). 
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Figure 43 – Expansion of the aryl region of the 500 MHz 1H NMR of the diastereomeric 
mixture formed from racemic dimethyl-DL-tartrate 182a and 1,3-phenyldiboronic acid 183 
showing splitting of the 2-phenyl proton at 8.48 ppm 
 
Integration of these diastereomeric resonances showed a 50:50 ratio of homochiral 
and heterochiral diastereomers formed in the reaction which is in perfect agreement 
with the ratio expected for a sample of racemic dimethyl-DL-tartrate 182a. The 
spectrum was then compared with the 500 MHz 
1
H NMR of the complex formed 
from enantiopure dimethyl-L-tartrate and 1,3-phenyldiboronic acid 183 which 
revealed, as expected, no diastereomeric splitting and only a single resonance for the 
2-phenyl proton at 8.48 ppm (Figure 44). 
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Figure 44 - Comparison of the 500 MHz 
1
H NMR spectrum of the boronate ester complex 
formed from enantiopure dimethyl-L-tartrate and 1,3-phenyldiboronic acid 183 (A) and of the 
500 MHz 
1
H NMR spectrum of the diastereomeric mixture formed from racemic dimethyl-DL-
tartrate 182a and 1,3-phenyldiboronic acid 183 
 
A pair of diastereomeric resonances were also seen for the methoxy protons of the 
dimethyl-DL-tartrate fragment of the resultant boronate esters at 3.91 ppm, thus 
providing diagnostic protons for both the chiral and achiral fragments of the 
boronate ester derivatives (Figure 45). 
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Figure 45 – 500MHz 1H NMR of the diastereomeric mixture formed from racemic dimethyl-
DL-tartrate 182a and 1,3-phenyldiboronic acid 183 with expansion of the diastereomeric 
methoxy region at 3.91 ppm 
 
In contrast to conventional chiral derivatization protocols in which the 
diastereomeric excess measured from integration of the 
1
H NMR spectrum directly 
affords the enantiomeric excess of the employed chiral substrate, integration of the 
1
H NMR spectrum obtained from a Horeau-type derivatization protocol does not 
directly give the enantiomeric excess of the chiral substrate. The diastereomeric 
resonances arise from homochiral (RR and SS) and heterochiral (RS and SR) 
diastereomers and thus the diastereomeric excess needs to be converted to the true 
enantiomeric excess by consideration of the statistical model discussed previously. 
This measured diastereomeric excess, taken from measurement of the relative 
homochiral and heterochiral resonances, is related to the true enantiomeric excess of 
the chiral substrate by the quadratic relationship reported by Horeau.
173
 Horeau 
reported that the enantiomeric purity (p) is calculated from the integrated peak areas 
for the homochiral (Q) and heterochiral (Q’) resonances and that p2 = (K-1)/(K+1). 
If the enantiopurity of the material with R stereochemistry is assumed to be x and 
the enantiopurity of the material with S stereochemistry is assumed to be (1-x) then 




 and meso (2x(1-x)) can be derived. These 
relationships can be used to generate the curve shown in Figure 46 which shows 
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how the measured diastereomeric excess (homochiral – heterochiral) relates to the 
enantiomeric excess of the starting diol (R-S). 
 
 
Figure 46 - Relationship between the measured diastereomeric excess (homochiral-
heterochiral) and the enantiomeric excess of a chiral substrate after Horeau-type derivatization 
 
The above graph is applicable to any dimeric Horeau-type derivatization and can be 
used to easily infer the enantiomeric excess of the chiral substrate employed in 
derivatization, for example, a measured diastereomeric excess of 74% corresponds 
to a substrate enantiomeric excess of 86%. Due to the quadratic relationship 
between the enantiomeric excess and measured diastereomeric excess both a 
positive and negative value of enantiomeric excess are possible for each value of 
diastereomeric excess. Thus, although this technique is able to determine 
enantiomeric excess, it is unable to determine which enantiomer is present in excess 
within a scalemic sample. 
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4.2.1 Synthesis of Chiral Diols Using Sharpless Dihydroxylation 
Reaction 
In order to determine the scope and limitations of this new chiral derivatization 
protocol a number of chiral diols which were not commercially available were 
synthesised since, our new bis-boronic acid template protocol was most likely to be 
useful for determining the enantiomeric excess of chiral diols produced in 
asymmetric protocols. 
Trans-β-methylstyrene was reacted with a mixture of AD-mix-α, AD-mix-β and 
methanesulfonamide in 1:1 tert-butanol and water at 0 °C for 24 hours in a 
Sharpless dihydroxylation reaction to afford the corresponding racemic mixture of 





Scheme 105 - Sharpless dihydroxylation of alkene 184 
 
A small range of substituted alkenes were then used to synthesise their 
corresponding racemic mixture of diols with methanesulfonamide used as an 
additive for reactions involving non-terminal alkenes (Table 9). 
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Table 9 - Synthesis of a range of chiral diols from their parent alkenes using the Sharpless 
dihydroxylation reaction conditions 
 
a MeSO2NH2 used only as an additive for reactions employing non-terminal alkenes as reagents.
213 
 
In all cases racemics mixture of the known chiral diols 182b,i,j were successfully 
synthesised in good yields (62-84%) and characterised by 
1
H NMR spectroscopy, 
mass spectrometry and the presence of a broad OH stretch in their IR spectrum. 
4.2.2 Scope and Limitations of the Chiral Derivatization Protocol 
To investigate the scope and limitations of this simple protocol, our synthesized 
racemic diols 182b,i,j and a range of commercially available racemic diols 182a,c-
h,k-m were derivatized with 1,3-phenyldiboronic acid 183 in methanol, with 3Å 
molecular sieves added to remove water and drive the equilibrium towards boronate 
ester formation (Table 10).  
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These derivatization reactions gave their corresponding diastereomeric boronate 
esters 187/188a-m in quantitative yield with their formation confirmed by 
1
H NMR 
spectroscopic analysis in deuterated chloroform, and by the appearance of a single 
boronate resonance in their respective 
11
B NMR spectrum. Analysis of the 500 MHz 
1
H NMR spectrum of the resultant mixture of diastereomeric boronate esters 
187/188a-m revealed separation of diastereomeric resonances in a number of cases, 
particularly those diol substrates containing phenyl and ester functionalities (182a-
e). Unfortunately diastereomeric boronate esters derived from alkyl chain based 
diols 182f-h showed no such splitting of the aryl proton of the core aryl template at 
its 2-position. All chiral diols containing vicinal stereocentres showed 
diastereomeric resonances for the aryl proton at the 2-position of the 1,3-
phenyldiboronic acid fragment with sufficient baseline resolution for their 
enantiopurities to be determined except for diol 182l. It was also seen that only 
dimethyl-DL-tartrate resulted in splitting of protons in the diol fragments of their 
diastereomeric boronate esters. In all other cases where splitting occurred only the 
proton at the 2-position of the aryl ring on the boronic acid fragment displayed 
baseline resolved diastereomeric resonances in their 500 MHz 
1
H NMR spectra. 
Diastereomeric resonances were also seen in the 
13
C NMR spectra for the 
derivatization products obtained from diols 182a,d,e,m which meant that 
13
C NMR 
spectroscopic analysis could be used to determine the enantiomeric excess of 
dibenzyl-DL-tartrate 182m (Figure 47). 
 
 
Figure 47 - Expansion of the aryl region of the 125 MHz 
13
C NMR of the diastereomeric 
mixture formed from racemic dibenzyl-DL-tartrate 182m and 1,3-phenyldiboronic acid 183 
showing splitting of the aryl carbon at 142.6 ppm 
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4.2.3 Attempted Improvements of Δδ Values 
In an attempt to improve the splitting of these resonances and increase the 
usefulness of this protocol, samples were analysed of selected mixtures of 
diastereomeric bis-boronate esters using 700 MHz NMR spectroscopy (with thanks 
to Prof. David Smith at the University of York for analysing these samples for us), 
however the additional strength of the magnetic field showed no improvement for 
these substrates whose signals were not already split at 500 MHz. Advanced NMR 
experiments and processing techniques were also carried out which showed some 
improvement in the splitting of diastereomeric resonances for diols 182k,m. We 
hypothesised that diastereomeric resonances were splitting in all cases, however, in 
some cases the Δδ values are very small, perhaps as small as 1 Hz and thus the 
broadness of the resonances in the 
1
H NMR spectra cause the diastereomeric peaks 
to overlap. This broadening could perhaps be caused by remote coupling to other 
protons and in fact, upon close inspection of the 
1
H NMR spectra, particularly for 
the aryl protons, small long range couplings were seen. In order to eliminate these 




H}) experiment was acquired. It was 
found for diol 182m that selective irradiation at 8.05 ppm with a low power pulse 
during acquisition removed these coupling effects causing a sharpening of the 
diastereomeric resonances at 8.47 ppm (Figure 48). 
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Figure 48 - Expansion of the aryl region of the 500 MHz 
1
H NMR of the diastereomeric 
mixture formed from racemic dibenzyl-DL-tartrate 182m and 1,3-phenyldiboronic acid 183, 
showing the effect on splitting of the diastereomeric resonance at 8.47ppm from a standard 
1
H 




H} experiment (B) 
 
This experiment equalises the up or down spins of the particular resonance 
irradiated so no remote coupling was observed and thus sharper peaks are observed. 
The same experiment was also able to provide improvement to the Δδ value for the 
derivatization of 182k (Figure 49). 
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Figure 49 - Expansion of the aryl region of the 500 MHz 
1
H NMR of the diastereomeric 
mixture formed from racemic 1-phenyl-1,2-ethanediol 182k and 1,3-phenyldiboronic acid 183, 
showing the effect on splitting of the diastereomeric resonance at 8.51ppm from a standard 
1
H 




H} experiment (B) 
 
Gaussian enhancement was also shown to be a useful processing technique for 
improving the splitting of diastereomeric resonances. This processing technique 
multiplies the raw FID signal obtained from the 
1
H NMR acquisition by a Gaussian 
function which artificially enhances the signal in the middle of the FID. When the 
FID is then processed, this Gaussian enhancement gives the effect that the signal has 
been obtained over a longer time, sharpening the peaks and resulting in an increase 
in the amount of baseline separation (Figure 50). 
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Figure 50 - Expansion of the aryl region of the 500 MHz 
1
H NMR of the diastereomeric 
mixture formed from racemic dibenzyl-DL-tartrate 182m and 1,3-phenyldiboronic acid 183, 
showing the effect on splitting of the diastereomeric resonance at 8.47ppm of using standard 







Therefore, it has been shown that advanced NMR techniques can be successfully 
employed to improve the baseline separation of diastereomeric resonances for diols 
which only display partial separation in their 
1
H NMR spectrum under standard 
conditions. 
4.2.4 Scalemic Sampling Studies 
In order to determine the accuracy of this protocol, scalemic samples of methyl-2,3-
dihydroxy-3-phenylpropionate 182d of 95%, 80% and 60% enantiomeric excess 
were derivatized with 1,3-phenyldiboronic acid 183 in methanol. Integration of the 
resultant 
1
H NMR spectra showed that the integral of the diastereomeric resonances 
at δ 8.57 ppm and δ 8.59 ppm varied with diastereomeric excess (Figure 51). 
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Figure 51 - Expansion of the diastereomeric aryl resonances at 8.58 ppm for the derivatization 
of diol 182d with 1,3-phenyldiboronic acid 183. Scalemic samples of diol 182d of 95%, 80% and 
60% were employed 
 
Using the calibration curve shown in Figure 46 it was determined that these samples 
had a measured enantiomeric excess of 94%, 78% and 58% respectively, showing 
excellent agreement with the known values of 95%, 80% and 60% e.e.. This 
scalemic sampling was also able to determine which resonance corresponded to the 
homochiral 187 and heterochiral 188 diastereomers. Therefore, it was determined 
that the most downfield resonance at 8.59 ppm was due to the homochiral 
diastereomer 187 and the upfield resonance of the pair (8.57 ppm) due to the 
heterochiral diastereomer 188 since, for all non-racemic samples the homochiral 
diastereomeric resonance will have the largest integral. 
4.2.5 Molecular Modelling to Explain Differences in Diastereomeric 
Resonances 
Molecular modelling software, Spartan, was used in an attempt to elucidate a model 




C NMR spectra of the 
derivatization products for only some of the diols investigated. Energy minimisation 
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and equilibrium geometry calculations using a semi-empirical (PM3) method were 
used to produce the lowest energy conformations of the heterochiral and homochiral 
boronate esters formed in the reaction between 1,3-phenyldiboronic acid 183 and 1-
phenyl-1,3-propanediol 182e (Figure 52). 
 
 
Figure 52 - Molecular modelling of the (R,S)-heterochiral (A) and (R,R)-homochiral (B) 
boronate ester conformers formed between 1,3-phenyldiboronic acid 183 and 1-phenyl-1,3-
propanediol 182e 
 
As can be seen from the two simple models in Figure 52, for the heterochiral model 
(A), the phenyl rings of the diol fragment point towards the aryl proton situated 
between the two boronate functionalities. The shielding effects of both of the phenyl 
rings cause a relative shift of its resonance to a higher δ value in the 1H NMR 
spectrum. In the homochiral model, one of the phenyl rings points away from the 
aryl proton and as a consequence the shielding effects for this isomer are thus much 
less than for the heterochiral model resulting in a chemical shift to a lower δ value. 
This is consistent with the observation of diastereomeric resonances being observed 
when the reaction between 1,3-phenyldiboronic acid 183 and (rac)-1-phenyl-1,3-
propanediol 182e was analysed by 500 MHz 
1
H NMR spectroscopy. In order to 
confirm whether this model might explain the larger Δδ values seen for certain 
diols, modelling was also performed on a diol that showed no splitting in its 500 
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MHz NMR spectrum. The same energy minimisation and equilibrium geometry 
calculations using a semi-empirical (PM3) method were performed on the 
heterochiral and homochiral boronate esters formed from reactions of 1,3-
phenyldiboronic acid 183 and 1,3-butanediol 182h (Figure 53). 
 
 
Figure 53 - Molecular modelling of the (R,S)-heterochiral (A) and (R,R)-homochiral (B) 
boronate ester conformers formed between 1,3-phenyldiboronic acid 183 and 1,3-butanediol 
182h 
 
The modelling of the 1,3-butanediol diboronate ester showed that, in the case of the 
heterochiral species, although the methyl groups of the diol fragment point towards 
the aryl proton between the two boronate ester units, they are not close enough to 
have any significant shielding effects on the proton. For the homochiral species, one 
methyl group points parallel to the aryl proton, whilst the other points away from the 
aryl ring. This arrangement would also cause no significant shielding effect on the 
aryl proton, and thus the difference in chemical shifts between the heterochiral and 
homochiral species is likely to be much smaller. 
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In conclusion, a new, simple protocol has been developed for the determination of 
the enantiomeric excess of chiral diols which the Horeau gambit to differentiate 
between heterochiral and homochiral diastereomers formed between a diol and an 
achiral bifunctional boronic acid template. This protocol has been shown to be 
successful for diols bearing anisotropically shielding groups adjacent to their diol 
functionalities, and molecular modelling has been used to rationalise the observed 
relative shift to higher δ value of their heterochiral diastereomers when compared to 
their homochiral diastereomers. In a number of cases diastereomeric resonances 




C NMR spectra of the derivatized diols, thus giving 
two sources for determination of their enantiomeric excess. For cases where Δδ 
values are small, alternative NMR spectroscopic experiments have been used to 
sharpen the diastereomeric resonances in the 
1
H NMR spectrum of the mixture of 
derivatization products. Both commercially sourced diols and those synthesised 
racemically from their parent alkenes using Sharpless dihydroxylation reactions 
have been employed, and the accuracy of this new NMR protocol for determining 








5.1 General Experimental Details 
All reagents and solvents used throughout this project were reagent grade unless 
otherwise reported and obtained from Acros Organics, Alfa Aesar, Fisher Scientific 
UK, Frontier Scientific Europe Ltd. or Sigma Aldrich Company Ltd. None of the 
reagents underwent further purification unless otherwise stated. All anhydrous 
solvents used were dried using an Innovative Technology PS-400-7 solvent 
purification system and all water was distilled. 4Å molecular sieves were activated 
by drying in an oven at 200 °C prior to use. All reactions were carried out at room 
temperature unless otherwise stated. 
Flash chromatography was performed using chromatography grade silica, 60Å 
particle size 35-70 microns obtained from Fisher Scientific UK. 
All 
1
H NMR spectra were obtained at 500 MHz, 400 MHz or 300 MHz, 
13
C NMR 
spectra obtained at 125 MHz, 100 MHz or 75 MHz and 
11
B NMR spectra obtained 
at 96 MHz using a Bruker Avance 500, 400 or 300 spectrometer. All chemical shift 
values (δ) are reported in parts per million (ppm) and are referenced to the residual 
solvent peak. All coupling constants, J, are reported to the nearest 0.1 Hz. 
Multiplicities of observed peaks in the NMR spectra are denoted with the following 
abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; quin, quintet; sex, sextet; 
hep, heptet; dd, doublet of doublets; dq, doublet of quartets; m, multiplet; br, broad; 
hetero, heterochiral; homo, homochiral. 
High resolution mass spectra were recorded on a Bruker Daltonics microTOF 
spectrometer with an electrospray source and external calibration. Masses were 
recorded were recorded in positive electrospray ionisation mode and were 
introduced by flow injection. Masses are accurate to 5 ppm and data was processed 





Infrared spectra were recorded on a Perkin Elmer Spectrum 100 FT-IR 
spectrometer, using a Universal ATR accessory for sampling, with only selected 
absorbances reported as ν in cm-1. 
Optical rotations were recorded on an Optical Activity Ltd AA-10 automatic 
polarimeter with a path length of 1 dm, concentrations (c) are quoted in g/100 mL. 
All capillary melting points were measured using Stuart digital SMP10 melting 
point apparatus with 1 degree resolution. 
X-ray crystallographic data was collected at 150K on a Nonius KappaCCD area 
detector diffractometer using Mo-Kα radiation (λ=0.71073 Å). All structures were 
solved by direct methods and refined on all F2 data using SHELXL-97 suite of 
programs, with hydrogen atoms included in idealised positions and refined using the 
riding model. 
 
5.2 General Procedures for Chapter 2 
5.2.1 General Procedure 1: (S,S)-α-Amino Nitrile Hydrochloride 
Formation 
In an adaptation to the literature procedure,
117,118
 (S)-1-(4-
methoxyphenyl)ethanamine (1.0 equiv.) was stirred in 1 M HCl in ether (1.0 equiv.) 
in ether to yield the amine hydrochloride salt as a white powder. The solvent was 
removed under reduced pressure and sodium cyanide was added (1.5 equiv.) in 
water. MeOH and the corresponding arylaldehyde (1.0 equiv) were added, and the 
mixture stirred for 16 hours. The reaction was diluted with water and the resulting 
solid collected via filtration and washed with n-hexane. If a single diastereomer was 
not precipitated from solution, the reaction mixture was extracted with CH2Cl2 and 
the organic layer dried over MgSO4, filtered and concentrated under reduced 
pressure. The crude material was dissolved in ether and saturated methanolic HCl 





amino nitrile hydrochloride diastereomer was collected via filtration and washed 
with n-hexane. 
5.2.2 General Procedure 2: (S)-α-Arylglycine Hydrochloride Formation 
The (S,S)-α-amino nitrile was treated with 6 M HCl(aq) (amount corresponding to a 
0.1 M solution) and the resultant mixture heated at 90 °C for four hours. The 
reaction mixture was then cooled to room temperature and extracted with ether. The 
aqueous layer was concentrated under reduced pressure to give white/yellow solid. 
The crude material was suspended in CDCl3 using a sonicator and filtered to yield 
the corresponding (S)-α-arylglycine hydrochloride as a white solid. 
5.2.3 General Procedure 3: Determination of the Enantiomeric Excess 
of (S)-α-Arylglycine Hydrochlorides 
The α-arylglycine hydrochloride was converted to its respective methyl ester 
hydrochloride by heating them at reflux at 85 °C in 3 M HCl(aq) in methanol for 12 
hours. The solvent was evaporated to give the methyl ester hydrochloride in a 
quantitative yield. This was subsequently treated with 2-formylphenylboronic acid 
(1.0 equiv), (S)-BINOL (1.1 equiv) and K2CO3 and stirred in CDCl3 with 4 Å 
molecular sieves for 5 minutes. The resultant mixture was then filtered through a 
small pad of Celite to give a solution ready for 
1
H NMR spectroscopic analysis. 
 








The title compound was prepared according to General Procedure 1 using (S)-1-(4-
methoxyphenyl)ethanamine (0.44 mL, 3.0 mmol) which was stirred in 1 M HCl 
solution in ether (3 mL, 3.0 mmol) in ether (3 mL) for ten minutes to yield the 
equivalent hydrochloride salt as a white powder. The solvent was removed under 
reduced pressure and sodium cyanide (221 mg, 4.5 mmol) was added in 5 mL of 
water. Benzaldehyde (0.30 mL, 3.0 mmol) in methanol (5 mL) was added and the 
reaction stirred for 16 hours. The reaction mixture was diluted with water (10 mL) 
and after work up and recrystallization from ether and saturated methanolic HCl the 
α-amino nitrile 122a (562 mg, 62%) was obtained as white needles. mp: 127-128 
°C; [α]D
25
 = -95 (c 0.525, CHCl3); 
1
H NMR (300 MHz; CDCl3) δH 7.49-7.46 (2H, 
m, ArH), 7.42-7.34 (5H, m, ArH), 6.93 (2H, d, J = 8.7 Hz, ArH), 4.38 (1H, s, 
CHCN), 4.20 (1H, q, J = 6.5 Hz, CHCH3), 3.82 (3H, s, CH3O), 1.41 (3H, d, J = 6.5 
Hz, CHCH3); 
13
C NMR (75 MHz; CDCl3) δC 161.1, 134.9, 131.3, 130.8, 130.2, 




The title compound was prepared according to General Procedure 1 using (S)-1-(4-
methoxyphenyl)ethanamine (0.44 mL, 3.0 mmol) which was stirred in 1 M HCl 
solution in ether (3 mL, 3.0 mmol) in ether (3 mL) for ten minutes to yield the 
equivalent hydrochloride salt as a white powder. The solvent was removed under 
reduced pressure and sodium cyanide (221 mg, 4.5 mmol) was added in 5 mL of 
water. p-Tolualdehyde (0.35 mL, 3.0 mmol) in methanol (5 mL) was added and the 
reaction stirred for 16 hours. The reaction mixture was diluted with water (10 mL) 
and after work up and recrystallization from ether and saturated methanolic HCl the 
α-amino nitrile 122b (739 mg, 77%) was obtained as white needles. mp: 118-119 
°C; [α]D
25
 = -100 (c 0.510, CHCl3); IR (film / cm
-1) ν = 3304 cm-1 (NH), 2228 (CN); 
1
H NMR (300 MHz; CDCl3) δH 7.39-7.33 (4H, m, ArH), 7.20 (2H, d, J = 8.0 Hz, 





CHCH3), 3.82 (3H, s, CH3O), 2.35 (3H, s, ArCH3), 1.40 (3H, d, J = 6.5 Hz, 
CHCH3); 
13
C NMR (75 MHz; CDCl3) δC 159.3, 138.9, 135.1, 132.5, 129.7, 128.2, 




The title compound was prepared according to General Procedure 1 using (S)-1-(4-
methoxyphenyl)ethanamine (0.44 mL, 3.0 mmol) which was stirred in 1 M HCl 
solution in ether (3 mL, 3.0 mmol) in ether (3 mL) for ten minutes to yield the 
equivalent hydrochloride salt as a white powder. The solvent was removed under 
reduced pressure and sodium cyanide (221 mg, 4.5 mmol) was added in 5 mL of 
water. o-Tolualdehyde (0.35 mL, 3.0 mmol) in methanol (5 mL) was added and the 
reaction stirred for 16 hours. The reaction mixture was diluted with water (10 mL) 
and after filtration the α-amino nitrile 122c (570 mg, 60%) was obtained as white 
plates. mp: 129-132 °C; [α]D
25
 = -189 (c 0.475, CHCl3); IR (film / cm
-1) ν = 3338 
cm
-1
 (NH), 2222 (CN); 
1
H NMR (400 MHz; CDCl3) δH 7.57-7.55 (1H, m, ArH), 
7.38 (2H, d, J = 8.7 Hz, ArH), 7.28-7.15 (3H, m, ArH), 6.92 (2H, d, J = 8.6 Hz, 
ArH), 4.39 (1H, s, CHCN), 4.20 (1H, q, J = 6.4 Hz, CHCH3), 3.83 (3H, s, CH3O), 
2.14 (3H, s, ArCH3), 1.40 (3H, d, J = 6.4 Hz, CHCH3); 
13
C NMR (75 MHz; CDCl3) 
δC 159.7, 136.7, 134.9, 133.8, 131.5, 129.5, 128.8, 127.7, 127.0, 119.5, 114.5, 56.7, 








The title compound was prepared according to General Procedure 1 using (S)-1-(4-
methoxyphenyl)ethanamine (0.44 mL, 3.0 mmol) which was stirred in 1 M HCl 
solution in ether (3 mL, 3.0 mmol) in ether (3 mL) for ten minutes to yield the 
equivalent hydrochloride salt as a white powder. The solvent was removed under 
reduced pressure and sodium cyanide (221 mg, 4.5 mmol) was added in 5 mL of 
water. p-Methoxybenzaldehyde (0.37 mL, 3.0 mmol) in methanol (5 mL) was added 
and the reaction stirred for 16 hours. The reaction mixture was diluted with water 
(10 mL) and after filtration the α-amino nitrile 122d (871 mg, 87%) was obtained as 
a white solid. mp: 109-111 °C; [α]D
20
 = -27.4 (c 0.475, MeOH); IR (film / cm
-1
) ν = 
3306 cm
-1
 (NH), 2227 (CN); 
1
H NMR (300 MHz; CDCl3) δH 7.40-7.35 (4H, m, 
ArH), 6.95-6.86 (4H, m, ArH), 4.32 (1H, s, CHCN), 4.18 (1H, q, J = 6.6 Hz, 
CHCH3), 3.82 (3H, s, CH3O), 3.81 (3H, s, CH3O), 1.40 (3H, d, J = 6.6 Hz, CHCH3); 
13
C NMR (75 MHz; CDCl3) δC 160.1, 159.3, 135.1, 128.5, 128.2, 127.5, 119.3, 
114.4, 56.3, 55.5, 55.4, 51.8, 24.9; HRMS (ES): m/z calculated for C18H21N2O2 [M 
+ H]
+




The title compound was prepared according to General Procedure 1 using (S)-1-(4-
methoxyphenyl)ethanamine (0.44 mL, 3.0 mmol) which was stirred in 1 M HCl 
solution in ether (3 mL, 3.0 mmol) in ether (3 mL) for ten minutes to yield the 
equivalent hydrochloride salt as a white powder. The solvent was removed under 
reduced pressure and sodium cyanide (221 mg, 4.5 mmol) was added in 5 mL of 
water. p-Hydroxybenzaldehyde (0.37 g, 3.0 mmol) in methanol (5 mL) was added 
and the reaction stirred for 16 hours. The reaction mixture was diluted with water 
(10 mL) and after filtration the α-amino nitrile 122e (819 mg, 86%) was obtained as 
a white solid. mp: 132-134 °C; [α]D
20
 = -40.7 (c 0.590, MeOH); IR (film / cm
-1) ν = 
3261 cm
-1
 (NH), 2228 (CN); 
1
H NMR (300 MHz; CDCl3) δH 7.37 (2H, app d, J = 





6.81 (2H, app d, J = 8.7 Hz, ArH), 4.30 (1H, s, CHCN), 4.16 (1H, q, J = 6.4 Hz, 
CHCH3), 3.82 (3H, s, CH3O), 1.40 (3H, d, J = 6.4 Hz, CHCH3); 
13
C NMR (75 MHz; 
CDCl3) δC 159.3, 156.4, 135.0, 128.7, 128.2, 127.3, 119.3, 115.9, 114.4, 56.3, 55.5, 







The title compound was prepared according to General Procedure 1 using (S)-1-(4-
methoxyphenyl)ethanamine (0.44 mL, 3.0 mmol) which was stirred in 1 M HCl 
solution in ether (3 mL, 3.0 mmol) in ether (3 mL) for ten minutes to yield the 
equivalent hydrochloride salt as a white powder. The solvent was removed under 
reduced pressure and sodium cyanide (221 mg, 4.5 mmol) was added in 5 mL of 
water. 2-Bromobenzaldehyde (0.35 mL, 3.0 mmol) in methanol (5 mL) was added 
and the reaction stirred for 16 hours. The reaction mixture was diluted with water 
(10 mL) and after filtration the α-amino nitrile 122f (662 mg, 58%) was obtained as 
white plates. mp: 117-119 °C; [α]D
25
 (d.e.= 90%) = -166 (c 0.525, CHCl3); IR (film / 
cm
-1) ν = 3333 cm-1 (NH), 2228 (CN); 1H NMR (300 MHz; CDCl3) δH 7.63-7.56 
(2H, m, ArH), 7.42-7.35 (3H, m, ArH), 7.28-7.21 (1H, m, ArH), 6.93-6.90 (2H, m, 
ArH), 4.66 (1H, s, CHCN), 4.18 (1H, q, J = 6.6 Hz, CHCH3), 3.83 (3H, s, CH3O), 
1.74 (1H, br s, NH), 1.42 (3H, d, J = 6.6 Hz, CHCH3); 
13
C NMR (75 MHz; CDCl3) 
δC 159.7, 135.2, 134.5, 134.1, 131.0, 129.7, 128.9, 128.6, 123.7, 118.9, 114.4, 56.7, 














The title compound was prepared according to General Procedure 1 using (S)-1-(4-
methoxyphenyl)ethanamine (0.44 mL, 3.0 mmol) which was stirred in 1 M HCl 
solution in ether (3 mL, 3.0 mmol) in ether (3 mL) for ten minutes to yield the 
equivalent hydrochloride salt as a white powder. The solvent was removed under 
reduced pressure and sodium cyanide (221 mg, 4.5 mmol) was added in 5 mL of 
water. 4-Fluorobenzaldehyde (0.32 mL, 3.0 mmol) in methanol (5 mL) was added 
and the reaction stirred for 16 hours. The reaction mixture was diluted with water 
(10 mL) and after work up and recrystallization from ether and saturated methanolic 
HCl the α-amino nitrile 122g (674 mg, 70%) was obtained as white needles. mp: 
137-138 °C; [α]D
25
 = -53 (c 0.510, MeOH); 
1
H NMR (300 MHz; (CD3)2SO) δH 
7.66-7.58 (2H, m, ArH), 7.39 (2H, d, J = 8.6 Hz, ArH), 7.23-7.17 (2H, m, ArH), 
6.87 (2H, d, J = 8.6 Hz, ArH), 5.19 (1H, s, CHCN), 4.16 (1H, q, J = 6.5 Hz, 
CHCH3), 3.64 (3H, s, CH3O), 1.49 (3H, d, J = 6.5 Hz, CHCH3); 
13
C NMR (75 MHz; 
(CD3)2SO) δC 159.7, 132.1, 129.8, 129.4, 128.8, 124.3, 116.0, 114.5, 114.2, 56.8, 
55.2, 48.2, 20.3; m/z (CI) 284 (M - HCl). 
 
(S)-2-(benzo[d][1,3]dioxol-5-yl)-2-(((S)-1-(4-
methoxyphenyl)ethyl)amino)acetonitrile hydrochloride 122h 
The title compound was prepared according to General Procedure 1 using (S)-1-(4-
methoxyphenyl)ethanamine (0.44 mL, 3.0 mmol) which was stirred in 1 M HCl 
solution in ether (3 mL, 3.0 mmol) in ether (3 mL) for ten minutes to yield the 





reduced pressure and sodium cyanide (221 mg, 4.5 mmol) was added in 5 mL of 
water. Piperonal (0.45 mL, 3.0 mmol) in methanol (5 mL) was added and the 
reaction stirred for 16 hours. The reaction mixture was diluted with water (10 mL) 
and after work up and recrystallization from ether and saturated methanolic HCl the 
α-amino nitrile 122h (558 mg, 54%) was obtained as a white solid. mp: 116-119 °C; 
[α]D
22
 = -60 (c 0.550, CHCl3); IR (film / cm
-1) ν = 3032 cm-1 (NH), 2049 (CN); 1H 
NMR (300 MHz; CDCl3) δH 7.64 (2H, d, J = 8.7 Hz, ArH), 7.24-7.22 (1H, m, ArH), 
7.01-6.79 (4H, m, ArH), 5.91 (2H, s, CH2), 4.57 (1H, s, CHCN), 4.41 (1H, q, J = 6.8 
Hz, CHCH3), 3.84 (3H, s, CH3O), 1.66 (3H, d, J = 6.4 Hz, CHCH3); 
13
C NMR (75 
MHz; CDCl3) δC 160.9, 150.1, 150.0, 148.3, 130.0, 129.8, 125.2, 124.6, 115.1, 
114.9, 110.7, 108.8, 102.0, 58.9, 55.5, 50.3, 20.6; HRMS (ES): m/z calculated for 
C18H19N2O3 [M + H]
+
: 311.1396; found: 311.1382. 
 
(S)-2-amino-2-phenylacetic acid hydrochloride 124a 
The title compound was prepared according to General Procedure 2 using α-amino 
nitrile 122a (124 mg, 0.47 mmol) and 5 mL of 6 M HCl(aq). α-Arylglycine 124a (53 
mg, 60%) was obtained as a white solid. [α]D
20
 = +152 (c 0.100, 1 M HCl); 
1
H NMR 
(400 MHz; D2O) δH 7.47-7.42 (5H, m, ArH), 5.07 (1H, s, CHCO2H); 
13
C NMR (100 
MHz; CDCl3) δC 171.2, 131.9, 130.2, 129.7, 128.1, 56.9; m/z (CI) 152 (M - HCl). 
 
(S)-2-amino-2-(p-tolyl)acetic acid hydrochloride 124b 
The title compound was prepared according to General Procedure 2 using α-amino 
nitrile 122b (150 mg, 0.53 mmol) and 5 mL of 6 M HCl(aq). α-Arylglycine 124b (60 
mg, 56%) was obtained as a white solid. [α]D
20
 = +70 (c 0.100, H2O); IR (film / cm
-
1) ν = 2976 cm-1 (br, NH), 2880 (br, OH), 1727 (C=O); 1H NMR (300 MHz; D2O) 





CHCO2H), 2.28 (3H, s, CH3); 
13
C NMR (75 MHz; D2O) δC 171.1, 140.8, 130.1, 
128.8, 128.0, 56.6, 20.3; HRMS (ES): m/z calculated for C9H12NO2 [M + H]
+
: 
166.0868; found: 166.0870. 
 
(S)-2-amino-2-(o-tolyl)acetic acid hydrochloride 124c 
The title compound was prepared according to General Procedure 2 using α-amino 
nitrile 122c (300 mg, 1.07 mmol) and 11 mL of 6 M HCl(aq). α-Arylglycine 124c 
(173 mg, 80%) was obtained as a white solid. [α]D
25
 = +90 (c 0.100, 5 M HCl); 
1
H 
NMR (300 MHz; D2O) δH 7.41-7.20 (4H, m, ArH), 5.05 (1H, s, CHCO2H), 2.04 
(3H, s, CH3); 
13
C NMR (75 MHz; D2O) δC 170.8, 137.4, 131.5, 130.3, 129.8, 127.1, 
126.8, 53.1, 18.8; m/z (CI) 166 (M - Cl). 
 
(S)-2-amino-2-(4-methoxyphenyl)acetic acid hydrochloride 124d 
The title compound was prepared according to General Procedure 2 using α-amino 
nitrile 122d (210 mg, 0.70 mmol) and 7 mL of 6 M HCl(aq). α-Arylglycine 124d (79 
mg, 52%) was obtained as a white solid. [α]D
22
 = +41.7 (c 0.120, H2O); IR (film / 
cm
-1) ν = 2969 (OH), 1733 (C=O); 1H NMR (300 MHz; D2O) δH 7.38 (2H, app d, J 
= 8.9 Hz, ArH), 7.03 (2H, app d, J = 8.9 Hz, ArH), 4.99 (1H, s, CHCO2H), 3.81 
(3H, s, CH3O); 
13
C NMR (75 MHz; D2O) δC 160.4, 130.0, 124.8, 115.3, 56.7, 55.7; 
HRMS (ES): m/z calculated for C9H12NO3 [M + H]
+
: 182.0817; found: 182.0809. 
 





The title compound was prepared according to General Procedure 2 using α-amino 
nitrile 122e (200 mg, 0.70 mmol) and 7 mL of 6 M HCl(aq). α-Arylglycine 124e (116 
mg, 81%) was obtained as a white solid. [α]D
22
 = +58.5 (c 0.205, H2O); IR (film / 
cm
-1) ν = 3000 (OH), 1728 (C=O); 1H NMR (300 MHz; D2O) δH 7.31 (2H, app d, J 
= 8.6 Hz, ArH), 6.91 (2H, app d, J = 8.6 Hz, ArH), 5.04 (1H, s, CHCO2H); 
13
C 
NMR (75 MHz; D2O) δC 171.7, 157.4, 130.2, 123.9, 116.6, 56.6; HRMS (ES): m/z 
calculated for C8H10NO3 [M + H]
+
: 168.0661; found: 168.0643. 
 
(S)-2-amino-2-(2-bromophenyl)acetic acid hydrochloride 124f 
The title compound was prepared according to General Procedure 2 using α-amino 
nitrile 122f (246 mg, 0.71 mmol) and 8 mL of 6 M HCl(aq). α-Arylglycine 124f (151 
mg, 80%) was obtained as a white solid. [α]D
25
 = +90 (c 0.100, 1 M HCl); IR (film / 
cm
-1) ν = 3409 (OH), 1747 (C=O); 1H NMR (300 MHz; D2O) δH 7.64 (1H, d, J = 
7.7 Hz, ArH), 7.38-7.33 (2H, m, ArH), 7.31-7.25 (1H, m, ArH), 5.45 (1H, s, 
CHCO2H); 
13
C NMR (75 MHz; D2O) δC 169.7, 133.0, 131.2, 130.5, 129.0, 128.0, 
123.1, 55.5; m/z (CI) 232 (M - HCl). 
 
(S)-2-amino-2-(4-fluorophenyl)acetic acid hydrochloride 124g 
The title compound was prepared according to General Procedure 2 using α-amino 
nitrile 122g (77 mg, 0.24 mmol) and 3 mL of 6 M HCl(aq). α-Arylglycine 124g (31 
mg, 63%) was obtained as a white solid. [α]D
22
 = +132 (c 0.100, 1 M HCl); 
1
H NMR 
(300 MHz; D2O) δH 7.39-7.34 (2H, m, ArH), 7.10 (2H, app t, J = 8.7 Hz, ArH), 5.05 
(1H, s, CHCO2H); 
13
C NMR (75 MHz; D2O) δC 170.7, 163.3, 130.5, 127.6, 116.7, 






(S)-2-amino-2-(benzo[d][1,3]dioxol-5-yl)acetic acid hydrochloride 124h 
The title compound was prepared according to General Procedure 2 using α-amino 
nitrile 122h (275 mg, 0.79 mmol) and 8 mL of 6 M HCl(aq). α-Arylglycine 124h 
(118 mg, 64%) was obtained as a white solid. [α]D
20
 = +70 (c 0.100, H2O); IR (film / 
cm
-1) ν = 2976 (br, NH), 2880 (br, OH), 1727 (C=O); 1H NMR (300 MHz; D2O) δH 
7.01-6.94 (3H, m, ArH), 6.03 (2H, s, CH2), 5.07 (1H, s, CHCO2H); 
13
C NMR (75 
MHz; D2O) δC 171.6, 149.0, 148.4, 125.7, 123.0, 109.5, 108.4, 102.2, 57.0; HRMS 
(ES): m/z calculated for C9H10NO4 [M + H]
+
: 196.0610; found: 196.0610. 
 
5.4 General Procedures for Chapter 3 
5.4.1 General Procedure 4: Chiral Hydroxylamine Formation 
Chiral hydroxylamines 135a-h were prepared according to adaptation of the general 
method of Wovkulich and Uskoković.133 MgSO4 (2.0 g) and p-anisaldehyde (1.0 
equiv.) was added to a solution of the corresponding chiral amine (1.0 g, 1.0 equiv.) 
in MeOH (25 mL). The mixture was stirred for 24 hours, filtered and the solvent 
evaporated under reduced pressure. The residue was then dissolved in anhydrous 
CH2Cl2 (5 mL), cooled to 0 °C and a solution of m-chloroperoxybenzoic acid (70%, 
1.2 equiv.) in anhydrous CH2Cl2 (30 mL) added dropwise. The reaction was stirred 
for 1 hour at 0 °C, warmed to room temperature and stirred for a further 3 hours. 
The resultant white suspension was filtered, neutralized with saturated aqueous 
NaHCO3 (20 mL) and washed with brine (20 mL). The organic layer was dried over 
MgSO4 and the solvent evaporated under reduced pressure to yield an oxaziridine 
intermediate. The crude oxaziridine was subsequently dissolved in anhydrous 
MeOH (20 mL) and hydroxylamine hydrochloride (2.0 equiv.) added in a single 





added to precipitate unreacted hydroxylamine hydrochloride, the solution was 
filtered and the solvent evaporated. Water (20 mL) and Et2O (20 mL) were added to 
the residue and the acidic aqueous layer then extracted with Et2O (10 x 20 mL), 
until all nonpolar substances had been removed (checked by TLC). The aqueous 
layer was saturated with NaHCO3 and extracted with Et2O (3 x 20 mL). The 
combined organic layers were then dried over MgSO4 and the solvent evaporated 
under reduced pressure to yield a hydroxylamine 135a-h that was purified by 
recrystallization from 1:4 CHCl3/hexane. 
5.4.2 General Procedure 5: Determination of the Enantiomeric Excess 
of Chiral Hydroxylamines 
To a solution of hydroxylamine 135a-h (30 mg) dissolved in CDCl3 (2 mL), 2-
formylphenylboronic acid (1 equiv.), (rac)-BINOL (1.1 equiv.) and Cs2CO3 (1.1 
equiv.) were added, MgSO4 was then added and the suspension stirred for 15 





5.5 Synthesis of Compounds in Chapter 3 
 
(R)-N-(1-phenylethyl)hydroxylamine 135a 
The title compound was prepared according to General Procedure 4 using (R)-α-
methylbenzylamine (1.05 mL, 8.25 mmol), p-anisaldehyde (1.00 mL, 8.25 mmol), 
m-chloroperoxybenzoic acid (3.42 g, 9.90 mmol, 70%) and hydroxylamine 
hydrochloride (1.15 g, 16.50 mmol) to afford hydroxylamine 135a as an off white 
solid (422 mg, 54%). mp: 96-97 °C; [α]D
22
 = +37.0 (c 2.0, CH2Cl2); (Lit (-43.5, c 
1.0, CH2Cl2 for (S)-1a)
156
; IR (film / cm
-1) ν = 3134 cm-1 (OH); 1H NMR (300 MHz; 





Hz, CH), 1.33 (3H, d, J = 6.7 Hz, CH3); 
13
C NMR (75 MHz; CDCl3): δC = 142.2 
(ArCCHCH3), 128.6 (ArCHCHC), 127.7 (ArCHCCH), 127.2 (ArCH(CH)2CCH), 
61.8 (CHCH3), 19.4 (CH3); HRMS (ES): m/z calculated for C8H12NO [M + H]
+
: 
138.0919; found: 138.0924. 
 
(S)-N-(1-(3-methoxyphenyl)ethyl)hydroxylamine 135b 
The title compound was prepared according to General Procedure 4 using (S)-3-
methoxy-α-methylbenzylamine (0.98 mL, 6.61 mmol), p-anisaldehyde (0.81 mL, 
6.61 mmol), m-chloroperoxybenzoic acid (2.74 g, 7.94 mmol, 70%) and 
hydroxylamine hydrochloride (0.92 g, 13.22 mmol) to afford hydroxylamine 135b 
as a white solid (432mg, 55%). mp 60-61 °C; [α]D
22
 = -40.0 (c 2.0, CH2Cl2); IR 
(film / cm
-1) ν = 3134 cm-1 (OH); 1H NMR (300 MHz; CDCl3): δH = 7.25 (1H, t, J = 
7.6 Hz, ArH), 6.93-6.85 (2H, m, ArH), 6.80 (1H, d, J = 7.5 Hz, ArH), 5.78 (2H, br s, 
NHOH), 4.08 (1H, q, J = 6.7 Hz, CH), 3.80 (3H, s, CH3O), 1.38 (3H, d, J = 6.7 Hz, 
CH3); 
13
C NMR (75 MHz; CDCl3): δC = 159.8, 144.0, 129.6, 119.4, 112.9, 112.8, 






The title compound was prepared according to General Procedure 4 using (S)-4-
chloro-α-methylbenzylamine (0.90 mL, 6.43 mmol), p-anisaldehyde (0.78 mL, 6.43 
mmol), m-chloroperoxybenzoic acid (2.66 g, 7.71 mmol, 70%) and hydroxylamine 
hydrochloride (0.89 g, 12.85 mmol) to afford hydroxylamine 135c as white needles 
(478 mg, 62%). mp 86-87 °C; [α]D
22
 = -47.0 (c 2.0, CH2Cl2); IR (film / cm





H NMR (300 MHz; CDCl3): δH = 7.28 (2H, d, J = 7.5 Hz, ArH), 





1.35 (3H, d, J = 6.7 Hz, CH3); 
13
C NMR (75 MHz; CDCl3): δC = 140.6, 133.3, 
129.1, 128,3, 61.1, 19.1; HRMS (ES): m/z calculated for C8H11ClNO [M + H]
+
: 
172.0529; found: 172.0534. 
 
(S)-N-(1-(p-tolyl)ethyl)hydroxylamine 135d 
The title compound was prepared according to General Procedure 4 using (S)-α,4-
dimethylbenzylamine (1.09 mL, 7.40 mmol), p-anisaldehyde (0.90 mL, 7.40 mmol), 
m-chloroperoxybenzoic acid (3.06 g, 8.88 mmol, 70%) and hydroxylamine 
hydrochloride (1.03 g, 14.79 mmol) to afford hydroxylamine 135d as a pale brown 
solid (238 mg, 38%). mp 79-81 °C; [α]D
22






H NMR (300 MHz; CDCl3): δH = 7.22 (2H, d, J = 7.5 Hz, ArH), 
7.16 (2H, d, J = 7.5 Hz, ArH), 5.78 (2H, br s, NHOH), 4.08 (1H, q, J = 6.6 Hz, CH), 
2.34 (3H, s, ArCH3), 1.38 (3H, d, J = 6.6 Hz, CH3); 
13
C NMR (75 MHz; CDCl3): δC 
= 139.2, 137.3, 129.3, 127.1, 61.5, 21.1, 19.4; HRMS (ES): m/z calculated for 
C9H14NO [M + H]
+
: 152.1075; found: 152.1082. 
 
(S)-N-(1-(naphthalen-2-yl)ethyl)hydroxylamine 135e 
The title compound was prepared according to General Procedure 4 using (S)-1-(2-
naphthyl)ethylamine (1.00 g, 5.84 mmol), p-anisaldehyde (0.71 mL, 5.84 mmol), m-
chloroperoxybenzoic acid (2.42 g, 6.42 mmol, 70%) and hydroxylamine 
hydrochloride (0.81 g, 11.68 mmol) to afford hydroxylamine 135e as a pale yellow 
solid (210 mg, 32%). mp 101-102 °C; [α]D
22
 = -48.0 (c 2.0, CH2Cl2); IR (film / cm
-
1) ν = 3162 cm-1 (OH); 1H NMR (300 MHz; CDCl3): δH = 7.80-7.83 (3H, m, ArH), 
7.77 (1H, s, ArH), 7.45-7.48 (3H, m, ArH), 5.08 (2H, br s, NHOH), 4.29 (1H, q, J = 
6.7 Hz, CH), 1.47 (3H, d, J = 6.7 Hz, CH3); 
13





138.8, 133.3, 133.1, 128.4, 127.9, 127.7, 126.4, 126.2, 126.0, 125.1, 61.9, 19.2; 
HRMS (ES): m/z calculated for C12H14NO [M + H]
+
: 188.1075; found: 188.1068. 
 
methyl hydroxy-L-valinate 135f 
The title compound was prepared according to General Procedure 4 using (L)-valine 
methylester (1.00 g, 7.62 mmol), p-anisaldehyde (0.93 mL, 7.62 mmol), m-
chloroperoxybenzoic acid (2.24 g, 9.15 mmol, 70%) and hydroxylamine 
hydrochloride (1.05 g, 15.25 mmol) to afford hydroxylamine 135f as a white solid 
(351 mg, 46%). mp 59-61 °C; [α]D
22
 = -10.0 (c 2.0, CH2Cl2); (Lit (-15.5, c 1.0, 
CH2Cl2)
157
; IR (film / cm
-1) ν = 3178 cm-1 (OH); 1H NMR (300 MHz; CDCl3): δH = 
5.92 (2H, br s, NHOH), 3.77 (3H, s, CH3O), 3.47 (1H, d, J = 6.7 Hz, CHNH), 1.91 
(1H, m, CHCH3), 0.96 (6H, t, J = 6.8 Hz, CH3); 
13
C NMR (75 MHz; CDCl3): δC = 
173.9, 71.2, 51.9, 29.0, 19.3, 19.2; HRMS (ES): m/z calculated for C6H14NO3 [M + 
H]
+
: 148.0974; found: 148.0988. 
 
(R)-N-(1-cyclohexylethyl)hydroxylamine 135g 
The title compound was prepared according to General Procedure 4 using (R)-
cyclohexylethylamine (1.17 mL, 7.86 mmol), p-anisaldehyde (0.96 mL, 7.86 mmol), 
m-chloroperoxybenzoic acid (3.26 g, 9.43 mmol, 70%) and hydroxylamine 
hydrochloride (1.09 g, 15.71 mmol) to afford hydroxylamine 135g as white needles 
(549 mg, 65%). mp 82 °C; [α]D
22
 = -4.0 (c 2.0, CH2Cl2); IR (film / cm





H NMR (300 MHz; CDCl3): δH = 5.48 (2H, br s, NHOH), 2.74 (1H, 
quin, J = 6.3 Hz, CHNH), 1.60-1.70 (5H, m, CH2), 1.36-1.48 (1H, m, CH), 1.07-
1.23 (3H, m, CH2), 0.99 (3H, d, J = 6.6 Hz, CH3), 0.86-0.95 (2H, m, CH2); 
13
C 
NMR (75 MHz; CDCl3): δC = 61.8, 40.0, 29.9, 28.1, 26.5, 14.4; HRMS (ES): m/z 
calculated for C8H17NO [M + H]
+







The title compound was prepared according to General Procedure 4 using (R)-2-
aminoheptane (1.31 mL, 8.68 mmol), p-anisaldehyde (1.06 mL, 8.68 mmol), m-
chloroperoxybenzoic acid (3.60 g, 10.41 mmol, 70%) and hydroxylamine 
hydrochloride (1.21 g, 17.36 mmol) to afford hydroxylamine 135h as a white solid 
(190 mg, 32%). mp 83-84 °C; [α]D
22
 = -3.0 (c 2.0, CH2Cl2); IR (film / cm





H NMR (300 MHz; CDCl3): δH = 5.16 (2H, br s, NHOH), 3.00 
(1H, sex, J = 6.2 Hz, CHNH), 1.24-1.34 (8H, m, CH2), 1.11 (3H, d, J = 6.4 Hz, 
CHCH3), 0.89 (3H, t, J = 7.0 Hz, CH2CH3); 
13
C NMR (75 MHz; CDCl3): δC = 57.4, 
33.4, 32.0, 25.6, 22.6, 17.5, 14.1; HRMS (ES): m/z calculated for C7H18NO [M + 
H]
+
: 132.1388; found: 132.1397. 
 
(E)-4-methoxybenzaldehyde oxime 137 
Hydroxylamine hydrochloride (104 mg, 1.50 mmol) was dissolved in 5:1 
ethanol:water (10 mL) and cooled to 0 °C. p-Anisaldehyde (0.09 mL, 0.75 mmol) 
was added to the resultant solution followed by the addition of sodium acetate (184 
mg, 2.25 mmol) portionwise. The reaction was warmed to room temperature and 
stirred for a further 24 hours. The ethanol was removed under reduced pressure and 
the reaction mixture diluted with water followed by extraction with dichloromethane 
(3 x 10 mL). The combined organic layers were washed with dilute NaOH (10 mL), 
dried over magnesium sulphate and the solvent removed under reduced pressure to 
afford the title compound as a white solid (107 mg, 94%). mp 59-61 °C;
214
 IR (film / 
cm
-1) ν = 3168 cm-1 (OH), 1606 cm-1 (C=N); 1H NMR (300 MHz; CDCl3): δH = 
8.40 (1H, br, s, OH), 8.11 (1H, s, NCH), 7.52 (2H, d, J = 8.8 Hz, ArH), 6.91 (2H, d, 
J = 8.8 Hz, ArH), 3.83 (3H, s, CH3O); 
13





133.0, 128.5, 124.6, 114.3, 55.3; HRMS (ES): m/z calculated for C8H10NO2 [M + 
H]
+




The title compound was prepared according to General Procedure 5 using (R)-N-(1-
phenylethyl)hydroxylamine (135a, 30 mg, 0.22 mmol), (R)-BINOL (69 mg, 0.24 
mmol), 2-formylphenylboronic acid (33 mg, 0.22 mmol) and Cs2CO3 (78 mg, 0.24 
mmol) to afford diastereomer (R,R)-138a. 
1
H NMR (500 MHz; CDCl3): δH(R,R) = 
8.11 (1H, s, HCN), 7.98-7.91 (3H, m, ArH), 7.83 (1H, d, J = 8.7 Hz, ArH), 7.50-
7.45 (3H, m, ArH), 7.41-7.36 (4H, m, ArH), 7.31 (1H, d, J = 8.7 Hz, ArH), 7.29-
7.15 (8H, m, ArH), 7.07 (1H, d, J = 8.6 Hz, ArH), 5.08 (1H, q, J = 7.0 Hz, CH3CH), 
1.69 (3H, d, J = 7.0 Hz, CH3); 
11
B NMR (96 MHz; CDCl3): δB(R,R) = 12.0; 
13
C 
NMR (75 MHz; CDCl3): δC(R,R) = 154.7, 154.3, 152.6, 143.9, 135.8, 135.5, 133.5, 
133.4, 131.5, 130.1, 130.0, 129.6, 129.2, 128.9, 128.3, 128.1, 127.7, 127.3, 127.2, 





The title compound was prepared according to General Procedure 5 using (R)-N-(1-
phenylethyl)hydroxylamine (135a, 30 mg, 0.22 mmol), (S)-BINOL (69 mg, 0.24 
mmol), 2-formylphenylboronic acid (33 mg, 0.22 mmol) and Cs2CO3 (78 mg, 0.24 
mmol) to afford diastereoisomer (R,S)-139a. 
1





7.93 (1H, s, HCN), 7.98-7.91 (3H, m, ArH), 7.83 (1H, d, J = 8.7 Hz, ArH), 7.50-
7.45 (3H, m, ArH), 7.41-7.36 (4H, m, ArH), 7.31 (1H, d, J = 8.7 Hz, ArH), 7.29-
7.15 (8H, m, ArH), 7.07 (1H, d, J = 8.6 Hz, ArH), 5.02 (1H, q, J = 7.0 Hz, CH3CH), 
1.67 (3H, d, J = 7.0 Hz, CH3); 
11
B NMR (96 MHz; CDCl3): δB(R,S) = 12.0; 
13
C 
NMR (75 MHz; CDCl3): δC(R,S) = 154.5, 152.7, 143.8, 135.7, 135.4, 134.8, 133.7, 
133.3, 131.6, 130.7, 130.0, 129.8, 129.5, 129.3, 128.7, 128.5, 128.0, 127.8, 127.3, 





The title compound was prepared according to General Procedure 5 using (S)-N-(1-
(3-methoxyphenyl)ethyl)hydroxylamine (135b, 30 mg, 0.18 mmol), (S)-BINOL (57 
mg, 0.20 mmol), 2-formylphenylboronic acid (27 mg, 0.18 mmol) and Cs2CO3 (64 
mg, 0.20 mmol) to afford diastereoisomer (S,S)-138b. 
1
H NMR (500 MHz; CDCl3): 
δH(S,S) = 8.23 (1H, s, HCN), 7.92-7.89 (2H, m, ArH), 7.87-7.83 (1H, m, ArH), 7.67 
(1H, d, J = 8.8 Hz, ArH), 7.47-7.40 (3H, m, ArH), 7.37-7.33 (3H, m, ArH), 7.31-
7.28 (3H, m, ArH), 7.25-7.18 (4H, m, ArH), 7.08 (1H, d, J = 8.7 Hz, ArH), 7.05-
7.02 (1H, m, ArH), 6.80 (1H, d, J = 7.6 Hz, ArH), 5.15 (1H, q, J = 7.0, CH3CH), 
3.44 (3H, s, CH3O), 1.74 (3H, d, J = 6.9 Hz, CH3); 
11
B NMR (96 MHz; CDCl3): 
δB(S,S) = 12.0; 
13
C NMR (75 MHz; CDCl3): δC(S,S) = 160.1, 154.6, 154.5, 152.7, 
144.1, 137.5, 135.5, 133.8, 133.5, 133.3, 131.3, 130.7, 130.5, 130.1, 129.6, 129.2, 
128.8, 128.6, 127.7, 127.2, 127.1, 126.1, 125.2, 123.8, 123.6, 123.2, 122.7, 122.6, 









The title compound was prepared according to General Procedure 5 using (S)-N-(1-
(3-methoxyphenyl)ethyl)hydroxylamine (135b, 30 mg, 0.18 mmol), (R)-BINOL (57 
mg, 0.20 mmol), 2-formylphenylboronic acid (27 mg, 0.18 mmol) and Cs2CO3 (64 
mg, 0.20 mmol) to afford diastereoisomer (S,R)-139b. 
1
H NMR (500 MHz; CDCl3): 
δH(S,R) = 7.93 (1H, s, HCN), 7.92-7.89 (2H, m, ArH), 7.87-7.83 (1H, m, ArH), 7.79 
(1H, d, J = 8.8 Hz, ArH), 7.47-7.40 (3H, m, ArH), 7.37-7.33 (3H, m, ArH), 7.31-
7.28 (3H, m, ArH), 7.25-7.18 (4H, m, ArH), 7.08 (1H, d, J = 8.7 Hz, ArH), 7.05-
7.02 (1H, m, ArH), 6.98 (1H, d, J = 7.6 Hz, ArH), 5.09 (1H, q, J = 7.0 Hz, CH3CH), 
3.74 (3H, s, CH3O), 1.89 (3H, d, J = 6.9, CH3); 
11
B NMR (96 MHz; CDCl3): δB(S,R) 
= 12.0; 
13
C NMR (75 MHz; CDCl3): δC(S,R) = 160.2, 154.4, 154.2, 152.7, 144.0, 
136.2, 135.4, 133.5, 133.3, 131.6, 130.6, 130.0, 129.5, 129.1, 128.7, 128.3, 128.0, 
127.7, 127.3, 127.0, 126.0, 125.2, 125.1, 124.6, 123.9, 123.7, 123.3, 122.8, 122.4, 




The title compound was prepared according to General Procedure 5 using (S)-N-(1-
(4-chlorophenyl)ethyl)hydroxylamine (135c, 30 mg, 0.17 mmol), (S)-BINOL (55 
mg, 0.19 mmol), 2-formylphenylboronic acid (26 mg, 0.17 mmol) and Cs2CO3 (63 
mg, 0.19 mmol) to afford diastereoisomer (S,S)-138c. 
1
H NMR (500 MHz; CDCl3): 





ArH), 7.78 (1H, d, J = 8.7 Hz, ArH), 7.44-7.35 (5H, m, ArH), 7.30-7.27 (1H, m, 
ArH), 7.24-7.18 (6H, m, ArH), 7.11 (2H, m, ArH), 7.03 (1H, d, J = 7.7 Hz, ArH), 
6.95 (1H, d, J = 8.7 Hz, ArH), 5.02 (1H, q, J = 7.0 Hz, CH3CH), 1.57 (3H, d, J = 7.0 
Hz, CH3); 
11
B NMR (96 MHz; CDCl3): δB(S,S) = 11.7; 
13
C NMR (75 MHz; CDCl3): 
δC(S,S) = 154.5, 154.1, 152.7, 144.0, 135.9, 135.6, 135.5, 133.8, 133.2, 131.4, 130.6, 
129.9, 129.3, 129.1, 128.8, 128.6, 128.0, 127.8, 127.1, 127.0, 126.0, 125.3, 125.2, 




The title compound was prepared according to General Procedure 5 using (S)-N-(1-
(4-chlorophenyl)ethyl)hydroxylamine (135c, 30 mg, 0.17 mmol), (R)-BINOL (55 
mg, 0.19 mmol), 2-formylphenylboronic acid (26 mg, 0.17 mmol) and Cs2CO3 (63 
mg, 0.19 mmol) to afford diastereoisomer (S,R)-139c. 
1
H NMR (500 MHz; CDCl3): 
δH(S,R) = 8.01 (1H, s, HCN), 7.95 (2H, d, J = 8.2 Hz, ArH), 7.89 (1H, d, J = 8.8 Hz, 
ArH), 7.77 (1H, d, J = 8.7 Hz, ArH), 7.44-7.35 (5H, m, ArH), 7.30-7.27 (1H, m, 
ArH), 7.24-7.18 (6H, m, ArH), 7.11 (2H, m, ArH), 7.03 (1H, d, J = 7.7 Hz, ArH), 
6.83 (1H, d, J = 8.7 Hz, ArH), 4.94 (1H, q, J = 7.0 Hz, CH3CH), 1.58 (3H, d, J = 7.0 
Hz, CH3); 
11
B NMR (96 MHz; CDCl3): δB(S,R) = 11.7; 
13
C NMR (75 MHz; CDCl3): 
δC(S,R) = 154.4, 154.0, 152.6, 143.9, 136.1, 135.7, 133.4, 133.3, 131.7, 130.0, 
129.6, 129.4, 128.7, 128.5, 128.3, 127.9, 127.8, 127.3, 127.2, 125.9, 125.1, 125.0, 








The title compound was prepared according to General Procedure 5 using (S)-N-(1-
(p-tolyl)ethyl)hydroxylamine (135d, 30 mg, 0.20 mmol), (S)-BINOL (62 mg, 0.22 
mmol), 2-formylphenylboronic acid (30 mg, 0.20 mmol) and Cs2CO3 (71 mg, 0.22 
mmol) to afford diastereoisomer (S,S)-138d which was recrystallized from CDCl3 
for X-ray crystallographic analysis. 
1
H NMR (500 MHz; CDCl3): δH(S,S) = 8.06 
(1H, s, HCN), 7.96 (2H, dd, J1 = 7.9 Hz, J2 = 3.7 Hz, ArH), 7.90 (1H, d, J = 8.6 Hz, 
ArH), 7.70 (1H, d, J = 8.7 Hz, ArH), 7.49 (2H, t, J = 8.7 Hz, ArH), 7.45 (1H, t, J = 
7.5 Hz, ArH), 7.42-7.39 (2H, m, ArH), 7.31 (1H, d, J = 7.4 Hz, ArH), 7.29-7.19 
(8H, m, ArH), 7.17-7.14 (2H, m, ArH), 7.11 (1H, d, J = 7.7 Hz, ArH), 5.15 (1H, q, J 
= 6.9 Hz, CH3CH), 2.40 (3H, s, ArCH3), 1.73 (3H, d, J = 6.9 Hz, CH3); 
11
B NMR 
(96 MHz; CDCl3): δB(S,S) = 12.0; 
13
C NMR (75 MHz; CDCl3): δC(S,S) = 154.7, 
154.3, 152.7, 143.6, 140.2, 140.0, 135.5, 133.7, 133.4, 132.4, 131.7, 131.5, 130.8, 
130.2, 130.0, 129.9, 128.6, 128.3, 127.9, 127.3, 126.2, 125.1, 125.0, 124.5, 123.9, 




The title compound was prepared according to General Procedure 5 using (S)-N-(1-
(p-tolyl)ethyl)hydroxylamine (135d, 30 mg, 0.20 mmol), (R)-BINOL (62 mg, 0.22 
mmol), 2-formylphenylboronic acid (30 mg, 0.20 mmol) and Cs2CO3 (71 mg, 0.22 
mmol) to afford diastereoisomer (S,R)-139d. 
1
H NMR (500 MHz; CDCl3): δH(S,R) 
= 7.96 (2H, dd, J1 = 7.9 Hz, J2 = 3.7 Hz, ArH), 7.90 (1H, s, HCN), 7.90 (1H, d, J = 
8.6 Hz, ArH), 7.84 (1H, d, J = 8.7 Hz, ArH), 7.49 (2H, t, J = 8.7 Hz, ArH), 7.45 
(1H, t, J = 7.5 Hz, ArH), 7.42-7.39 (2H, m, ArH), 7.32 (1H, d, J = 7.4 Hz, ArH), 
7.29-7.19 (8H, m, ArH), 7.17-7.14 (2H, m, ArH), 7.11 (1H, d, J = 7.7 Hz, ArH), 
5.10 (1H, q, J = 6.9 Hz, CH3CH), 2.46 (3H, s, ArCH3), 1.80 (3H, d, J = 6.9 Hz, 
CH3); 
11
B NMR (96 MHz; CDCl3): δB(S,R) = 12.0; 
13
C NMR (75 MHz; CDCl3): 





130.1, 130.0, 129.4, 129.2, 128.7, 128.5, 128.0, 127.7, 127.3, 127.1, 126.1, 125.2, 




The title compound was prepared according to General Procedure 5 using (S)-N-(1-
(naphthalen-2-yl)ethyl)hydroxylamine (135e, 30 mg, 0.16 mmol), (S)-BINOL (50 
mg, 0.18 mmol), 2-formylphenylboronic acid (24 mg, 0.16 mmol) and Cs2CO3 (57 
mg, 0.18 mmol) to afford diastereoisomer (S,S)-138e. 
1
H NMR (500 MHz; CDCl3): 
δH(S,S) = 8.21 (1H, s, HCN), 7.90 (2H, t, J = 9.1 Hz, ArH), 7.84-7.73 (5H, m, ArH), 
7.64-7.56 (2H, m, ArH), 7.44-7.36 (4H, m, ArH), 7.34-7.28 (3H, m, ArH), 7.27-7.20 
(3H, m, ArH), 7.19-7.12 (3H, m, ArH), 6.84 (1H, d, J = 8.7 Hz, ArH), 5.34 (1H, q, J 
= 7.0 Hz, CH3CH), 1.83 (3H, d, J = 6.9 Hz, CH3); 
11
B NMR (96 MHz; CDCl3): 
δB(S,S) = 11.7; 
13
C NMR (75 MHz; CDCl3): δC(S,S) = 154.7, 154.5, 143.8, 135.6, 
133.8, 133.7, 133.5, 132.9, 131.8, 131.5, 130.9, 130.0, 129.9, 129.4, 128.4, 128.3, 
128.2, 127.9, 127.3, 127.2, 127.0, 126.2, 125.4, 125.1, 125.0, 124.5, 124.2, 123.8, 




The title compound was prepared according to General Procedure 5 using (S)-N-(1-
(naphthalen-2-yl)ethyl)hydroxylamine (135e, 30 mg, 0.16 mmol), (R)-BINOL (50 





mg, 0.18 mmol) to afford diastereoisomer (S,R)-139e. 
1
H NMR (500 MHz; CDCl3): 
δH(S,R) = 7.97 (1H, s, HCN), 7.90 (2H, t, J = 9.1 Hz, ArH), 7.84-7.73 (5H, m, ArH), 
7.64-7.56 (2H, m, ArH), 7.44-7.36 (4H, m, ArH), 7.34-7.28 (3H, m, ArH), 7.27-7.20 
(3H, m, ArH), 7.19-7.12 (3H, m, ArH), 6.85 (1H, d, J = 8.7 Hz, ArH), 5.31 (1H, q, J 
= 7.0 Hz, CH3CH), 1.93 (3H, d, J = 6.9 Hz, CH3); 
11
B NMR (96 MHz; CDCl3): 
δB(S,R) = 11.7; 
13
C NMR (75 MHz; CDCl3): δC(S,R) = 154.6, 154.1, 152.7, 144.0, 
135.5, 133.9, 133.4, 133.3, 133.2, 131.9, 131.7, 131.1, 130.0, 129.9, 129.5, 129.4, 
128.7, 128.6, 128.5, 128.4, 127.9, 127.7, 127.5, 127.3, 127.2, 127.1, 126.9, 126.0, 





The title compound was prepared according to General Procedure 5 using (S)-
methyl 2-(hydroxyamino)-3-methylbutanoate (135f, 30 mg, 0.20 mmol), (S)-BINOL 
(64 mg, 0.22 mmol), 2-formylphenylboronic acid (27 mg, 0.20 mmol) and Cs2CO3 
(64 mg, 0.22 mmol) to afford diastereoisomer (S,S)-138f. 
1
H NMR (500 MHz; 
CDCl3): δH(S,S) = 8.50 (1H, s, HCN), 7.93-7.83 (4H, m, ArH), 7.51 (1H, t, J = 7.3 
Hz, ArH), 7.47-7.41 (3H, m, ArH), 7.39-7.29 (5H, m, ArH), 7.26-7.20 (2H, m, 
ArH), 7.15 (1H, d, J = 8.7 Hz, ArH), 4.39 (1H, d, J = 9.0 Hz, CHCO2Me), 3.85 (3H, 
s, CH3O), 2.53 (1H, hept, J = 9.0 Hz, CHCH3), 1.05 (6H, dd, J1 = 22.6 Hz, J2 = 6.7 
Hz, CH3); 
11
B NMR (96 MHz; CDCl3): δB(S,S) = 11.5; 
13
C NMR (75 MHz; CDCl3): 
δC(S,S) = 167.4, 154.6, 154.3, 152.7, 147.2, 136.2, 133.7, 133.5, 133.4, 133.3, 131.5, 
130.1, 130.0, 128.8, 128.7, 128.4, 128.0, 127.9, 126.1, 124.5, 123.8, 123.7, 123.6, 










The title compound was prepared according to General Procedure 5 using (S)-
methyl 2-(hydroxyamino)-3-methylbutanoate (135f, 30 mg, 0.20 mmol), (R)-
BINOL (64 mg, 0.22 mmol), 2-formylphenylboronic acid (27 mg, 0.20 mmol) and 
Cs2CO3 (64 mg, 0.22 mmol) to afford diastereoisomer (S,R)-139f. 
1
H NMR (500 
MHz; CDCl3): δH(S,R) = 8.48 (1H, s, HCN), 7.93-7.83 (4H, m, ArH), 7.51 (1H, t, J 
= 7.3 Hz, ArH), 7.47-7.41 (3H, m, ArH), 7.39-7.29 (5H, m, ArH), 7.26-7.20 (2H, m, 
ArH), 7.11 (1H, d, J = 8.7 Hz, ArH), 4.37 (1H, d, J = 9.0 Hz, CHCO2Me), 3.77 (3H, 
s, CH3O), 2.56 (1H, hept, J = 9.0 Hz, CHCH3), 1.11 (6H, dd, J1 = 38.8 Hz, J2 = 6.7 
Hz, CH3); 
11
B NMR (96 MHz; CDCl3): δB(S,R) = 11.5; 
13
C NMR (75 MHz; CDCl3): 
δC(S,R) = 167.0, 154.4, 154.2, 152.7, 146.7, 136.0, 133.4, 131.6, 130.9, 130.2, 
130.0, 129.3, 128.5, 128.3, 127.9, 127.3, 127.2, 125.8, 125.1, 124.5, 123.9, 123.6, 




The title compound was prepared according to General Procedure 5 using (R)-N-(1-
cyclohexylethyl)hydroxylamine (135g, 30 mg, 0.21 mmol), (R)-BINOL (66 mg, 
0.23 mmol), 2-formylphenylboronic acid (31 mg, 0.21 mmol) and Cs2CO3 (75 mg, 
0.23 mmol) to afford diastereoisomer (S,R)-138g. 
1
H NMR (500 MHz; CDCl3): 
δH(R,R) = 7.99 (1H, s, HCN), 7.94-7.84 (4H, m, ArH), 7.49 (1H, t, J = 6.8 Hz, 





ArH), 3.68 (1H, quin, J = 6.7 Hz, CHCH3), 1.94-1.87 (1H, m, CH), 1.71-1.59 (4H, 
m, CH2), 1.50 (3H, d, J = 6.7 Hz, CH3), 1.22-1.01 (4H, m, CH2), 0.89-0.82 (2H, m, 
CH2); 
11
B NMR (96 MHz; CDCl3): δB(R,R) = 11.8; 
13
C NMR (75 MHz; CDCl3): 
δC(R,R) = 154.8, 154.2, 152.7, 144.0, 135.3, 133.4, 131.7, 130.8, 130.0, 129.2, 
128.7, 128.3, 127.9, 127.7, 127.3, 127.1, 125.9, 125.0, 124.6, 124.0, 123.9, 123.7, 




The title compound was prepared according to General Procedure 5 using (R)-N-(1-
cyclohexylethyl)hydroxylamine (135g, 30 mg, 0.21 mmol), (S)-BINOL (66 mg, 
0.23 mmol), 2-formylphenylboronic acid (31 mg, 0.21 mmol) and Cs2CO3 (75 mg, 
0.23 mmol) to afford diastereoisomer (R,S)-139g. 
1
H NMR (500 MHz; CDCl3): 
δH(R,S) = 7.90 (1H, s, HCN), 7.94-7.84 (4H, m, ArH), 7.49 (1H, t, J = 6.8 Hz, ArH), 
7.42 (2H, t, J = 8.6 Hz, ArH), 7.38-7.28 (7H, m, ArH), 7.24-7.20 (2H, m, ArH), 3.57 
(1H, quin, J = 6.7 Hz, CHCH3), 1.97-1.90 (1H, m, CH), 1.71-1.59 (4H, m, CH2), 
1.36 (3H, d, J = 6.7 Hz, CH3), 1.22-1.01 (4H, m, CH2), 0.84-0.78 (2H, m, CH2); 
11
B 
NMR (96 MHz; CDCl3): δB(R,S) = 11.8; 
13
C NMR (75 MHz; CDCl3): δC(R,S) = 
154.7, 154.4, 152.7, 143.9, 135.2, 133.7, 133.5, 131.6, 130.7, 130.0, 129.1, 128.6, 
128.4, 128.0, 127.9, 127.1, 125.8, 125.1, 124.6, 124.0, 123.9, 123.7, 123.2, 122.7, 








The title compound was prepared according to General Procedure 5 using (R)-N-
(heptan-2-yl)hydroxylamine (135h, 30 mg, 0.23 mmol), (R)-BINOL (72 mg, 0.25 
mmol), 2-formylphenylboronic acid (34 mg, 0.23 mmol) and Cs2CO3 (82 mg, 0.25 
mmol) to afford diastereoisomer (R,R)-138h. 
1
H NMR (500 MHz; CDCl3): δH(R,R) 
= 8.03 (1H, s, HCN), 7.96-7.86 (4H, m, ArH), 7.49-7.44 (3H, m, ArH), 7.41-7.36 
(3H, m, ArH), 7.34 (1H, d, J = 8.7 Hz, ArH), 7.32-7.22 (5H, m, ArH), 3.89 (1H, 
sex, J = 7.3 Hz, CHCH3), 1.93-1.86 (1H, m, CH2), 1.54-1.47 (1H, m, CH2), 1.44 
(3H, d, J = 7.0 Hz, CHCH3), 1.24-1.14 (6H, m, CH2), 0.85 (3H, t, J = 7.0 Hz, 
CH2CH3); 
11
B NMR (96 MHz; CDCl3): δB(R,R) = 11.9; 
13
C NMR (125 MHz; 
CDCl3): δC(R,R) = 154.8, 154.3, 152.6, 143.9, 135.2, 133.8, 133.4, 131.5, 130.6, 
130.0, 129.2, 128.8, 128.4, 128.1, 127.7, 127.3, 127.1, 126.1, 125.2, 125.1, 124.7, 




The title compound was prepared according to General Procedure 5 using (R)-N-
(heptan-2-yl)hydroxylamine (135h, 30 mg, 0.23 mmol), (S)-BINOL (72 mg, 0.25 
mmol), 2-formylphenylboronic acid (34 mg, 0.23 mmol) and Cs2CO3 (82 mg, 0.25 
mmol) to afford diastereoisomer (R,S)-139h. 
1
H NMR (500 MHz; CDCl3): δH(R,S) 
= 7.99 (1H, s, HCN), 7.96-7.86 (3H, m, ArH), 7.79 (1H, d, J = 8.6 Hz, ArH), 7.49-
7.44 (3H, m, ArH), 7.41-7.36 (3H, m, ArH), 7.32-7.22 (5H, m, ArH), 7.16 (1H, d, J 
= 8.7 Hz, ArH), 3.84 (1H, sex, J = 7.3 Hz, CHCH3), 1.93-1.86 (1H, m, CH2), 1.54-
1.47 (1H, m, CH2), 1.36 (3H, d, J = 7.0 Hz, CHCH3), 1.24-1.14 (6H, m, CH2), 0.96 
(3H, t, J = 7.0 Hz, CH2CH3); 
11
B NMR (96 MHz; CDCl3): δB(R,S) = 11.9; 
13
C NMR 
(125 MHz; CDCl3): δC(R,S) = 154.6, 154.2, 152.7, 143.6, 135.3, 133.7, 133.5, 
131.6, 130.8, 130.0, 129.1, 128.7, 128.4, 128.3, 128.0, 127.9, 127.1, 126.0, 125.1, 






5.6 General Procedures for Chapter 4 
5.6.1 General Procedure 6: Dihydroxylation of Alkenes 
Racemic diols 182b,i,j were prepared according to the literature procedure.
213
 AD-
mix-α (0.70 g) and AD-mix-β (0.70 g) were dissolved in 1:1 tert-butanol:water (10 
mL) and stirred at room temperature to produce two clear phases. 
Methanesulfonamide (1.00 mmol) was added if the alkene is non-terminal and the 
mixture cooled to 0 °C. The corresponding alkene was then added (1.00 mmol) and 
the reaction stirred vigorously at 0 °C for 24 hours. Sodium sulfite was added and 
the reaction allowed to warm to room temperature and stirred for a further one hour. 
The reaction mixture was extracted with dichloromethane (3 x 10 mL) and when 
methanesulfonamide was employed the combined organic layers were washed with 
2 M potassium hydroxide solution. The combined organic layers were dried over 
magnesium sulphate and the solvent evaporated under reduced pressure. The crude 
product was purified by silica gel flash column chromatography (ethyl 
acetate/hexane) to afford the corresponding dihydroxylated product. 
5.6.2 General Procedure 7: Determination of the Enantiomeric Excess 
of Chiral Diols  
To a solution of 1,3-phenyldiboronic acid (20 mg, 0.12 mmol) suspended in MeOH 
the appropriate chiral diol (0.24 mmol) and 3Å molecular sieves were added and the 
suspension stirred for 20 minutes at room temperature, before filtering and 
evaporating the solvent under reduced pressure. The resultant product was then 
dissolved in CDCl3 before acquiring a 500 MHz 
1







5.7 Synthesis of Compounds in Chapter 4 
 
(rac)-1-phenylpropane-1,2-diol 182b 
The title compound was prepared according to General Procedure 6 using trans-β-
methylstyrene (0.13 mL, 1 mmol) and methanesulfonamide (95 mg, 1.00 mmol) to 
afford diol 182b as a white solid (128 mg, 84%). mp 54-55 °C;
215






H NMR (300 MHz; CDCl3): δH = 7.35-7.25 (5H, m, ArH), 4.36 
(1H, app t, PhCH), 3.89-3.83 (1H, m, CHCH3), 2.75 (1H, br s, PhCHOH), 2.62 (1H, 
br s, CH3CHOH), 1.06 (3H, app t, CH3); 
13
C NMR (75 MHz; CDCl3): δC = 141.0, 
128.5, 128.2, 126.9, 79.5, 72.3, 18.8; HRMS (ES): m/z calculated for C9H11O2 [M - 
H]
-
: 151.0759; found: 151.0773. 
 
1-(p-tolyl)ethane-1,2-diol 182i 
The title compound was prepared according to General Procedure 6 using 4-
methylstyrene (0.13 mL, 1.00 mmol) to afford diol 182i as a white solid (120 mg, 
79%). mp 77-78 °C;
216
 IR (film / cm
-1) ν = 3244 cm-1 (OH); 1H NMR (300 MHz; 
CDCl3): δH = 7.25 (2H, d, J = 7.4 Hz, ArH), 7.17 (2H, d, J = 7.9 Hz, ArH), 4.79 
(1H, dd, J1 = 8.1 Hz, J2 = 3.7 Hz, CHOH), 3.76-3.61 (2H, m, CH2OH), 2.64 (2H, br 
s, OH), 2.35 (3H, s, CH3); 
13
C NMR (75 MHz; CDCl3): δC = 137.8, 137.5, 129.3, 










The title compound was prepared according to General Procedure 6 using 
allylbenzene (0.13 mL, 1.00 mmol) to afford diol 182j as an orange oil (94 mg, 
62%). 
1
H NMR (300 MHz; CDCl3): IR (film / cm
-1) ν = 3337 cm-1 (OH); δH = 8.27-
8.13 (5H, m, ArH), 3.90-3.82 (1H, m, CHOH), 3.61 (1H, dd, J1 = 11.2 Hz, J2 = 3.2 
Hz, CH2OH), 3.43 (1H, dd, J1 = 11.2 Hz, J2 = 3.2 Hz, CH2OH), 2.75-2.62 (2H, m, 
CH2), 2.23 (2H, br s, OH); 
13
C NMR (75 MHz; CDCl3): δC = 137.7, 129.4, 128.7, 







The title compound was prepared according to General Procedure 7 using racemic 
diol 182a to afford a Horeau series of diboronate esters as a white solid. 
1
H NMR 
(500 MHz; CDCl3): δH = 8.59 and 8.57 (1H, app d, Δδ = 0.020 ppm, BCCHCB), 
8.09 (2H, d, J = 7.4 Hz, BArH), 7.51 (1H, t, J = 7.5 Hz, BArH), 5.16 (4H, s, CH), 
3.92 and 3.91 (12H, app d, Δδ = 0.010 ppm, CH3O); 
11
B NMR (96 MHz; CDCl3): 
δB = 31.7; 
13
C NMR (125 MHz; CDCl3): δC = 169.8, 142.5 (hetero ArC), 142.4 







The title compound was prepared according to General Procedure 7 using racemic 
diol 182b to afford a Horeau series of diboronate esters as a white solid. 
1
H NMR 
(500 MHz; CDCl3): δH = 8.51 and 8.50 (1H, app d, Δδ = 0.012 ppm, BCCHCB), 
8.07 (2H, d, J = 7.4 Hz, BArH), 7.49 (1H, t, J = 7.5 Hz, BArH), 7.42-7.40 (8H, m, 
ArH), 7.38-7.35 (2H, m, ArH), 5.07 (2H, d, J = 7.5 Hz, CHPh), 4.50 (2H, quin, J = 
6.2 Hz, CHMe), 1.57 (6H, d, J = 6.2 Hz, CH3); 
11
B NMR (160 MHz; CDCl3): δB = 
32.6; 
13
C NMR (125 MHz; CDCl3): δC = 142.0 (hetero ArC), 141.9 (homo ArC), 
140.6 (hetero ArC), 140.5 (homo ArC), 138.1, 128.7, 128.3, 127.4, 125.7 (hetero 
ArC), 125.6 (homo ArC), 86.1, 81.7, 21.2. 
 
1,3-bis(4,5-diphenyl-1,3,2-dioxaborolan-2-yl)benzene 187/188c 
The title compound was prepared according to General Procedure 7 using racemic 
diol 182c to afford a Horeau series of diboronate esters as a white solid. 
1
H NMR 
(500 MHz; CDCl3): δH = 8.65 and 8.63 (1H, app d, Δδ = 0.024 ppm, BCCHCB), 
8.16 (2H, d, J = 7.5 Hz, BArH), 7.53 (1H, t, J = 7.3 Hz, BArH), 7.42-7.34 (20H, m, 
ArH), 5.36 (4H, s, CH); 
11
B NMR (96 MHz; CDCl3): δB = 31.5; 
13
C NMR (125 








The title compound was prepared according to General Procedure 7 using racemic 
diol 182d to afford a Horeau series of diboronate esters as a white solid. 
1
H NMR 
(500 MHz; CDCl3): δH = 8.59 and 8.57 (1H, app d, Δδ = 0.020 ppm, BCCHCB), 
8.14 (2H, d, J = 7.4 Hz, BArH), 7.53 (1H, t, J = 7.5 Hz, BArH), 7.47-7.40 (8H, m, 
ArH), 7.40-7.37 (2H, m, ArH), 5.65 (2H, dd, J1 = 2.9 Hz, J2 = 6.1 Hz, CHPh), 4.90 
(2H, d, J = 6.1 Hz, CHCO2Me), 3.90 (6H, s, CH3O); 
11
B NMR (96 MHz; CDCl3): 
δB = 30.7; 
13
C NMR (125 MHz; CDCl3): δC = 171.0, 142.4, 140.3, 138.8, 128.9, 
128.6, 127.6, 125.4 (hetero ArC), 125.3 (homo ArC), 82.6, 81.9, 52.8; HRMS (ES): 
m/z calculated for C26H24B2O8Na [M + Na]
+
: 509.1554; found: 509.1540. 
 
1,3-bis(4-phenyl-1,3,2-dioxaborinan-2-yl)benzene 187/188e 
The title compound was prepared according to General Procedure 7 using racemic 
diol 182e to afford a Horeau series of diboronate esters as a white solid. 
1
H NMR 
(500 MHz; CDCl3): δH = 8.47 and 8.46 (1H, app d, Δδ = 0.020 ppm, BCCHCB), 
8.03 (2H, d, J = 7.3 Hz, BArH), 7.47-7.41 (9H, m, ArH), 7.35 (2H, m, ArH), 5.33 
(2H, app dd, J1 = Hz, J2 = Hz, OCH), 4.30-4.17 (4H, m, OCH2), 2.36 (2H, dq, J1 = 
Hz, J2 = Hz, CH2), 2.13-2.05 (2H, m, CH2); 
11
B NMR (96 MHz; CDCl3): δB =; 
13
C 
NMR (125 MHz; CDCl3): δC = 142.7 (hetero ArC), 142.6 (homo ArC), 139.7 
(hetero ArC), 139.6 (homo ArC), 136.4, 128.5, 127.5, 127.0, 125.3, 72.8, 61.0 
(hetero ArC), 60.9 (homo ArC), 35.4; HRMS (ES): m/z calculated for 
C24H24B2O4Na [M + Na]
+







The title compound was prepared according to General Procedure 7 using racemic 
diol 182f to afford a Horeau series of diboronate esters as a colourless oil. 
1
H NMR 
(500 MHz; CDCl3): δH = 8.32 (1H, s, BCCHCB), 7.93 (2H, d, J = 7.4 Hz, BArH), 
7.42 (1H, t, J = 7.4 Hz, BArH), 4.74 (2H, sex, J = 6.6 Hz, CHCH3), 4.47 (2H, t, J = 
8.2 Hz, CH2O), 3.91 (2H, t, J = 8.3 Hz, CH2O), 1.43 (6H, d, J = 6.2 Hz, CH3);
 11
B 
NMR (96 MHz; CDCl3): δB = 35.7; 
13
C NMR (125 MHz; CDCl3): δC = 141.6, 
137.7, 127.3, 73.8, 72.6, 21.8. 
 
1,3-bis(4-(tert-butyl)-1,3,2-dioxaborolan-2-yl)benzene 187/188g 
The title compound was prepared according to General Procedure 7 using racemic 
diol 182g to afford a Horeau series of diboronate esters as a colourless oil. 
1
H NMR 
(500 MHz; CDCl3): δH = 8.29 (1H, s, BCCHCB), 7.93 (2H, d, J = 7.4 Hz, BArH), 
7.40 (1H, t, J = 7.5 Hz, BArH), 4.31-4.25 (4H, m, CH2), 4.18-4.11 (2H, m, CH), 
0.95 (18H, s, CH3); 
11
B NMR (96 MHz; CDCl3): δB = 33.8; 
13
C NMR (125 MHz; 








The title compound was prepared according to General Procedure 7 using racemic 
diol 182h to afford a Horeau series of diboronate esters as a colourless oil. 
1
H NMR 
(500 MHz; CDCl3): δH = 8.23 (1H, s, BCCHCB), 7.85 (2H, d, J = 7.4 Hz, BArH), 
7.35 (1H, t, J = 7.6 Hz, BArH), 4.34-4.28 (2H, m, CHCH3), 4.23-4.29 (2H, m, 
CH2O), 4.16-4.10 (2H, m, CH2O), 2.03 (2H, dq, J1 = 14.4 Hz, J2 = 3.5 Hz, CH2), 
1.84-1.77 (2H, m, CH2), 1.39 (6H, d, J = 6.3 Hz, CH3);
 11
B NMR (160 MHz; 
CDCl3): δB = 31.3; 
13
C NMR (125 MHz; CDCl3): δC = 139.2, 135.9, 126.8, 67.6, 
61.2, 34.3, 23.0. 
 
1,3-bis(4-(p-tolyl)-1,3,2-dioxaborolan-2-yl)benzene 187/188i 
The title compound was prepared according to General Procedure 7 using racemic 
diol 182i to afford a Horeau series of diboronate esters as a white solid. 
1
H NMR 
(500 MHz; CDCl3): δH = 8.49 (1H, br s, BCCHCB), 8.05 (2H, d, J = 7.5 Hz, BArH), 
7.49 (1H, t, J = 7.9 Hz, BArH), 7.30 (4H, d, J = 8.5 Hz, ArH), 7.22 (4H, d, J = 8.5 
Hz, ArH), 5.59 (2H, t, J = 7.5 Hz, OCH), 4.75 (2H, t, J = 8.0 Hz, OCH2), 4.75 (2H, 
app t, OCH2), 2.38 (6H, s, CH3O); 
11
B NMR (160 MHz; CDCl3): δB = 31.4; 
13
C 
NMR (125 MHz; CDCl3): δC = 142.0, 138.2, 138.0, 129.5, 127.5, 125.8, 125.7, 







The title compound was prepared according to General Procedure 7 using racemic 
diol 182j to afford a Horeau series of diboronate esters as a white solid. 
1
H NMR 
(500 MHz; CDCl3): δH = 8.32 (1H, s, BCCHCB), 7.94 (2H, d, J = 7.4 Hz, BArH), 
7.42 (1H, t, J = 7.4 Hz, BArH), 7.35-7.32 (4H, m, ArH), 7.29-7.25 (6H, m, ArH), 
4.84 (2H, quin, J = 6.7 Hz, OCH), 4.37 (2H, app t, CH2O), 4.09 (2H, dd, J1 = 6.9 
Hz, J2 = 8.3 Hz, CH2O), 3.16 (2H, dd, J1 = 13.9 Hz, J2 = 6.2 Hz, CH2), 2.91 (2H, dd, 
J1 = 13.9 Hz, J2 = 6.9 Hz, CH2); 
11
B NMR (160 MHz; CDCl3): δB = 31.8; 
13
C NMR 
(125 MHz; CDCl3): δC = 141.6, 137.9, 136.7 (hetero ArC), 136.6 (homo ArC), 
129.4, 128.6, 127.3, 126.8, 77.9, 70.5, 42.2. 
 
1,3-bis(4-phenyl-1,3,2-dioxaborolan-2-yl)benzene 187/188k 
The title compound was prepared according to General Procedure 7 using racemic 
diol 182k to afford a Horeau series of diboronate esters as a colourless oil. 
1
H NMR 
(500 MHz; CDCl3): δH = 8.48 (1H, br s, BCCHCB), 8.06 (2H, d, J = 7.4 Hz, BArH), 
7.49 (1H, t, J = 7.5 Hz, BArH), 7.42-7.39 (8H, m, ArH), 7.37-7.34 (2H, m, ArH), 





Hz, J2 = 9.0 Hz, CH2); 
11
B NMR (160 MHz; CDCl3): δB = 32.0; 
13
C NMR (125 




The title compound was prepared according to General Procedure 7 using racemic 
diol 182l to afford a Horeau series of diboronate esters as a colourless oil. 
1
H NMR 
(500 MHz; CDCl3): δH = 8.29 (1H, br s, BCCHCB), 7.90 (2H, d, J = 7.5 Hz, BArH), 
7.38 (1H, t, J = 7.4 Hz, BArH), 4.44 (2H, d, J = 8.7 Hz, CH2O), 2.43-2.38 (2H, m, 
OCHCH2CH), 2.24-2.19 (2H, m, OCCH), 2.16-2.13 (2H, m, CH2),  1.99-1.92 (4H, 
m, CH2),  1.47 (6H, s, CH3CO), 1.30 (6H, s, CH3), 1.19 (2H, d, J = 10.9 Hz, CH2), 
0.88 (6H, s, CH3); HRMS (ES): m/z calculated for C26H26B2O4Na [M + Na]
+
: 




The title compound was prepared according to General Procedure 7 using racemic 
diol 182m to afford a Horeau series of diboronate esters as a white solid. 
1
H NMR 
(500 MHz; CDCl3): δH = 8.49 (1H, br s, BCCHCB), 8.08 (2H, d, J = 8.8 Hz, 





CH2) 5.15 (4H, s, CH); 
11
B NMR (96 MHz; CDCl3): δB = 31.3; 
13
C NMR (125 
MHz; CDCl3): δC = 171.4, 169.1, 142.5 (hetero ArC), 142.4 (homo ArC), 139.1, 































































































































































































































































































































































































































































































































































































































































































































































































































































X-Ray Crystallographic Data 
All X-ray structures were obtained by Dr. Mary Mahon at the University of Bath 
and deposited into the Cambridge Crystallographic Data Centre. 
 
X-ray Crystallographic Data for (S,S)-p-tolyl-α-amino nitrile 122b 
CCDC No. - 811794 
 
 
Figure 54 - X-ray crystal structure of (S,S)-p-tolyl-α-amino nitrile 122b 
 
Table 1.  Crystal data and structure refinement for 1. 
                                                        
 Identification code k10tdj1 
 Empirical formula C18 H21 Cl N2 O 
 Formula weight 316.82 
 Temperature 150(2) K 
 Wavelength 0.71073 Å 
 Crystal system Orthorhombic 
 Space group P212121 
 Unit cell dimensions a = 6.5880(1)Å  = 90o 
       b = 13.1300(3)Å  = 90o 
       c = 18.3980(3)Å  = 90o 
 Volume 1591.43(5) Å
3
 
 Z 4 
 Density (calculated) 1.322 Mg/m
3
 







 F(000) 672 
 Crystal size 0.40 x 0.30 x 0.10 mm 
 Theta range for data collection 3.63 to 27.44
o
 
 Index ranges -8<=h<=8; -17<=k<=17; -23<=l<=23 
 Reflections collected 30416 
 Independent reflections 3623 [R(int) = 0.0776] 
 Reflections observed (>2) 2751 
 Data Completeness 0.996 
 Absorption correction Semi-empirical from equivalents 
 Max. and min. transmission 0.954 and 0.880 
 Refinement method Full-matrix least-squares on F
2
 
 Data / restraints / parameters 3623 / 1 / 198 
 Goodness-of-fit on F
2
 1.038 
 Final R indices [I>2(I)] R1 = 0.0399   wR2 = 0.0855 
 R indices (all data) R1 = 0.0661  wR2 = 0.0960 
 Absolute structure parameter -0.7(15) 







H1 located and refined at a distance of 0.98 Å from N1. 
 
Absolute stereochemistry not definitive from crystallography – assigned on basis of 
chemical information. 
 
Hydrogen bonding present. 
 
 
Hydrogen bonds with  H..A < r(A) + 2.000 Angstroms  and  <DHA > 110 
deg. 
 
 D-H           d(D-H)   d(H..A)   <DHA    d(D..A)   A 
 
 N1-H1          0.974    2.209   171.54    3.175    N2 [ x-1/2, -






   
 Table 2.  Atomic coordinates ( x 10
4
) and equivalent isotropic 




) for 1.U(eq) is defined 
 as one third of the trace of the orthogonalized Uij tensor. 
                                                             
                                                             
  Atom   x   y   z  U(eq) 
                                  
O(1) 9437(2) 9398(1) 6249(1) 40(1) 
N(1) 3210(2) 7996(1) 8612(1) 28(1) 
N(2) 5415(2) 8228(1) 10287(1) 43(1) 
C(1) 3909(2) 8867(1) 9040(1) 29(1) 
C(2) 4784(3) 8532(1) 9749(1) 32(1) 
C(3) 2218(3) 9635(1) 9159(1) 28(1) 
C(4) 681(3) 9463(1) 9657(1) 31(1) 
C(5) -864(3) 10164(1) 9755(1) 33(1) 
C(6) -905(3) 11072(1) 9364(1) 37(1) 
C(7) 626(3) 11230(1) 8856(1) 44(1) 
C(8) 2170(3) 10532(1) 8758(1) 38(1) 
C(9) -2564(3) 11845(2) 9488(1) 54(1) 
C(10) 4847(2) 7291(1) 8386(1) 29(1) 
C(11) 3858(3) 6314(1) 8122(1) 39(1) 
C(12) 6147(2) 7810(1) 7820(1) 26(1) 
C(13) 8105(3) 8128(1) 7969(1) 32(1) 
C(14) 9259(2) 8662(1) 7464(1) 32(1) 
C(15) 8440(2) 8877(1) 6790(1) 29(1) 
C(16) 6490(3) 8555(1) 6623(1) 32(1) 
C(17) 5365(3) 8031(1) 7132(1) 29(1) 
C(18) 11290(3) 9895(2) 6440(1) 53(1) 
                                     





   
 Table 3.   Bond lengths [Å] and angles [
o
] for 1. 
  
O(1)-C(15) 1.3745(18) O(1)-C(18) 1.428(2) 
N(1)-C(1) 1.463(2) N(1)-C(10) 1.480(2) 
N(1)-H(1) 0.974(5) N(2)-C(2) 1.145(2) 
C(1)-C(2) 1.493(2) C(1)-C(3) 1.518(2) 
C(1)-H(1A) 1.0000 C(3)-C(4) 1.384(2) 
C(3)-C(8) 1.391(2) C(4)-C(5) 1.384(2) 
C(4)-H(4) 0.9500 C(5)-C(6) 1.392(2) 
C(5)-H(5) 0.9500 C(6)-C(7) 1.391(3) 
C(6)-C(9) 1.509(3) C(7)-C(8) 1.381(3) 
C(7)-H(7) 0.9500 C(8)-H(8) 0.9500 
C(9)-H(9A) 0.9800 C(9)-H(9B) 0.9800 
C(9)-H(9C) 0.9800 C(10)-C(12) 1.512(2) 
C(10)-C(11) 1.519(2) C(10)-H(10) 1.0000 
C(11)-H(11A) 0.9800 C(11)-H(11B) 0.9800 
C(11)-H(11C) 0.9800 C(12)-C(13) 1.383(2) 
C(12)-C(17) 1.397(2) C(13)-C(14) 1.391(2) 
C(13)-H(13) 0.9500 C(14)-C(15) 1.380(2) 
C(14)-H(14) 0.9500 C(15)-C(16) 1.387(2) 
C(16)-C(17) 1.379(2) C(16)-H(16) 0.9500 
C(17)-H(17) 0.9500 C(18)-H(18A) 0.9800 
C(18)-H(18B) 0.9800 C(18)-H(18C) 0.9800 
                                           
C(15)-O(1)-C(18) 117.23(14) C(1)-N(1)-C(10) 114.23(12) 
C(1)-N(1)-H(1) 107.5(10) C(10)-N(1)-H(1) 108.2(10) 
N(1)-C(1)-C(2) 111.17(12) N(1)-C(1)-C(3) 111.47(13) 
C(2)-C(1)-C(3) 110.64(12) N(1)-C(1)-H(1A) 107.8 
C(2)-C(1)-H(1A) 107.8 C(3)-C(1)-H(1A) 107.8 
N(2)-C(2)-C(1) 176.66(17) C(4)-C(3)-C(8) 118.19(16) 
C(4)-C(3)-C(1) 121.64(13) C(8)-C(3)-C(1) 120.16(15) 
C(5)-C(4)-C(3) 121.07(15) C(5)-C(4)-H(4) 119.5 
C(3)-C(4)-H(4) 119.5 C(4)-C(5)-C(6) 121.06(16) 
C(4)-C(5)-H(5) 119.5 C(6)-C(5)-H(5) 119.5 
C(7)-C(6)-C(5) 117.50(16) C(7)-C(6)-C(9) 121.72(16) 
C(5)-C(6)-C(9) 120.78(17) C(8)-C(7)-C(6) 121.45(15) 
C(8)-C(7)-H(7) 119.3 C(6)-C(7)-H(7) 119.3 
C(7)-C(8)-C(3) 120.70(17) C(7)-C(8)-H(8) 119.7 
C(3)-C(8)-H(8) 119.7 C(6)-C(9)-H(9A) 109.5 
C(6)-C(9)-H(9B) 109.5 H(9A)-C(9)-H(9B) 109.5 
C(6)-C(9)-H(9C) 109.5 H(9A)-C(9)-H(9C) 109.5 
H(9B)-C(9)-H(9C) 109.5 N(1)-C(10)-C(12) 108.92(12) 
N(1)-C(10)-C(11) 107.78(13) C(12)-C(10)-C(11) 113.78(13) 





















C(13)-C(12)-C(10) 121.80(13) C(17)-C(12)-C(10) 120.61(14) 
C(12)-C(13)-C(14) 121.89(14) C(12)-C(13)-H(13) 119.1 
C(14)-C(13)-H(13) 119.1 C(15)-C(14)-C(13) 119.35(15) 
C(15)-C(14)-H(14) 120.3 C(13)-C(14)-H(14) 120.3 
O(1)-C(15)-C(14) 124.40(15) O(1)-C(15)-C(16) 115.68(14) 
C(14)-C(15)-C(16) 119.92(14) C(17)-C(16)-C(15) 119.95(15) 
C(17)-C(16)-H(16) 120.0 C(15)-C(16)-H(16) 120.0 
C(16)-C(17)-C(12) 121.36(16) C(16)-C(17)-H(17) 119.3 









109.5   
  
Symmetry transformations used to generate equivalent atoms: 
                                                            





   




) for 1. The anisotropic 
displacement 






 U11 + ... + 2 h k a* b* U 
                                                                                 
  Atom  U11  U22  U33  U23  U13  U12 
                                                
O(1) 31(1) 48(1) 42(1) 14(1) 7(1) -2(1) 
N(1) 24(1) 33(1) 28(1) -1(1) 0(1) -2(1) 
N(2) 47(1) 43(1) 40(1) -4(1) -13(1) 9(1) 
C(1) 28(1) 32(1) 27(1) 2(1) -2(1) -2(1) 
C(2) 31(1) 32(1) 35(1) -5(1) -3(1) 2(1) 
C(3) 28(1) 28(1) 27(1) -1(1) -4(1) -4(1) 
C(4) 35(1) 28(1) 31(1) 2(1) -1(1) -1(1) 
C(5) 33(1) 36(1) 32(1) -2(1) -2(1) -1(1) 
C(6) 39(1) 34(1) 40(1) -5(1) -10(1) 4(1) 
C(7) 54(1) 32(1) 45(1) 9(1) -2(1) 3(1) 
C(8) 42(1) 35(1) 37(1) 9(1) 2(1) -4(1) 
C(9) 56(1) 47(1) 58(1) -5(1) -9(1) 17(1) 
C(10) 26(1) 32(1) 29(1) 4(1) 0(1) 3(1) 
C(11) 42(1) 31(1) 45(1) 1(1) 8(1) -2(1) 
C(12) 25(1) 26(1) 27(1) -1(1) 0(1) 4(1) 
C(13) 30(1) 39(1) 28(1) 2(1) -4(1) 2(1) 
C(14) 23(1) 36(1) 35(1) 0(1) -2(1) -1(1) 
C(15) 27(1) 29(1) 31(1) 3(1) 8(1) 4(1) 
C(16) 29(1) 39(1) 26(1) 3(1) -1(1) 3(1) 
C(17) 25(1) 34(1) 30(1) -1(1) -2(1) -1(1) 
C(18) 28(1) 59(1) 73(1) 30(1) 2(1) -4(1) 





   
 Table 5.   Hydrogen coordinates ( x 10
4
) and isotropic displacement 




) for 1. 
                                     
  Atom   x   y   z  U(eq) 
                                  
H(1A) 5011 9213 8759 35 
H(4) 686 8854 9936 37 
H(5) -1914 10024 10095 40 
H(7) 608 11832 8569 52 
H(8) 3209 10666 8413 46 
H(9A) -3779 11644 9216 80 
H(9B) -2106 12515 9320 80 
H(9C) -2884 11878 10008 80 
H(10) 5709 7132 8819 35 
H(11A) 2929 6469 7721 59 
H(11B) 3099 6001 8522 59 
H(11C) 4909 5842 7953 59 
H(13) 8678 7977 8431 39 
H(14) 10597 8876 7581 38 
H(16) 5931 8696 6158 38 
H(17) 4029 7815 7012 35 
H(18A) 12287 9385 6596 79 
H(18B) 11039 10375 6838 79 
H(18C) 11816 10265 6018 79 
H(1) 2250(20) 7617(11) 8910(8) 42(5) 





   
   
 Table 6.   Dihedral angles [
o
] for 1. 
                                         
  Atom1  -  Atom2  -  Atom3  -  Atom4  Dihedral 
                                                  
C(10) - N(1) - C(1) - C(2) -64.30(16) 
C(10) - N(1) - C(1) - C(3) 171.75(12) 
N(1) - C(1) - C(2) - N(2) -13(3) 
C(3) - C(1) - C(2) - N(2) 112(3) 
N(1) - C(1) - C(3) - C(4) 75.86(18) 
C(2) - C(1) - C(3) - C(4) -48.39(19) 
N(1) - C(1) - C(3) - C(8) -103.35(16) 
C(2) - C(1) - C(3) - C(8) 132.40(16) 
C(8) - C(3) - C(4) - C(5) -0.1(2) 
C(1) - C(3) - C(4) - C(5) -179.29(14) 
C(3) - C(4) - C(5) - C(6) -1.0(2) 
C(4) - C(5) - C(6) - C(7) 2.1(2) 
C(4) - C(5) - C(6) - C(9) -178.38(16) 
C(5) - C(6) - C(7) - C(8) -2.2(3) 
C(9) - C(6) - C(7) - C(8) 178.28(17) 
C(6) - C(7) - C(8) - C(3) 1.2(3) 
C(4) - C(3) - C(8) - C(7) 0.0(2) 
C(1) - C(3) - C(8) - C(7) 179.20(15) 
C(1) - N(1) - C(10) - C(12) -70.16(15) 
C(1) - N(1) - C(10) - C(11) 165.96(12) 
N(1) - C(10) - C(12) - C(13) 109.16(16) 
C(11) - C(10) - C(12) - C(13) -130.59(16) 
N(1) - C(10) - C(12) - C(17) -67.64(18) 
C(11) - C(10) - C(12) - C(17) 52.6(2) 
C(17) - C(12) - C(13) - C(14) 1.0(2) 
C(10) - C(12) - C(13) - C(14) -175.91(15) 
C(12) - C(13) - C(14) - C(15) -0.5(2) 
C(18) - O(1) - C(15) - C(14) -11.1(2) 
C(18) - O(1) - C(15) - C(16) 169.29(15) 
C(13) - C(14) - C(15) - O(1) -179.99(15) 
C(13) - C(14) - C(15) - C(16) -0.4(2) 
O(1) - C(15) - C(16) - C(17) -179.67(15) 
C(14) - C(15) - C(16) - C(17) 0.7(2) 
C(15) - C(16) - C(17) - C(12) -0.2(2) 
C(13) - C(12) - C(17) - C(16) -0.7(2) 
C(10) - C(12) - C(17) - C(16) 176.27(14) 
                                         
                                         









X-ray Crystallographic Data for nitrono-boronate ester (S,R)-139d 
CCDC No. - 1415709 
 
 
Figure 55 – X-ray crystal structure of nitrono-boronate ester (S,R)-139d 
 
 
Table 1.  Crystal data and structure refinement for 1. 
                                                                                                                         
 Identification code k12tdj2 
 Empirical formula C36.50 H26.50 B Cl5.50 N O3 
 Formula weight 732.87 
 Temperature 150(2) K 
 Wavelength 0.71073 Å 
 Crystal system Hexagonal 
 Space group P65 
 Unit cell dimensions a = 22.2610(3)Å alpha = 90
o
 
       b = 22.2610(3)Å beta = 90
o
 
       c = 14.8460(2)Å gamma = 120
o
 
 Volume 6371.32(15) Å
3
 
 Z 6 
 Density (calculated) 1.146 Mg/m
3
 
 Absorption coefficient 0.404 mm
-1
 
 F(000) 2250 
 Crystal size 0.45 x 0.30 x 0.30 mm 
 Theta range for data collection 3.66 to 27.48
o
 
 Index ranges -24<=h<=0; 0<=k<=28; -18<=l<=19 





 Independent reflections 9679 [R(int) = 0.0000] 
 Reflections observed (>2sigma) 7174 
 Data Completeness 0.997 
 Absorption correction Semi-empirical from equivalents 
 Max. and min. transmission 0.955 and 0.828 
 Refinement method Full-matrix least-squares on F
2
 
 Data / restraints / parameters 9679 / 31 / 434 
 Goodness-of-fit on F
2
 1.038 
 Final R indices [I>2sigma(I)] R1 = 0.0655   wR2 = 0.1675 
 R indices (all data) R1 = 0.0910  wR2 = 0.1793 
 Absolute structure parameter 0.09(7) 






The asymmetric unit in this structure contains one molecule of  compound X, one full 
molecule of chloroform in which the chlorides have been modelled as being are 
disordered over 2 positions and a diffuse region of solvent for which a sensible model 
could not be constructed. Thus the latter was treated with PLATON-SQUEEZE, and 
based on pre-PLATON analysis of the difference Fourier electron density map, it has 
been included herein as one half of a chloroform molecule per asymmetric unit. 
 
Some distance and ADP restraints were included in the full molecule of chloroform – 





                                                                                                                       
                                                                                                                         
 Table 2.  Atomic coordinates ( x 10
4
) and equivalent isotropic 




) for 1.U(eq) is defined 
 as one third of the trace of the orthogonalized Uij tensor. 
                                                                                                                         
                                                                                                                         
  Atom   x   y   z  U(eq) 
                                                                                                                          
Cl(1) 1462(1) 7799(1) 359(1) 71(1) 
Cl(2) 6207(3) 8096(4) -469(4) 129(2) 
Cl(3) 7066(2) 7627(3) 355(5) 146(2) 
Cl(4) 6367(3) 8171(4) 1426(5) 103(2) 
Cl(2A) 6504(4) 7974(3) -551(3) 148(2) 
Cl(3A) 6951(3) 7391(3) 816(4) 127(2) 
Cl(4A) 6434(6) 8296(6) 1292(7) 170(5) 
O(1) 2048(1) 6304(1) 4084(1) 34(1) 
O(2) 1247(1) 5052(1) 4199(1) 36(1) 
O(3) 1815(1) 5474(1) 2856(1) 39(1) 
N(1) 2370(1) 5638(1) 2329(2) 34(1) 
C(1) 1546(1) 6458(1) 3850(2) 34(1) 
C(2) 1714(2) 6977(2) 3186(2) 40(1) 
C(3) 1248(2) 7157(2) 2925(2) 45(1) 
C(4) 562(2) 6796(2) 3262(2) 44(1) 
C(5) 33(2) 6928(2) 2922(2) 60(1) 
C(6) -636(2) 6548(2) 3222(3) 67(1) 
C(7) -813(2) 6013(2) 3842(3) 63(1) 
C(8) -323(2) 5883(2) 4189(2) 51(1) 
C(9) 378(2) 6269(2) 3928(2) 41(1) 
C(10) 908(1) 6140(2) 4271(2) 36(1) 
C(11) 785(1) 5659(2) 5032(2) 35(1) 
C(12) 513(1) 5742(2) 5883(2) 40(1) 
C(13) 438(2) 6323(2) 6079(2) 46(1) 
C(14) 179(2) 6371(2) 6903(2) 57(1) 
C(15) -20(2) 5864(2) 7547(2) 55(1) 
C(16) 64(2) 5317(2) 7404(2) 51(1) 
C(17) 346(1) 5230(2) 6577(2) 40(1) 
C(18) 493(2) 4699(2) 6442(2) 44(1) 
C(19) 805(1) 4653(2) 5673(2) 40(1) 
C(20) 956(1) 5142(2) 4967(2) 36(1) 
C(21) 2591(1) 5579(1) 4200(2) 34(1) 
C(22) 2737(2) 5497(2) 5092(2) 39(1) 
C(23) 3362(2) 5545(2) 5327(2) 41(1) 
C(24) 3859(2) 5663(2) 4680(2) 40(1) 
C(25) 3726(2) 5730(2) 3789(2) 38(1) 
C(26) 3099(1) 5682(1) 3557(2) 34(1) 
C(27) 2956(1) 5738(2) 2619(2) 36(1) 
C(28) 2210(2) 5631(2) 1353(2) 42(1) 
C(29) 2008(2) 6172(2) 1140(2) 40(1) 
C(30) 2521(2) 6866(2) 1103(2) 44(1) 
C(31) 2363(2) 7372(2) 860(2) 49(1) 
C(32) 1680(2) 7174(2) 666(2) 50(1) 





C(34) 1322(2) 5992(2) 959(2) 47(1) 
C(35) 1682(2) 4897(2) 1088(2) 52(1) 
C(36) 6335(2) 7682(2) 513(3) 86(1) 
B(1) 1916(2) 5603(2) 3871(2) 35(1) 






                                                                                                                       
                                                                                                                         
 Table 3.   Bond lengths [Å] and angles [
o
] for 1. 
   
Cl(1)-C(32) 1.747(3) Cl(2)-C(36) 1.821(8) 
Cl(3)-C(36) 1.709(6) Cl(4)-C(36) 1.718(6) 
Cl(2A)-C(36) 1.677(7) Cl(3A)-C(36) 1.844(7) 
Cl(4A)-C(36) 1.718 O(1)-C(1) 1.368(3) 
O(1)-B(1) 1.471(4)  O(2)-C(20) 1.374(3) 
O(2)-B(1) 1.462(4) O(3)-N(1) 1.349(3) 
O(3)-B(1) 1.530(4)  N(1)-C(27) 1.284(4) 
N(1)-C(28) 1.491(4) C(1)-C(10) 1.380(4) 
C(1)-C(2) 1.419(4) C(2)-C(3) 1.342(4) 
C(3)-C(4) 1.416(5) C(4)-C(9) 1.429(4) 
C(4)-C(5) 1.440(5) C(5)-C(6) 1.368(6) 
C(6)-C(7) 1.397(6) C(7)-C(8) 1.362(5) 
C(8)-C(9) 1.408(5)  C(9)-C(10) 1.440(4) 
C(10)-C(11) 1.484(4) C(11)-C(20) 1.383(4) 
C(11)-C(12) 1.453(4) C(12)-C(13) 1.415(5) 
C(12)-C(17) 1.440(4) C(13)-C(14) 1.379(5) 
C(14)-C(15) 1.373(6) C(15)-C(16) 1.337(6) 
C(16)-C(17) 1.436(4) C(17)-C(18) 1.390(5) 
C(18)-C(19) 1.366(4) C(19)-C(20) 1.425(4) 
C(21)-C(22) 1.396(4) C(21)-C(26) 1.409(4) 
C(21)-B(1) 1.604(4)  C(22)-C(23) 1.387(4) 
C(23)-C(24) 1.388(4) C(24)-C(25) 1.379(4) 
C(25)-C(26) 1.389(4) C(26)-C(27) 1.447(4) 
C(28)-C(35) 1.511(5) C(28)-C(29) 1.513(5) 
C(29)-C(30) 1.389(5) C(29)-C(34) 1.399(4) 
C(30)-C(31) 1.384(5) C(31)-C(32) 1.387(5) 
C(32)-C(33) 1.369(5) C(33)-C(34) 1.384(5) 
                                                                                                                         
C(1)-O(1)-B(1) 117.2(2) C(20)-O(2)-B(1) 120.8(2) 
N(1)-O(3)-B(1) 119.4(2) C(27)-N(1)-O(3) 124.4(2) 
C(27)-N(1)-C(28) 123.1(2) O(3)-N(1)-C(28) 112.3(2) 
O(1)-C(1)-C(10) 121.1(2) O(1)-C(1)-C(2) 117.7(2) 
C(10)-C(1)-C(2) 121.2(3) C(3)-C(2)-C(1) 121.0(3) 
C(2)-C(3)-C(4) 120.3(3) C(3)-C(4)-C(9) 119.6(3) 
C(3)-C(4)-C(5) 121.4(3) C(9)-C(4)-C(5) 118.9(3) 
C(6)-C(5)-C(4) 120.5(3) C(5)-C(6)-C(7) 119.9(3) 
C(8)-C(7)-C(6) 121.1(4) C(7)-C(8)-C(9) 121.8(3) 
C(8)-C(9)-C(4) 117.8(3) C(8)-C(9)-C(10) 123.3(3) 
C(4)-C(9)-C(10) 118.9(3) C(1)-C(10)-C(9) 118.2(3) 
C(1)-C(10)-C(11) 119.1(2) C(9)-C(10)-C(11) 122.6(2) 
C(20)-C(11)-C(12) 118.1(2) C(20)-C(11)-C(10) 121.3(2) 
C(12)-C(11)-C(10) 120.6(3) C(13)-C(12)-C(17) 118.4(3) 
C(13)-C(12)-C(11) 122.8(3) C(17)-C(12)-C(11) 118.7(3) 
C(14)-C(13)-C(12) 119.8(3) C(15)-C(14)-C(13) 122.0(4) 
C(16)-C(15)-C(14) 120.2(3) C(15)-C(16)-C(17) 121.9(3) 
C(18)-C(17)-C(16) 122.9(3) C(18)-C(17)-C(12) 119.5(3) 
C(16)-C(17)-C(12) 117.5(3) C(19)-C(18)-C(17) 121.9(3) 
C(18)-C(19)-C(20) 119.5(3) O(2)-C(20)-C(11) 121.6(2) 





C(22)-C(21)-C(26) 116.3(3) C(22)-C(21)-B(1) 125.2(2) 
C(26)-C(21)-B(1) 118.5(2) C(23)-C(22)-C(21) 121.3(3) 
C(22)-C(23)-C(24) 120.9(3) C(25)-C(24)-C(23) 119.4(3) 
C(24)-C(25)-C(26) 119.4(3) C(25)-C(26)-C(21) 122.6(2) 
C(25)-C(26)-C(27) 119.1(2) C(21)-C(26)-C(27) 118.3(2) 
N(1)-C(27)-C(26) 123.8(2) N(1)-C(28)-C(35) 108.5(2) 
N(1)-C(28)-C(29) 111.0(2) C(35)-C(28)-C(29) 115.2(3) 
C(30)-C(29)-C(34) 118.8(3) C(30)-C(29)-C(28) 119.2(3) 
C(34)-C(29)-C(28) 121.9(3) C(31)-C(30)-C(29) 120.9(3) 
C(30)-C(31)-C(32) 118.7(3) C(33)-C(32)-C(31) 121.7(3) 
C(33)-C(32)-Cl(1) 118.4(3) C(31)-C(32)-Cl(1) 119.9(3) 




Cl(3)-C(36)-Cl(4A) 113.6(5) Cl(2A)-C(36)-Cl(4) 124.6(5) 
Cl(3)-C(36)-Cl(4) 114.4(4) Cl(4A)-C(36)-Cl(4) 10.4(7) 
Cl(2A)-C(36)-Cl(2) 27.4(3) Cl(3)-C(36)-Cl(2) 108.8(4) 
Cl(4A)-C(36)-Cl(2) 97.3(6) Cl(4)-C(36)-Cl(2) 106.2(4) 
Cl(2A)-C(36)-
Cl(3A) 
107.7(4) Cl(3)-C(36)-Cl(3A) 26.4(3) 
Cl(4A)-C(36)-
Cl(3A) 
107.0(5) Cl(4)-C(36)-Cl(3A) 103.2(4) 
Cl(2)-C(36)-Cl(3A) 134.9(3) O(2)-B(1)-O(1) 113.4(2) 
O(2)-B(1)-O(3) 100.3(2) O(1)-B(1)-O(3) 110.1(2) 
O(2)-B(1)-C(21) 116.7(2) O(1)-B(1)-C(21) 106.0(2) 
O(3)-B(1)-C(21) 110.3(2)   
   
Symmetry transformations used to generate equivalent atoms: 






                                                                                                                       
                                                                                                                         




) for 1. The anisotropic 
displacement 






 U11 + ... + 2 h k a* b* U 
                                                                                                                         
  Atom  U11  U22  U33  U23  U13  U12 
                                                                                                                             
Cl(1) 84(1) 70(1) 63(1) 2(1) -16(1) 42(1) 
Cl(2) 111(3) 118(4) 115(3) 5(2) 26(2) 25(2) 
Cl(3) 78(2) 152(4) 198(6) -107(4) -18(3) 50(3) 
Cl(4) 70(2) 91(2) 108(3) -48(2) 25(2) 11(2) 
Cl(2A) 196(7) 113(3) 71(2) 3(2) 12(3) 29(4) 
Cl(3A) 73(2) 150(4) 134(4) -3(3) 1(2) 36(2) 
Cl(4A) 172(8) 172(8) 127(5) -40(5) 44(4) 58(6) 
O(1) 31(1) 39(1) 26(1) 1(1) 2(1) 14(1) 
O(2) 36(1) 39(1) 27(1) -1(1) 2(1) 16(1) 
O(3) 29(1) 54(1) 28(1) -3(1) 2(1) 16(1) 
N(1) 34(1) 41(1) 25(1) -3(1) 2(1) 16(1) 
C(1) 38(1) 37(1) 25(1) -2(1) -3(1) 17(1) 
C(2) 43(2) 43(2) 27(1) 3(1) 6(1) 17(1) 
C(3) 60(2) 43(2) 34(2) 4(1) 1(1) 26(2) 
C(4) 57(2) 55(2) 33(1) 0(1) -1(1) 36(2) 
C(5) 80(3) 83(3) 42(2) 8(2) -5(2) 60(2) 
C(6) 63(2) 104(3) 59(2) 3(2) -8(2) 61(2) 
C(7) 50(2) 100(3) 49(2) 4(2) 2(2) 46(2) 
C(8) 51(2) 77(2) 34(2) 5(2) 2(1) 38(2) 
C(9) 45(2) 54(2) 28(1) 2(1) 1(1) 28(1) 
C(10) 38(1) 48(2) 25(1) -2(1) 1(1) 23(1) 
C(11) 26(1) 48(2) 25(1) 3(1) 1(1) 14(1) 
C(12) 26(1) 63(2) 28(1) -2(1) -2(1) 19(1) 
C(13) 48(2) 66(2) 31(2) -3(1) 1(1) 34(2) 
C(14) 60(2) 83(2) 40(2) -7(2) 5(2) 46(2) 
C(15) 46(2) 90(3) 32(2) -7(2) 6(1) 37(2) 
C(16) 28(1) 78(2) 26(1) 7(1) 2(1) 11(2) 
C(17) 26(1) 55(2) 25(1) 4(1) 1(1) 11(1) 
C(18) 35(1) 52(2) 29(1) 14(1) 5(1) 9(1) 
C(19) 32(1) 42(2) 36(1) 5(1) -1(1) 10(1) 
C(20) 28(1) 44(2) 27(1) 3(1) 0(1) 12(1) 
C(21) 38(1) 35(1) 30(1) -3(1) -2(1) 17(1) 
C(22) 40(2) 49(2) 29(1) -2(1) -1(1) 22(1) 
C(23) 47(2) 50(2) 31(1) -1(1) -4(1) 27(1) 
C(24) 44(2) 45(2) 39(2) -3(1) -4(1) 28(1) 
C(25) 43(2) 39(2) 39(2) -3(1) 2(1) 24(1) 
C(26) 34(1) 33(1) 30(1) -6(1) 0(1) 14(1) 
C(27) 36(1) 40(2) 28(1) -4(1) 1(1) 17(1) 
C(28) 38(2) 59(2) 21(1) -3(1) 4(1) 18(1) 
C(29) 35(1) 54(2) 19(1) 0(1) 1(1) 15(1) 
C(30) 36(2) 59(2) 27(1) -2(1) -2(1) 16(1) 
C(31) 43(2) 49(2) 34(2) -1(1) 0(1) 8(1) 
C(32) 58(2) 62(2) 32(2) 6(1) -1(1) 31(2) 
C(33) 37(2) 67(2) 39(2) 6(1) -1(1) 18(2) 





C(35) 54(2) 62(2) 34(2) -16(1) -5(1) 25(2) 
C(36) 73(3) 77(3) 81(3) -13(2) 17(2) 17(2) 






                                                                                                                       
                                                                                                                         
 Table 5.   Hydrogen coordinates ( x 10
4
) and isotropic displacement 




) for 1. 
                                                                                                                         
  Atom   x   y   z  U(eq) 
                                                                                                                           
H(2) 2162 7199 2921 48 
H(3) 1380 7529 2513 54 
H(5) 149 7282 2485 72 
H(6) -979 6648 3010 80 
H(7) -1283 5736 4025 75 
H(8) -457 5522 4619 61 
H(13) 566 6679 5643 55 
H(14) 137 6767 7029 68 
H(15) -218 5901 8096 65 
H(16) -67 4977 7863 61 
H(18) 374 4358 6898 53 
H(19) 920 4298 5609 48 
H(22) 2401 5406 5546 47 
H(23) 3452 5497 5941 49 
H(24) 4287 5698 4848 48 
H(25) 4060 5808 3338 46 
H(27) 3317 5855 2194 43 
H(28) 2645 5760 1012 51 
H(30) 2986 6995 1245 53 
H(31) 2717 7845 828 59 
H(33) 698 6370 562 61 
H(34) 963 5523 1010 56 
H(35A) 1244 4756 1403 78 
H(35B) 1855 4585 1253 78 
H(35C) 1604 4875 436 78 






                                                                                                                       
                                                                                                                         
                                                                                                                         
 Table 6.   Dihedral angles [
o
] for 1. 
                                                                                                                         
  Atom1  -  Atom2  -  Atom3  -  Atom4  Dihedral 
                                                                                                                         
B(1) - O(3) - N(1) - C(27) 18.0(4) 
B(1) - O(3) - N(1) - C(28) -167.1(2) 
B(1) - O(1) - C(1) - C(10) 67.5(3) 
B(1) - O(1) - C(1) - C(2) -114.9(3) 
O(1) - C(1) - C(2) - C(3) -179.7(3) 
C(10) - C(1) - C(2) - C(3) -2.2(4) 
C(1) - C(2) - C(3) - C(4) -4.7(5) 
C(2) - C(3) - C(4) - C(9) 4.2(5) 
C(2) - C(3) - C(4) - C(5) -173.2(3) 
C(3) - C(4) - C(5) - C(6) 176.5(4) 
C(9) - C(4) - C(5) - C(6) -0.9(5) 
C(4) - C(5) - C(6) - C(7) -2.1(6) 
C(5) - C(6) - C(7) - C(8) 3.2(6) 
C(6) - C(7) - C(8) - C(9) -1.3(6) 
C(7) - C(8) - C(9) - C(4) -1.6(5) 
C(7) - C(8) - C(9) - C(10) -179.2(3) 
C(3) - C(4) - C(9) - C(8) -174.8(3) 
C(5) - C(4) - C(9) - C(8) 2.6(4) 
C(3) - C(4) - C(9) - C(10) 2.9(4) 
C(5) - C(4) - C(9) - C(10) -179.7(3) 
O(1) - C(1) - C(10) - C(9) -173.3(2) 
C(2) - C(1) - C(10) - C(9) 9.2(4) 
O(1) - C(1) - C(10) - C(11) 4.2(4) 
C(2) - C(1) - C(10) - C(11) -173.3(2) 
C(8) - C(9) - C(10) - C(1) 168.1(3) 
C(4) - C(9) - C(10) - C(1) -9.4(4) 
C(8) - C(9) - C(10) - C(11) -9.3(4) 
C(4) - C(9) - C(10) - C(11) 173.1(3) 
C(1) - C(10) - C(11) - C(20) -48.2(4) 
C(9) - C(10) - C(11) - C(20) 129.2(3) 
C(1) - C(10) - C(11) - C(12) 128.5(3) 
C(9) - C(10) - C(11) - C(12) -54.0(4) 
C(20) - C(11) - C(12) - C(13) 168.4(3) 
C(10) - C(11) - C(12) - C(13) -8.5(4) 
C(20) - C(11) - C(12) - C(17) -8.3(4) 
C(10) - C(11) - C(12) - C(17) 174.9(2) 
C(17) - C(12) - C(13) - C(14) -3.0(4) 
C(11) - C(12) - C(13) - C(14) -179.7(3) 
C(12) - C(13) - C(14) - C(15) -0.9(5) 
C(13) - C(14) - C(15) - C(16) 3.2(5) 
C(14) - C(15) - C(16) - C(17) -1.4(5) 
C(15) - C(16) - C(17) - C(18) 174.3(3) 
C(15) - C(16) - C(17) - C(12) -2.5(4) 
C(13) - C(12) - C(17) - C(18) -172.3(3) 
C(11) - C(12) - C(17) - C(18) 4.5(4) 





C(11) - C(12) - C(17) - C(16) -178.6(2) 
C(16) - C(17) - C(18) - C(19) -175.5(3) 
C(12) - C(17) - C(18) - C(19) 1.2(4) 
C(17) - C(18) - C(19) - C(20) -3.0(4) 
B(1) - O(2) - C(20) - C(11) 61.2(3) 
B(1) - O(2) - C(20) - C(19) -122.2(3) 
C(12) - C(11) - C(20) - O(2) -176.8(2) 
C(10) - C(11) - C(20) - O(2) 0.0(4) 
C(12) - C(11) - C(20) - C(19) 6.7(4) 
C(10) - C(11) - C(20) - C(19) -176.5(2) 
C(18) - C(19) - C(20) - O(2) -177.7(2) 
C(18) - C(19) - C(20) - C(11) -1.1(4) 
C(26) - C(21) - C(22) - C(23) 2.8(4) 
B(1) - C(21) - C(22) - C(23) -174.1(3) 
C(21) - C(22) - C(23) - C(24) -1.4(5) 
C(22) - C(23) - C(24) - C(25) -0.3(4) 
C(23) - C(24) - C(25) - C(26) 0.4(4) 
C(24) - C(25) - C(26) - C(21) 1.2(4) 
C(24) - C(25) - C(26) - C(27) -178.7(3) 
C(22) - C(21) - C(26) - C(25) -2.7(4) 
B(1) - C(21) - C(26) - C(25) 174.3(3) 
C(22) - C(21) - C(26) - C(27) 177.2(3) 
B(1) - C(21) - C(26) - C(27) -5.7(4) 
O(3) - N(1) - C(27) - C(26) 0.4(4) 
C(28) - N(1) - C(27) - C(26) -174.0(3) 
C(25) - C(26) - C(27) - N(1) 173.5(3) 
C(21) - C(26) - C(27) - N(1) -6.5(4) 
C(27) - N(1) - C(28) - C(35) 110.2(3) 
O(3) - N(1) - C(28) - C(35) -64.8(3) 
C(27) - N(1) - C(28) - C(29) -122.2(3) 
O(3) - N(1) - C(28) - C(29) 62.8(3) 
N(1) - C(28) - C(29) - C(30) 75.3(3) 
C(35) - C(28) - C(29) - C(30) -160.9(3) 
N(1) - C(28) - C(29) - C(34) -106.3(3) 
C(35) - C(28) - C(29) - C(34) 17.5(4) 
C(34) - C(29) - C(30) - C(31) -2.2(4) 
C(28) - C(29) - C(30) - C(31) 176.3(3) 
C(29) - C(30) - C(31) - C(32) 0.8(4) 
C(30) - C(31) - C(32) - C(33) -0.1(5) 
C(30) - C(31) - C(32) - Cl(1) 179.9(2) 
C(31) - C(32) - C(33) - C(34) 0.9(5) 
Cl(1) - C(32) - C(33) - C(34) -179.2(3) 
C(32) - C(33) - C(34) - C(29) -2.3(5) 
C(30) - C(29) - C(34) - C(33) 2.9(4) 
C(28) - C(29) - C(34) - C(33) -175.5(3) 
C(20) - O(2) - B(1) - O(1) -30.8(3) 
C(20) - O(2) - B(1) - O(3) -148.1(2) 
C(20) - O(2) - B(1) - C(21) 92.9(3) 
C(1) - O(1) - B(1) - O(2) -51.8(3) 
C(1) - O(1) - B(1) - O(3) 59.6(3) 
C(1) - O(1) - B(1) - C(21) 178.9(2) 
N(1) - O(3) - B(1) - O(2) -150.4(2) 





N(1) - O(3) - B(1) - C(21) -26.7(3) 
C(22) - C(21) - B(1) - O(2) -49.1(4) 
C(26) - C(21) - B(1) - O(2) 134.2(3) 
C(22) - C(21) - B(1) - O(1) 78.3(3) 
C(26) - C(21) - B(1) - O(1) -98.5(3) 
C(22) - C(21) - B(1) - O(3) -162.5(3) 
C(26) - C(21) - B(1) - O(3) 20.7(3) 
                                                                                                                         
                                                                                                                         
Symmetry transformations used to generate equivalent atoms: 
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